var title_f37_45_38608="Fluorouracil: Patient drug information";
var content_f37_45_38608=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Fluorouracil: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804635\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?11/24/11653?source=see_link\">",
"       Fluorouracil (systemic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/27/41396?source=see_link\">",
"       Fluorouracil (topical): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12484 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-481E12C6DB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38608=[""].join("\n");
var outline_f37_45_38608=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?11/24/11653?source=related_link\">",
"      Fluorouracil (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/27/41396?source=related_link\">",
"      Fluorouracil (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_45_38609="Patient information: Developmental dysplasia of the hip (The Basics)";
var content_f37_45_38609=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83525\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/48/3841\">",
"         Hip",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/0/27663\">",
"          Pavlik harness",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?30/31/31218\">",
"         Patient information: Newborn appearance (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Developmental dysplasia of the hip (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/developmental-dysplasia-of-the-hip-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H265788860\">",
"      <span class=\"h1\">",
"       What is developmental dysplasia of the hip?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Developmental dysplasia of the hip is a condition that causes hip joint problems, mostly in babies and children. The hip joint is a &ldquo;ball and socket&rdquo; joint. It&rsquo;s called that because the top of the thigh bone is ball-shaped and fits into part of the pelvic bone (",
"      <a class=\"graphic graphic_figure graphicRef82793 \" href=\"mobipreview.htm?3/48/3841\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      In developmental dysplasia of the hip, the &ldquo;socket&rdquo; part of the joint doesn&rsquo;t form normally. Because of this, the hip joint is too loose. The &ldquo;ball&rdquo; part can slip out of the joint too easily. If it slips completely out of the joint, doctors call it &ldquo;dislocation.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H265788875\">",
"      <span class=\"h1\">",
"       What are the symptoms of developmental dysplasia of the hip?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Developmental dysplasia of the hip usually causes no symptoms in babies. People usually find out their baby has it during a routine exam. All babies are checked for developmental dysplasia of the hip after birth. Plus, doctors and nurses check for this condition at every routine visit until a child is walking.",
"     </p>",
"     <p>",
"      Sometimes, people find out their child has developmental dysplasia of the hip when their child has an X-ray of the hip done for another reason.",
"     </p>",
"     <p>",
"      In toddlers and older children, development dysplasia of the hip can cause symptoms. It can make 1 leg look shorter or turned away from the body. It can also cause a child to limp or walk in an uneven way.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H265788890\">",
"      <span class=\"h1\">",
"       Is there a test for developmental dysplasia of the hip?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The doctor or nurse will check for this condition by moving your baby&rsquo;s legs around in the hip joint. He or she will also check to make sure that both legs look the same, and that 1 leg does not seem shorter than the other.",
"     </p>",
"     <p>",
"      The doctor or nurse might also order an X-ray or imaging test. The test done most often to check for developmental dysplasia of the hip is an imaging test called an ultrasound. Imaging tests create pictures of the inside of the body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H265788905\">",
"      <span class=\"h1\">",
"       How is developmental dysplasia of the hip treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends mostly on your child&rsquo;s age.",
"     </p>",
"     <p>",
"      Babies younger than 2 weeks old aren&rsquo;t always treated right away. That&rsquo;s because a loose hip joint can be normal in newborn babies. It sometimes gets better on its own. If your baby has a loose hip, the doctor or nurse will keep checking it to see if the condition goes away or lasts.",
"     </p>",
"     <p>",
"      Treatment for babies ages 2 weeks to 6 months usually involves wearing a device to hold the hip joint in place so that the bones can grow normally. The device most often used is called a &ldquo;Pavlik harness&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef83482 \" href=\"mobipreview.htm?27/0/27663\">",
"       figure 2",
"      </a>",
"      ). Babies usually need to wear this for 2 to 3 months.",
"     </p>",
"     <p>",
"      Treatment for babies and children older than 6 months usually involves a procedure or surgery to put the hip joint bones back in the correct position. Then your child will need to wear a cast for 3 to 4 months to keep the hip joint in place.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H265788920\">",
"      <span class=\"h1\">",
"       Does developmental dysplasia of the hip cause long-term problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;This depends on different factors, including how old your child was when the condition was found and how severe it was. Many babies with this condition have no long-term hip problems.",
"     </p>",
"     <p>",
"      Some children, especially those who were found to have the condition later in childhood, have hip joint pain or damage later on.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H265788935\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/31/31218?source=see_link\">",
"       Patient information: Newborn appearance (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/45/38609?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83525 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-47BF19C4B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38609=[""].join("\n");
var outline_f37_45_38609=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H265788860\">",
"      What is developmental dysplasia of the hip?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H265788875\">",
"      What are the symptoms of developmental dysplasia of the hip?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H265788890\">",
"      Is there a test for developmental dysplasia of the hip?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H265788905\">",
"      How is developmental dysplasia of the hip treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H265788920\">",
"      Does developmental dysplasia of the hip cause long-term problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H265788935\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83525\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/48/3841\">",
"      Hip",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/0/27663\">",
"       Pavlik harness",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/31/31218?source=related_link\">",
"      Patient information: Newborn appearance (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_45_38610="Human papillomavirus (HPV) vaccine";
var content_f37_45_38610=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/45/38610/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38610/contributors\" id=\"au2927\">",
"       Philip E Castle, PhD, MPH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/45/38610/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38610/contributors\" id=\"se636\">",
"       Martin S Hirsch, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/45/38610/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38610/contributors\" id=\"de8449\">",
"       Allyson Bloom, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/45/38610?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HPV VACCINE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Human papillomavirus is a virus that causes cervical cancer and genital warts. Persistent infection with certain types of HPV can lead to cancer of the cervix, which affects more than 10,000 American women every year. HPV can also cause cancers of the vulva, vagina, and anus, although these cancers are much less common than cervical cancer. HPV also causes cancers of the head and neck in men and women.",
"    </p>",
"    <p>",
"     Two vaccines (Gardasil and Cervarix) are available to prevent infection with several types of HPV known to cause cervical cancer. It is hoped that these vaccines will significantly reduce the number of women who develop cervical cancer and pre-cancer.",
"    </p>",
"    <p>",
"     This article discusses human papillomavirus and the human papillomavirus vaccine. Articles that discuss cervical cancer, cervical cancer screening (Pap smears), and genital warts are also available. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/4/15429?source=see_link\">",
"      \"Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/53/8019?source=see_link\">",
"      \"Patient information: Cervical cancer screening (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/60/4035?source=see_link\">",
"      \"Patient information: Genital warts in women (Beyond the Basics)\"",
"     </a>",
"     .) An article that discusses vaccines recommended for adults is also available. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/25/39318?source=see_link\">",
"      \"Patient information: Adult vaccines (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     More detailed information about human papillomavirus vaccines is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/17/19738?source=see_link\">",
"      \"Recommendations for the use of human papillomavirus vaccines\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHAT IS HPV?",
"     </span>",
"    </p>",
"    <p>",
"     Human papillomavirus (HPV) is a virus that is spread by skin-to-skin contact, including sexual intercourse, oral sex, anal sex, or any other contact involving the genital area (eg, hand to genital contact). Condoms do not provide complete protection from HPV infection because condoms do not cover all exposed genital skin. People do not become infected with HPV by touching an object, such as a toilet seat.",
"    </p>",
"    <p>",
"     The risk of HPV exposure increases with the number of sexual partners you have and the number of partners your partner has. It has been estimated that 75 to 80 percent of sexually active adults will acquire HPV infection before the age of 50. A majority of women and men become infected with HPV for the first time between ages 15 and 25 years. Most people who are infected with HPV have no signs or symptoms and clear the infection within two years, often without treatment.",
"    </p>",
"    <p>",
"     In 10 to 20 percent of women, however, the infection persists. In this situation, there is a greater chance of developing cervical pre-cancer and then cancer. However, it usually takes at least 20 years for HPV infection to cause cervical cancer. Thus, regular testing is important in detecting cervical abnormalities early, before cancer develops. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/53/8019?source=see_link\">",
"      \"Patient information: Cervical cancer screening (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Over 100 different types of HPV have been identified; more than 40 of these are known to infect the cervix and approximately 15 are known to cause cervical cancer. Researchers have labeled the HPV types as being high or low risk for causing cervical cancer.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       HPV types 6 and 11 can cause about 90 percent of genital warts. These types are low-risk because they do not cause cervical cancer. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/60/4035?source=see_link\">",
"        \"Patient information: Genital warts in women (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Types 16 and 18 are the high-risk types that cause most (about 70 percent) cases of cervical cancer. HPV types 45 and 31 are also high-risk types, causing about 5 to 10 percent of cervical cancers.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     There are two HPV vaccines available. Talk to your healthcare provider to determine which vaccine is best for you.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       One HPV vaccine (Gardasil) helps to prevent infection with four HPV types (6, 11, 16, and 18)",
"      </li>",
"      <li>",
"       The other vaccine (Cervarix) prevents infection with HPV types 16 and 18, and it may offer some protection against HPV types 45 and 31.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      HPV VACCINE TIMING AND DOSE",
"     </span>",
"    </p>",
"    <p>",
"     Gardasil is given by injection and requires three doses; the first injection is followed by a second and third dose two and six months later, respectively.",
"    </p>",
"    <p>",
"     Cervarix is also given by injection and requires three doses, although the schedule is slightly different than with Gardasil; the first injection is followed by a second and third dose one and six months later, respectively.",
"    </p>",
"    <p>",
"     It is not clear if the vaccine is effective if fewer than three doses are given. If you miss a dose, talk to your healthcare provider about how many more doses you need.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Who should be vaccinated?",
"     </span>",
"     &nbsp;&mdash;&nbsp;In the United States, HPV vaccination with either vaccine is recommended for all girls and women who are between ages 9 and 26 years. Vaccination with Gardasil is recommended for boys and men who are between ages 9 and 21 years and can be given up to 26 years of age. &nbsp;",
"    </p>",
"    <p>",
"     With both vaccines, you will have the greatest protection from HPV if you are vaccinated BEFORE becoming sexually active. The vaccine does not help to get rid of HPV infection or any cervical abnormality after it has occurred. However, if you are less than 26 years old and you have been sexually active, had genital warts, a positive HPV test, or an abnormal Pap smear, you may still obtain some (albeit less) benefit from the HPV vaccine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      How long am I protected?",
"     </span>",
"     &nbsp;&mdash;&nbsp;Scientists do not know exactly how long the vaccine protects against HPV infection. Clinical trials show that it provides protection for at least five years.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Do I still need a Pap smear?",
"     </span>",
"     &nbsp;&mdash;&nbsp;You do not need to have a pelvic exam or test for cervical cancer (eg, Pap smear) before you have the HPV vaccine. Cervical cancer screening (Pap smear) is recommended to start at age 21 [",
"     <a class=\"abstract\" href=\"mobipreview.htm?37/45/38610/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     However, getting the HPV vaccine does not mean that you can skip cervical cancer screening in the future, since the vaccine does not treat pre-existing infections. Other types of high-risk HPV, which are not prevented by the vaccine, can also cause cervical cancer. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/53/8019?source=see_link\">",
"      \"Patient information: Cervical cancer screening (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      HPV VACCINE SIDE EFFECTS AND PRECAUTIONS",
"     </span>",
"    </p>",
"    <p>",
"     The HPV vaccine may cause mild redness, tenderness, or swelling near the injection site. There is no thimerosal (a mercury derivative used as a preservative) in the HPV vaccine. There may be an increased risk of passing out or developing blood clots after an injection of Gardasil. However, there are no known long-term side effects of the HPV vaccine.",
"    </p>",
"    <p>",
"     The vaccine is not currently recommended during pregnancy, although there are no known risks to a fetus if the vaccine is given.",
"    </p>",
"    <p>",
"     Despite recent concerns about the safety of the vaccine, most experts continue to believe that the benefits of the vaccine outweigh its risks [",
"     <a class=\"abstract\" href=\"mobipreview.htm?37/45/38610/abstract/2\">",
"      2",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      DOES THE VACCINE REALLY WORK?",
"     </span>",
"    </p>",
"    <p>",
"     Results from vaccine studies show that the HPV vaccine in women is very effective in preventing HPV infections and cervical pre-cancers caused by HPV [",
"     <a class=\"abstract\" href=\"mobipreview.htm?37/45/38610/abstract/3-6\">",
"      3-6",
"     </a>",
"     ]. HPV vaccination of women may also reduce the risk of genital warts in their male sexual partners. Studies also show that the HPV vaccine in men reduces the risk of developing genital warts and persistent HPV infection, which may decrease the spread of HPV to sexual partners.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      OTHER SEXUALLY TRANSMITTED INFECTIONS",
"     </span>",
"    </p>",
"    <p>",
"     The HPV vaccine is not perfect, meaning that some women will acquire an HPV infection despite having being vaccinated. In addition, the vaccine does not prevent other sexually transmitted infections (STIs), including human immunodeficiency virus (HIV), herpes, chlamydia, and gonorrhea.",
"    </p>",
"    <p>",
"     It is important to practice safer sex to reduce the risk of all STIs. This includes using a male or female condom with every sexual act. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/2/22563?source=see_link\">",
"      \"Patient information: Barrier methods of birth control (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784952784\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3053333719\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/22/5475?source=see_link\">",
"      Patient information: Human papillomavirus (HPV) vaccine (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/48/12035?source=see_link\">",
"      Patient information: Vaccines (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/32/28163?source=see_link\">",
"      Patient information: Cervical cancer (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/4/23619?source=see_link\">",
"      Patient information: Vaccines for adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/57/1940?source=see_link\">",
"      Patient information: Screening for sexually transmitted diseases (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/44/4803?source=see_link\">",
"      Patient information: Urethritis (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3053333784\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/4/15429?source=see_link\">",
"      Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/53/8019?source=see_link\">",
"      Patient information: Cervical cancer screening (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/60/4035?source=see_link\">",
"      Patient information: Genital warts in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/25/39318?source=see_link\">",
"      Patient information: Adult vaccines (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/2/22563?source=see_link\">",
"      Patient information: Barrier methods of birth control (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/33/1562?source=see_link\">",
"      Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link\">",
"      Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31065?source=see_link\">",
"      Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=see_link\">",
"      Cervical intraepithelial neoplasia: Management",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/10/13480?source=see_link\">",
"      Clinical trials of human papillomavirus vaccines",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23144?source=see_link\">",
"      Condylomata acuminata (anogenital warts)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/6/21610?source=see_link\">",
"      Epidemiology of human papillomavirus infections",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28537?source=see_link\">",
"      Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/17/19738?source=see_link\">",
"      Recommendations for the use of human papillomavirus vaccines",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/34/27178?source=see_link\">",
"      Treatment of vulvar and vaginal warts",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26455?source=see_link\">",
"      Virology of human papillomavirus infections and the link to cancer",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Cancer Institute",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nci.nih.gov/cancertopics/factsheet/prevention/HPV-vaccine\">",
"      www.nci.nih.gov/cancertopics/factsheet/prevention/HPV-vaccine",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National HPV and Cervical Cancer Public Education Campaign",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Telephone: 1-866-280-6605",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cervicalcancercampaign.org/\">",
"      www.cervicalcancercampaign.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Center for Disease Control and Prevention",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/std/hpv/STDFact-HPV-vaccine-young-women.htm\">",
"      www.cdc.gov/std/hpv/STDFact-HPV-vaccine-young-women.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Social Health Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ashastd.org/\">",
"      www.ashastd.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?37/45/38610/abstract/2-7\">",
"      2-7",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 27, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/45/38610?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38610/abstract/1\">",
"      Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62:147.",
"     </a>",
"    </li>",
"    <li>",
"     www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm179549.htm (Accessed on October 14, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38610/abstract/3\">",
"      Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38610/abstract/4\">",
"      Villa LL, Costa RL, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006; 95:1459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38610/abstract/5\">",
"      Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369:2161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38610/abstract/6\">",
"      Olsson SE, Villa LL, Costa RL, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. Vaccine 2007; 25:4931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38610/abstract/7\">",
"      Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007; 369:1693.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f37_45_38610=[""].join("\n");
var outline_f37_45_38610=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HPV VACCINE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHAT IS HPV?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           HPV VACCINE TIMING AND DOSE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           HPV VACCINE SIDE EFFECTS AND PRECAUTIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           DOES THE VACCINE REALLY WORK?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           OTHER SEXUALLY TRANSMITTED INFECTIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f37_45_38611="Ileal necrosis closed loop";
var content_f37_45_38611=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 578px\">",
"   <div class=\"ttl\">",
"    Ileal necrosis secondary to internal hernia with closed loop obstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 558px; height: 377px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF5Ai4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5Uop8UbyyJHEpeRyFVVGSSegFfUvxL8D6ZF8Hp/DtgNGfW/Clpb3032a4je6kY7vtXmIDuVBvVhn29qAPleivRvhlomiaxGBq1j57mUpuErr2yPusK9Du/h/4Tt/uaKjuRkK9zPj9HFAHztRWp4jhht9evobe3SCJJWVY1ZmCjPTLEn8zWbx/dFADaKdx/dFHH90UANop3H90Ucf3RQA2incf3RRx/dFADaKdx/dFPidElRniWRVYEoSQGHpwc0ARUV9eeEfhv8L/ABT4YsNX07w+rLPGDIv265/dv/Ep/edc10CfBH4dAqH8Oj5u/wBuueP/ACJQB8R0V9yt8DvhoVyvh7oP+f65/wDjlMHwO+GwyD4d5Az/AMf1z/8AHKAPh2ivtL/hTnw3MbH/AIR8Bs4GL645/wDIlc74j+Evgu1INpofljHa7nOT+L0AfJ9FfTtr8MfB+6N5NF3oPvJ9pnBI/wC+66dPhB8P5oBNFoHynjb9suOD/wB/KAPjuivsy3+DXw/ZgH8P9e/2y44/8iVYb4I/D9sqPD+0kcH7bcfn/rKAPiuivrG7+EHg+3Dh9DPynGRdT4P/AI/Xm3xi8F+HvDvhm3u9I077NcPPsLedI+VxnozEUAeL0U7j+6KOP7ooAbRTuP7oo4/uigBtFesfAbwjovix/FA1qzF1JY6ebi2j854/mGcn5WGenfjmvWdT+FHgc/DXS9bt9Ba3vJwDIWu5yTwexfH5UAfJ1Fa3ia3trTXr23s4wkEblVXcTj8Sc17Z+zvAW+H3jS5toLpr2K5sxHJZaSmpTqCX3BYnBBBHU9hz2oA+faK9Q/aO06DTvirqH2W0s7SC5hguEt7dPLMe6MZEiDAWQkEkD1968xyP7ooAbRTsj+6KMj+6KAG0U7I/uijI/uigBtFOyP7ooyP7ooAbRTsj+6KMj+6KAG0U7I/uijI/uigBtFOyP7ooyP7ooAbRTsj+6KMj+6KAG0U7I/uijI/uigBtFOyP7ooyP7ooAbRTsj+6KMj+6KAG0U7I/uijI/uigBtFOyP7ooyP7ooAbRTsj+6KMj+6KAG0U7I/uijI/uigBtFOyP7ooyP7ooAbRTsj+6KMj+6KAG0U5sYHGKbQA5HaN1eNirqcqynBB9RVr+0L0TTTC7uPOnQpLJ5rbpFPUMc8g4HBqnTuwoA9I+EfzNIv924Rv0r2q6VRC7kjI55rw74QyAalNGeQXQ/zr6m8LeH9Pg0SXXvFL7bHO2OInAbnGTQB8aeONv8AwluqbehnY8Vh16H8f9DtvD/xT1e0sD/or7LiMf3Q6BsfhmvPBycDk0AKrMudpI3DBpteufDf4L6l4jjjvtbd9O05huVMfvZB7Z6D6/lXvPhr4deFvDaKLLTIXnH/AC2nHmSfmen4YoA+O7LQ9VvlBs9NvZ1P8UcLMPzxWg/gvxLHAZn0S+EYGSTEf5da+3kgiHCRICOOnWpNqsGBjX8sg0AfAlzZXdqM3NrPCPWSMr/Oq9felzptldwtHPZQMh6jYK838XfBrQdZ3yWMIsbg5O+345916H9KAPlSiu88W/C/XPDxmkCrdWsf8acNj3WuNt9PuriQRxwsGJwAwxQB33wT+IE3g7X1trmRjo94wWZOvlt0Dj+vtX2BomsRXQjUESbzwQe3avkT4c/DO51rVwdXKwWsWCUDZZz6V7dJo2reGis2nOXhhGQnrQB7RFt8+WLBynY+9NvmWO0lkdcEDgetcT4H8ewajeeXfxiG78vDBvXNdxeRLeKmxgMnPByKAOOsYbi4vt2/5v7voKu61Z7rctJztGDWz9hW2u96njGce9SXUS3MEg/vDHTp70Acbptqjwygrl1PY9a17CDyMqv3T1zWbCX0m82TIcNw59R611Nm9vMoCgFTyD3oAjihU5ZFwOn0rQtUA4kBIPT2piOinCcD86r3GoKFdX+WMdWJxQBn63CiQSs4GzkAE8mvmj9pLVI1XSNHjbLqGuJBnpngD8hXuviHV4DCzPMEtYQXd29BXxx4816TxJ4qv9Rc5R32xj0QcAflQBz9FFFABRRRQB2Xwi8V3fg/x1p+oWeHR28i4hYZEsTdVP6H8K+jvHXjiPVbO2sYbMWNmvMUa9Cfevl7wFam78WafGF3YfcR9BXufiy2J0dG2ANCWOR9DQB89azKZ9WvZT/FIx/Wm2Op3+nhxYXt1bB8FhDKybsdM4PNV3JMkhJyST/OmUAPmlknleWaR5JHOWdySWPqSaZRRQAUUUUAFFFFABRRSojSMFRWZj0CjJoASitqx8MapdsAbZ4VPeUFc/Qda7bQPhm9wQ1ydwB5LHgf8BHNAHmEaPIwWNGYnsozWvaeGtUuQjC2MatwDJx+nX9K900/wnpGlRhmCtjsBsU/Xua6KytIFjMlpbp5eDl0XgY9TQB4Ta/DnU5V3OX+iRHn8TitmL4VSkIGebcRk5dVGfToa9kdlDeXvyyjcVzyKcpVmBH3j0zQB5JH8KBs+eT5v+unH8qnHwpthne46Z4kP+Feplfug9DVS9vLayhL3MyKB2PXFAHnP/CrNPijaSeZhGoLMQ54Aqvb/DGwvbRLmxufOhf7rLJwf0qx418c2DWElpE8oMvDBByVqh4M+IGl6TD9inW4W1ByhZc7T+B6UAJN8J5NrNHNIfQb1/wrJvPhnqEMZZHc47GPOfxB/pXtNhfWuoxJc2NzFcIwzmNs4H9KuKuWIOcHtQB82Xng/WLYEiASqP7pwfyOKw7i2ntmxcQyRn/aUivq5o45kxLGpTp8wzWZf+HdOuw26FEJ4xjK/keKAPl6lr2LX/hbG7F9PYY/2Pl/Q8V5/rHhDVdMY74TIvsMN+X+FAHO0UrqyOVdSrDqGGCKSgAooooAKKKKACiiigAooooAD90U2nH7optABTuwptO7CgDufhHOkevzI5A3Rhhn2P8A9evruK3l8Z+BrHSLK6toZ7W5ja4SYZDxKcnjvxXxd4Adk8SRBDgvG69PbP8ASvoeBp4PDsssMsn2j7JId2ccFDQB4x8dtai8T/FjV7jTcSwiRLSEx8iTy1CAj64r1b4O/B5dHWLWfFEUct86hobRgGWL3Pq38q5f9m3wUura1c+I9Qj3W9ixW3DDIaX+9+FfTLkvt3NhgKAIsdBgKAOwpGyOeoI9KcRgAg8eg60A7jgkke3rQAz7uC3GRwBTN5AJ5I6H2oXD5JfgHge1DblPXGe3pQAI/ll9wJLcDFREgHPQ56U4y/O2Rhe3t70wyLkNknPYDrQBS1K2hu4JI7hC6upWvFtf0WKHUyr2isqnAbBBr2+9KvEzEsB0xXBLaXOt60yQZMcTbWbHagB3gLQprdPO+dVfHB9K9Zt7RJoFidN6kc7h1rmhp81rbqiyN8mCSvGRWrF4tsrS32yysJUGAgXLGgDzz4j+GRpl5FeadL9mmkJw2eCfQntWTpfxC1fRYkOpRgR525fv9MdRXceKb6TxGYxb2+II1PEo5YmvKNY8PaddyTRmea1uY2wIHbKj6e1AHsWk/EjTNRsxvkXzCOPrWjb+J7GR/LLqh65Lda+brLw9qVrdSRWjeZuPylTnGa6rTPBmrzndfXyxfMPlViTQB6h4i1y0uvKhQYmkbCMBmse81u68NTww3EqvHIPk3tj9ap6X4Xt7VFWW7uZCpyobsfUVavfDAvZ1muJmu2XGPO5xQBq2XixrmEYKhx1O7rVDUdYd/lmdmz0Re9OtvDlvHM8ssjBW/gUYwa1ktbS2TbHChlC5B6nFAHC6to2qeJ4TbZa2s2OMKMEj3rnL39n2xkj3x6xJbSdxtDqa9v0+KW8+WFdmTgnFb9notvC6tOplfOcHpQB8syfs76pO5GmaskwAyDJblc/iCa4PxX8LfFXhrc95p7Twr1kt8vj6jr+lffYIQDy1CDpgDFNmW3u4glxHG6cg7hzQB+ZzAqSrAgjqD2or7D+M3wStPEFlLqXh4CHUo1L7duPMHof8a+Qr60nsbuW1u4miniYo6MMEEUAd98C9Evtb8a7NMhaWWGBnIHYcCvVvHZnsNEvYruMxTRqysrcHOKxf2dtQh8L+BvFPiQJuulure1zjOE+9x+dd3+06bcWCX6lVlubIMw7nPA4oA+RepakoXofpRQAUUUUAFFFABJAAJJ6AUAFS2ttPdyiO2iaRz2UV1XhvwNqGqyp9oR4UYZC4+Yj39Pxr2Hw14RsdDgRfKikm6kkfL/8Ar+tAHnHhb4Z3F40c2rM8duedqcZ/GvTNM8LaJoyD7LbR7uBuPJP19atvqEkty6WzbLeL5Wcc7j6Y9Ko3krZYxDDjqQf5UALezW6zAM3mLniNAAFqsmoS2fnm0RI1A3ISec+5rPWGTzt27bwTgdD/APXqt9mE1kn28ebINwwf7vofegDYj1O9naJ5UijiK5kjPznd7GrA1WXyhE5ZUbsrcH3rnHv1tbZY47eVIVjySF+VcdvrS6ddy3EmZYWjA5ifnaV9/egDpzex5HmGQ7up9aieeGQsWMq4/i/vfSs1swRszFnUc4zzz2pouFyy7yEU4yw4BPagCzqF1cXFu8mm3RKxrtZDwwPrXJ69qcVtbWzuyXV0WJYzS4KqB1x3xXS2x+zyM0rK2/5ZWBwPavPviLp72PiGF4lDxXEe1fNX5Qc9B70AYXizT703y3rxSPFd/NGQhx9KybrTL+0iWS6srmGNhkNJEyg/iRXvcmrpB4Zsl1S2Wwkt4AYzJhl3AcMB3ryXUvHGr3OjTaP9qMtlIx3u4y0mT+lAHOaff3enTrNY3EsEgOco2Pzr1j/hZTWdlCL2FvtqQqzJwUnJ7hh04rx016x4cudH8UeBF0ExJDq9qh8t3UFpOSeG6456UAadj8XdLlIW9066tx/fjYP+nFbtr8SPC05/4/JkbsJIiv618/31pNY3UltcoySxnBBFQUAfWFleWt5p/wBsguYHgbBU+ap5Jx2rF1TxFpiu9reWpnOdvQEE+xrwTwlrZ0TUhLIpktnGJI+oPoce1eg4N3bvqFg6yLJ8yqT0oAvT6JofiG5eP5Y2zgK2dyn69a4/xP8ADnUtK3S2oM8I5x3x9atC8nVZELHzSco6dj9a73wr4lcxw6drPlea6gpLu3Aj0PvQB8/yI8blJFKOOCGGCKSvoHxl4HtNbheWCNI7kcqRgE/T29q8T1zQb3R5mW4QtGDgSAfzHagDKooooAKKKKACiiigAP3RTacfuim0AFO7Cm07sKAOh8BBj4mtynVVc/oa+mbNHS2hZgoR4wCO3Svm74b8eJAeMiFuv4CvrPSPCuoar4dW9s2hQjISF+smBzigDT8I2dtY6RFHbRJDFktsRAo/StmbyQe5Y9sVS0OMppduGIRx8pXFWZR83Xaw4PHWgBy3KrE0XkxEP1JPIqqBxkbwo7dahnTbIzseParh82W3itbRosNgyyN96gCoCpbCnBNSDlSDu2qcnisvzGtdcewkAwF3I571dMzsrRoxwTzjoKAHyDDNIzKEPAI9KYZTCDxngYxTJFVosMMANhielJv+QE/Mg6kDn2oAZcz74pItxBkXaMev+NXtBsIdOtSqIoY/ePfNU4gZ5QuwApwXI71oS5ZkQEL74oAbMzPKflzGOnNYYjVbi4k8nLlsBsA5+lbUwf6IfTvWNGzAyNknc3GaAJI1fBccY68CvOvG8Xm68jxcHG1lxjNejRxhWwf4hkAHqfeuG8VIU1LzSwXjqD1oA5/Tnm0+/E/myMjHgbuAK7aLxTp8jFJmaKXb025zWFotqtzdyfalMo25WMfxAdR9a0dS8O4uRNYgSoEDYIydp9PWgDbGrW7KJIJt64GVK4NXLG9ubqRTaIQjfKSUPH403wr4ftrm1a6iRmQnDF+OfcV3MUMdvCI4o1SMLnaOMmgDEs9EuJ+bmZSV7AdauR6bHFcFSh4xhga1FXKFmO0npzzQIjnMj4GPvdeKAJrYRW4VAhZe2DT0m/fDb09M/pTAXS3Crgn+8R2+tORD1wDt4z2NAFlJPNfDsnv61IVjBGCwB6Gqir15Pr71ImwrkswbPQjNAF+AKf7xz6nOfavmn9qn4bIsKeKNJhw6jF0ir1H978K+j4s7gSAdp4GcU7WdPg1nRLywu4g8MqMpU8545oA+O/2Z/EFnaTa7out2JvtKu445zH6SKePz4/Kr/wC0Fqk1/HPdXB2mTZFHGpwsag8L+QrS8J+Ah4RvtVkW5EzzSbYsLjYgPQ+9cX8crsEQW2Bu8zJIPoP/AK9AHkY6H6UUDofpRQAUUV3/AMJ/A7+K9es4JkzFNJtVc4/4EfYUAc/4b8K6hrjq0arb2pODPLwv4dyfpXrHg7wRpunTeYgaeRBzPIgLZ/2R0A/Wvqbw38O/Dei2EdmbOK6nVRukmALH6DsPpXn/AI18NR6NrMiQAR28wym0Y49KAOSjNpHILe1VY5G5ZVHX3rN1e7EUZt1ILE/MVOCuf51c1SR9NsZRp9oZJ8ZBHPHvXJ+Hnd4vMuT+9ZmZmbr9PegDfSJYbZI1ZAFXKlejfUetEsSSAl1Q4HJB71qeHtNi8ReI7fTkvYLPzlJVpoycn+6BxkkZxyOlew23gLwx4bsZNQ1hzcpbrueW6b5FHso6+mDmgD57uLKVE8xUZ4QcHI6N7GqM0M1y/wAkbKhHKY5zXbeLfGcPiDUFWCL7Lp1upFtAgCqq+uBxk98fSsNJUlRZLaUlDzgrigDDWC4jtQi/vHZuQwwR7/hT7Gze3iETXBnYE/O55/Or832lZSfkYZzyMH6UxroLuMkIEncI3OPWgChfWoZWOwkjgNnocfrXN6TDqtlfH7QyyaeykbHAJXHTkV3COkkO+baFPABPJH+NVJNLge5a4hk+ZgFKFjjA9qAKDiO+heOeE7c4KuuM4rC8eJp95e6fpgK/b50Cl/mPlLnjHPtXa29iryL84kVT0HIHsa5We0vIviNFe2dmJIE+R2aNmAXHqRj6YoAsNoMupeHfsN88sq2a7VllbmTuMeoFeOatYyadqE1tMMMh4+navoHxE1zp2lLNbQ/arrczkSE/KD2HavD/ABHJNq19LfrAytgLLH3QgY/KgDDqewu5rC8iurZyk0TBlIqCigD2Zzo/jLwrJqNzp002pQISY7U7Xdv6143NG8UrxyI0bqcFHGCPY123w58WRaC0sE6ENID5M2chHxxkema5LV5rufU7mXUXd7t3LSM/Un1oAp16N8MYbjULea3VWdIzwAOma8/tbaa7mWG2jaSRjgBRXptnbz+HfAr2trdJFqmoXSQgq2GA74/lQB0knhL7TIUd4YLpMkIGxurjL5JbDUwssRhkjbBB5z9K52bVdZ0jUUivJn862ONrPknnoT3ruL6cav4Vs9WeIh95UrxnPt7UAeracUuNPtJwwUugJxyenrUOs6Pa6rCwMKCYjiQrkke9VfDf2mHw1aLLC7ME6oM4HqTXUeHrC4v54beWVfNmYKEQY4zQB5jqHwD1rUoEudIsSm8FtyH5D/wE/wBDXlninwPr3hi6lg1SxkQx8sQDwPXFfpNawJbWsUEY+SNAg+gFeefHLRbHUvC3nzhEvYmAhkx8xB6r7jFAH57UV1/j/wAOf2VetPaxkW5Pzr/cPr9DXIUAFFFFAAfuim04/dFNoAKd2FNp3YUAdb8MlDeIXLAECE8E4/iFfafgS3uNQ0HRhZzRoNOvGeZc9Yyp/wAa+LPhk2PEEo27swE4/wCBLX0rpmp3mnwH7LJLB5iYcIeGFAHot0Ihe3P2U/ufNbaRznmopmMkm5QCRxnNM0AI+lxFX4K5OfWlkAQElh6HigCKQ7s72wc98kUyYXMKtLYyRCcDHzcg+1ShlBJHK46etNkRXcsF2hQMigDPtRJc3hnvkRZ9uCM9/Y1NJIQCHQHPqacyOCoI+me9RTTJHEZWCoseSxagB1xIFmVNhdiuSoOc/hUEE6ravJjylTqDTtL1S2uJJriDDFVwDjH86zNcRp0tLSGQRyXUgL7Txtzk80Ab2nxmO1VmwZJDuJByOas7nUHcwXbxyOtRNb+WVjGeMYOeDipnCspHUsM4IzQBVuZWSNvL2DAyfasqGMxrlVUnrwa2p44zGTHjJQ5IHSsONdsWAzlh6Dn8KALqKcoRuVmOenSuZ8fpFBo08pXLlgckZFdLH5hQNnIx8xUcge9cX8Rrn/iVtCrDbIRg/TrQBh+Db17WWK/lCvFFMA5JPfrXuHizTPJ02w1nR42aKPHmpGOTG3f8M1866Bej+zNTsdzeYB5seT3+lfQ/wR8TL4i8KfZbjHn237tlbqV7GgB1jbCy8wQyHyZvnKOOhNabyYjQsFdv4eMcU7UYHs7l4nbK/wAA9qiDEqoUAkcAYNAEh8zJBCKWGRikeL7QwYP69/6UsuxdjI+B0Iz0NRMSuduQxOMpQBZihRYhsYmTup7UmWZ+4X+In0pqlnJ4AK9SOP1p0caEtvbgjjGTQBM0iiIKJFfnnC4NTQRmSItHsO3qCap7VBVRh36AEYq3C3GJNgOMYFAFq0V/MDSbOBwPWrke8yFnBA5B29AKzgwVwNylF+Y+9P1XUPsWn3Fw247EJAzjNAHiutyb9ZvkjUHZKa8A+Nr51WBSADuYnB+lfW0ml6WNDvoJ0Daz9mF7I+eV3HgV8dfGKYS+I49pONhOPQ5NAHBjv9KKB3ooAt6TZNf6hFbrnaTliB0Xua+ovg5bW3h67sL+dAmGH/AU6AV4b8PdLMjQyFGLXT7AQM4QdTXv0KxwQLsdtgG0Ejpj1FAH0rG0cqrMhDBhlWHcGuf8eaT/AGpocnlrmaH514yfcVR+GWt/2no32aRw09t8v/Ae1dkRkYPSgD5r1ENBC80UcU0qKdu7IP4jvXKeCtJ1vxVqVxHa20SRRsWuJXXy4YB6k9uPTmvV/GmmW2j+KV+1Qu+n3DCQhDtYjPIBrjfiHq97qenx2GlL/Z+ixtxZ2vyBvdz/ABHv+tAGpNq+k+Frd7fwkY77WsFW1OaPKIehEKnj8T+ua5f4hePPEPie102xe0CxW4UzCOTb5so6yEfyXtzXOzJc2Mgimy4Chsg9M9KnF6zIA8R3e+CCPrQBTjPJ82MKc/OOef8ACr9v+7KksQo43Z4Aq/FE/lKVhYHHGeaWRGAKyo43dChyp9M0AQw3ZWQI4Ld8qd2fpmm6p9rWNjpUqWzsMOHjDBwexz0qeMwwvhnlOMfIFAqfxFpHiC/0UTaLp4eNyuZS+0be/wCNAHFaSjyPKun3UJUBgzSg9R1A9Oe9V2uZYWmFzdm3EeBuZTkH27Go/EWm29nBKbpm3sNkyqSJQo/uGuOa7ur0pYW1lHPAp3wTTOfkQfxEg4FAHqmiS7btreO5MjD5jMR8zDHTAog0bVp/E0Vz/ahXTw2WgDff9qi0Z0Op2UtttbMJ8yVBuU8dc+ldhYKylNxRiWHzjjFAHH3Xi/Rtauri00+SaG+t2YJFMoCuV6kEfj1rgbu4kur2dorYwTM2EJbIPqcV1et+ELHwxf6jrkl2bq4mdzBEsW1Yyx7889a5S6AtlhilY/aX+dgV42+lAGYfDkd7Ph5ls5zyflyr+4HaprvwfbWTbJLxpnxn5V2j8B1rsPCXh2bUI2u7qBgJHyhwcKPar/ivT10yyDSKjSnCK7kAj6YoA4TRvBFvqUytJqqWcO4AiaM5/A13WprprPLp9xa6XdfYlESSzcO+B/e61pfDTwrbeMNSRWlaKCxAyRyWb1rX8W+E59M8TLbQtC0TpvWZlx/316mgDho3hjiT7DZxQgg71hXGKzr/AEuTXNPSOL91eRyb4g74ye4z7ivRJNAjuSTqEryBgBtQeWh/KszW9AbTtO8/RYw/ltloWk3Aj1HpQBxN74YinuIdlosjtLmZxkYHfPrXUeK9PSTTdJ0vRJPPtYxgJEMgt3JNXfD1vfaovmX8W23X7kQHGfrXVadpkVpu8tFDZ42c4H9KAGeGNPn03R4be5dpCvdgePavXPhZo2+d9SlIKRjbGAoAye9cFpdo13dQW8SEzSsFHUnn3r3zS7SHStPt7OM4CLjP949zQBdkdY0aRyFVRkknoK8K8e+IH1zU28ks1pESsYA49zXe/FLXv7O0xLCIt51z97aM4Tv+deRKGcb5g23PC/8A1qAMDxJpFvqOnujRb3KnhiTuHuK+dfEGlyaTqLwMD5Z5jY9xX1O5cjcW25GAFyxAryb4t6MkiNPHu3D50zyT6igDx+ikpaAA/dFNpx+6KbQAU7sKbTuwoA6X4eSeX4iX5tu6Jhn8v8K+lLUF7aMFiqFAentXzH4Icp4ltsAEkMP/AB019MaVKZdPtXKYDICaAO98Lsf7HgUZyox+taFym4h3Us2eQKzvB5J0qRTuBVyck1pMD90sRnsO9AFdiRKFBwGHSh4mT5mZGUDbgHBp+1t5LMcD1FRMHDdVJyfmI6UARgiB9zFiQcgg54pk9tDewSC7yYGOWHfFO2ASjzH+c8kA4pHUzxSTJJtAGAznI+lADdbuLBLGBLJIzKCABECcr71BYQi51MSf8s40wCf7xqLYYYxMzBFA+8o61fsYhbxBWIBkO8sF5+lAGhLGjqQxbdnrmlEqjiVfuqAMdRUa8I3ms5+naoEEow7KMHpnvQA3UpBFY3DIRwpbOOvHrXFaZ4htzbgvdKrAYweAK6PxpdC38NajI3IMewKT1J44rx/TbNpYWdGQEAfL60AeiXXia2tYwfMTDjG7Pf6V574gvWvLjDyrsDZ5PUfSp7TTCFYmcsOuDz+AqDxNoohsbeWJSbgk5V+B0oAqFiviHS57IGQORG2FwNp613fgDV28PeMfOtmEunyv5ZfO3jOMEeuazfCMFnJ4etptYn8p0dkEaDBA+o5qXXtOt1usaPGsaRqJITkgNjnOfb3oA+ltQtU1K0V4WAkxlHH8q5sQywOd7HcOG45+tV/AutGfRbaeOZZo3Qb8c4b61cluC8ssTkJJ2fH31PcUARSorglTk5zt/rTmMUGGyGyAeOQPxpx8uJQrgcjC4zlveljwI9q4VSeE4oAQqpYskh2kZK0A7QpGQuMHFNhVWJDqCOxB5JqVVww+cBehIGT9KAGKys/DMw+nSrSoNylehHQjrUCpEmQNxZjg9wKtwgrISCMAZyfSgCd4xt6KmONuKxfGWyLw1M53FCy5AHbIzWwickrIrMRnOeayvHsrL4Rl+bliFw1AHPeI5dOtINZ1iC/WefU7eKCOIHlFQc8V8V/Em4E/iWQA52IB+fP9a+jNSu2XTbg4UOIyFJ6ZPFfLvia4+1a9fSbgw8wgEdwOKAMwd/pTo0MkiIoyzEAU0d/pWt4XhEmsRuy7kgBlI/3RmgD1z4b2oXUXKxMVs4RCpU8g9z+ZNelurFVZCcjsyDmuA+FaFra6uWHLYGdpzk816IhLoOGJVeGXPH4UAbPgbW10fXo3lUpHIfLcEdjXtt5IY41nQkhffjB7mvnR/mCmRd6g5EicjP0617f4Q1WPW9EaB2BmiXy3G7kjHBoAr/EHTRrHhp57Uh54B5iFec+orxJWOG3goSPm4zXtGg6j9h1SbSb5Qkbk+WWI5Pv9a8x8e6M2g+IZE2AWk5LwsDg+60AcrqunpqSt+9CvgfMuB09q5IaAYdWiFxORbA7hJjAY+hI6V3IeMtgzDPG3cRn86bPCxOUWUHPLIAR+IBoAaApC5VWbHBRs0pID7fLZJOOCuN31okhRs4eeCbH30GCP6U1BLHGPMn+1DuZFw4/KgCprUck8EkltBGbpUICscZ49uprq/B/jKbUPB8dk+lzx3CJ5LGRdq8dwRWFsZhujDvjnDAKwrqtJG+zhMaeWVGGzxzQBw+q6MhlWG5jyJMqrmMEgfWue03wDpGnyzizuZvLnIyp4OAfu9Olep+InhGm7ZVAYnC7m2n8K5C2Mi3JPysg+7ycgfjQBW07TILNWS2iRlxtUqAuB6AVDHqUUt6sTxnbA4DdeD24rE+J3iK98PWmnjTo4zd3UjYMi+ZgDHT3ya6OylQ6BZahrIitNTkj3Tqg5z+fBxjg0Acx47s5r/U7eGASvPLgJE3TrnNYdlaLqvjMRXExaODaH3REZIGCv4VcutT8zxLb6pZTukMLEAk/MBVfwTp17qviK6uVuisRlLStnG859qAPR9Mtp9NW7/tG7tpbUyGSDbHtEaAdDj+dedeKdRTW753jjUQ25wuAcynPb1rsvFNxcPALLSwqF+HmXkEenP9KyP7BnSeJ7k7IvlO7yiBn69BQBN4XsbzSLNbzSZ7m1vD8zLkkn0B7Gutjurm5HmX0vmXTgFyy7sn+lW0aN0jgSPCBMBgMD86pb23tHGQ2OhA4/OgBTuYZdAQT1xxVG9uIiUtVfdNLnaiJnA9T6VZkjuhGwebfID9zOAPTGKLWJIJGkOxJiOSw+b8TxQBNbQtFAIwF4GcAf17Vc8s4XzDCqr93ABP61FCgkG9gz8dW+6P8AP41Ys4JL+6itLZRJNIwRQqf40Ad/8J9MEtzPqk+7yoBsjL9Ce5/CuxsZWvtaknaRTDEDtA5wBWRrV1beHtCg0WJyJTH87E/n+JqpPctovw8vLxSRPdLtiw3IzwOf1oA898X6y2r+JLyZT+63+ShXkhR9fWqKDavEkzc8KSBVFWjWfy41YJtBDbvmZu5xVuNwsfTHqHBOfxoAGO4DfLj684/CuN+IsZNpbuN7Lkjc2Frtdx2gBEQepXr+FcX8Sgh0aCTeoYS4xtJNAHgGq2/2XUJ4sYAbI+h5FVa3PFaE3MFwX3eamCfcHFYdAAfuim04/dFNoAKd2FNp3YUAavhaQx+ILJhx85H5givqr4aaSmtWEcb3BhjigLM/UD6+1fJejyeVq1m/pKv86+tfg5fLFaXltMdj3du0SEnA3jpQB22iW1xpkk9peHIyHjkUZDqe4q+5G/5iD6ZyDTLedpPDmnRXw26jASnHdKhaQ7uCqnOMueKAFc5kxIwOM9e1QbWD/e4POD3+lPIDMVYhx1JHSmy7eQpGegyO1AELo0mdijDcHJ5qndWm4RmSb5IRkAHAP1FX4yFQtKTuBwcDpUF3m5V4U2gEfNng0AVpJ4ppraCKdGLnO3qSorbYqinbgMeK5HyYoPGFkUTaPs7LknjPtXTscNEHyW5xnoaAFkZ3XaiM7D+6c/nUkshVB8pLDgfNyDSoAsJChwT2Q/rTJhFJtChi/wDePY0Acj8TblLXQLeCZg5nlyQeoAFcFpZ8mRQQQp+cMRgY9Oa7f4ltHfpZ2Vqssl0CW2Rru5pfAvhi7lt4pPENuyQq2RE/LH0+lADNC0J9QljlfCAN0x96sj4m3AiuorVYESSFCSw6MK9Zk8mAhkXZEOpA6eleT/GHVbS8v7eztgGeJd00nQAHtQBj/DTUbPUtRW0vYpA8au8YUEgn3rqdQ05Wha3fCOSRgkjirvwTtLLTtDmum8lppZSu89Qo96TxLMb/AFyeW3MYROFGcbsdxQBP8KppNKMmiTSozFi8QB5C+leoS27JHHnEjqcjngV45Z3DDU9MlVFVhOA0iNyB0xXsTMFAJIznAJ60AI8LB90bqw6lV5xSIC53biU9sU0yPHnJIZeOO9T27QyMyurxSsOWHTH0oAjiVpHIx16HFSxReWHKIQvTJPf2p/2Wb5WiCSjPPltk/l1p8wkyEkjk29eBjFAES/MMKDx1HrVi3jLFv3YVPUnrRHbXMy7Y0bYepJx+taUWmRiNA7Mdpyeep+tAFeCLzsqAoUd81xXxXlaK2tbGFyAT5j/N1rtPEF5Dpdg90WASPjAPU14hr2oXOsanJdXUkfJxGqnOFoA4/wAe6othoMx+bIQt27dP1xXzO7F3Zj1Y5Nev/GjUisP2RJCRuEf5cn9SK8foAB3+ldD4aj2abqFxsBJ2Qgn3OT/KueHQ/Sur0qNYtBtcsN807NtyOQMCgD174WKx02cRIQRIoyueOK7mIDzCnm4kB43kDP4iuA+FMjyQ30SLh0cZAbBIr0JWkCv5hHlrwd67ifagCKTYJNxbynH+1lTWp4Z16bRNYjuwWliYbJVCkfLWMzM4wUYL/dTBBqEpJkMiSEDj5TjH1FAHrXjfS49f0+117RJmMkQDExjJZR6j1FSwxW/jnwt9nuGQahB91wOQR0P41w/g7xVdeH7ny51drKQ/PERu/EHtXcXUEDRDXvC1x8qNvmjQZ47gr1/CgDyu5s57C8mtLmIpImVIYD9MVTUQlUJWQgcDGc/mK9gvbPS/HumC8sCqX8YwQ6bWz6MDzj3rynU9MudNvGtry3eKVSQSPu/Xp0oArsobOwFMerf060KGBbcPmwMlScU+Mwz7g0qkDj5Wy36dqDEh580bRyoOSB9CaAGnypOTGwP94KSP/r1mWHiXUIvEcsFhNA+n26brgkchvQelZHxC1oaRpKRWzlbi6O3K/wAI7sMVh6EhtvCeqNpyi8M/ymcsQ27v0PNAHVX+tz6pfC5cNPJk7I0bCxL680/WdWj0DTY7zU70QWztsXKbmJIzgYBrAm03XND8LQTC2V5ZSAYpDkAHp05qW91K2fR47DWvsNyxO02z5GWHpnv7igDpNG1LRvEOkwaosMM9vaO3lzTQgGNu+CenauA8X65dahdtBYuzQM20AL8rfiO1ZF74jmeL+zLCJbPT4yQLeEYAz1ye9LpOn3/2qC7iQxRqw2uzhFHuM0APksbhLOe2Kq1wxG4pkBfYetdn4FshYaHIAFZjJl2yFP0Oay/E+slEedZYpmEYSZvLwGcnue596l0XU5bHyp2JAdcnAyB9AeKANPxP4ts/Db26SwGa9mGFi8vse4PSuZ8NJrtrfarLql7MtjOWaGOZ8liTkEKemBXW6xq+malBB9ssreV4XEsbycYYfQZFZOo3hv5zI8nJ6KF4X6H0oAu3PiqPT7dTOs0spwuUUYP1ya6SJnntozIzFWAYhRhRn1Ark7nR/wC0NPhfzI/kIYFsAcevrXWWM0U9rHuRXlwAwwFjBH0oAkT5AREFKf8ATMc5/Hn8qeEXcCFlY8E4HT/GpxufbhUGOAFwcfSmFpUyocDHUIME+2aAIpCkikiZI2HRS2GPv6V6P4LtbPwroMviPXZVhDLtgD9cHpj1JqDwX4ZaSNdX8Q7LfToR5gWbgtjuSei1geIfH+k+PtXk8O6da38U1vIVtJ/LDRTP2IHYelAFrR7t/HHihfszKAT5kjsOdoPTHatH4ualC81rpNu6+RaDdIA+MNjAH5Vp6fp1j8NvD00gKza5fD5m7k//ABI615tdSRT3LyyeZPcSNueVznJPU5FAFeJtqEoy4Jx1BxU8byuAApAzwRzxUJYO23zEJzzvNSBYVHLqWJ6En9KAJmUgEu4K+5wK4/4mSkaBGuVKtKM4bNddnghTn6IM1zfj6M3HhmRfMZtrBumD1oA8N8QI0mkRvsYeTOVJPoR/9auYrsNRizp+pQlDkASgk9wa5CgAP3RTacfuim0AFO7Cm07sKAHRuY5EcdVYEV9J+CpUn01wuQA+QQcc4r5pNfQnw0leXTCCylWijfp/s0Ad7oOqTR+MLC0ndxFJEw+ZsjPavQ2iVjiRAMdD615n5cSXtlckjfFKpDHsDwa9SDkx5UBgMHHtQBXBiiLb1LKR1ztA/wAahhQz3AESs+5SAAKsyPuXc44z0I605ibdUaNyrtyQvG0UAUEiEAk84YXk9eh96SSMiHfMUKtzkjt2qR8SFEkH7onLEdaZO8M6sVVgVGBngAUAVF0v7UZtR2giy27QPQ9c1YtiEYBgSScoRXY+FdER9Hllm+VrtMFQeAO1chcRvp+ryabdjLx8o+fvr60APAf94SQCDwBzUMkrYZSQAeRtPNSgAlgjnAHryPrUa7eA4Az1yKAM5vFvh3Tpniu9Qht7iP8A1iMMuDWV/wALEg1rVY9L8LpLO8v3rhgVCDucVxfj2wik13Uvs8EZmwGEmcdvetH9nvTCt9qt9Og/d4iBHTPegD1yG3aGzjich5NuGY9D615X4h03T5ZL+9vbh44IiQUXkSH0r2N32gqpJXHQ14Tqd/BJo+v2zuTI9wzRgjqQe1AGf4D1yOKe407JiEkhMCk8NntXZPBIr7hEM9ASawvBHhLVBe6S/wBgT7ch8wTA7gqHuw/wr0zW/DNzZaksUkhlikXeHx1PfA7UAcXPAsaAR7xsYSOARmvW9ImNxo0Ex3NIyAAsvUVwGv6NPZQyT7o3tnBAljwwz6Guy8A3CXHhy13nLdCeeKANcQqAGbGRTnjclsAfXvirUQQnKhyw6A9MUpVijNGzcHoaAKAhLnbtJfg7s9KuRzzQthJWA+pxUhR2BKqRj8KrsfK+d5EAHX5hxQBeivrkt8pVx6Maqan4ltbMSfbbiKGNV5Oa4Dxj48+ys9npIDTYIMn92vBvi1rd9Z6HZzW2qzC7kmIkIb7wx0/CgD2I+KV+JXja08O6PK0OlW2Z7mboZAOwrR8aaQmi2WTAIVSUorr/ABLjPWvC/hZ4ons7nSNRtJJJNRkLwXH7vaCM8c9Dx1r1Pxn4pvNbsJDOY1htk2oi85Y9zQB81/E69a51iKNmDbFLE+7HNcdWp4ouTda9eSHH3yvHTjisugAHQ/SupnURQaTEw4EW/t/ETXLpycV0+sZ/tC3USI22FApAzjAHFAHe/CfUIo/El1abn/epkAjjI9K9gwo4AfnptXd+hr550vUHsNdsbtAMKRu2nGa+g7C5jniS4i27HXcvU5zQBEyo+TIBkdex/EcU0xx4ZiyfN04P/wBenyDKHJVuefO+YD6dDVdolKEsFC99o2/lzQBHPGN2UmKOBnAGAfxFXtJ1i80mdLmxnaKUcEB9yv7EGqYdB8pkBUnjzGAZfz61UurT7QjoOVb7sqqBt/LrQB7J4R1ey1+8WezhisdYj+aWMghZx3IxXT6ha6XrwktNRjgeSNtq7ZRuz7Y5FfPelHVNCmh1ZQZXtnB3qMZHuB7VrfE/StQvbm18QaFdmLTr6IShUZlZJf4+R0z7+9AHpF98MbR3LWl0UGchZEBx+P8A9auR8aeCdf0zTWm0lYbhlHOCWwPTBrt/hJ4pm8RaCY7xmkurXCNKV27x64ruyARgjINAHxPpXhy/8R6rdx6ok6XFuuSkw8sDP93HFaHw9jt5LLVtIkhHnxSkA7M9DjgivqjxH4dS/spTp4itr7bhJNvB9j7V8/6d4Q1vR/GL6ldQfYbW3YtctuCrL9MdRQBn/GnxE1jHpFlChHloGdlXkEDoM157qH2PURDq15ZFrqNfkYkqc9iR0NepeJ9I0zxxqVrNFcQ7I5MyMH3FsdQMVz/xljsNC0q1sLARi5uDtVVI4UeuKAPOdLt5b3UYooVh+1zvhTgDbk9a7Tx/p7abeaTpFjIkrRANM+AcsawfC6DS9X0+5vgYY0O7LDIz/WvRdNto5L251W5/eSS58shaAPPvGenrJNa28caKnG90+7vI96k0m4c6ehVslPkYZ7jipde0q40zfK/mNYzEsS+WCEnrnqKwtI1H7PHItxIqneTlTwfpnigDoDIoO4LvP0zj86n8uWa0MzMog7gELisG51GZ4twhZmfhZOAf061638LNMh8ReBpheeWXRmRnA5H1oA84l1kWkUts26WJ0JAkYY6e1ZPhTWNVsbiQWygW8h+SEqWMjf3R3rqtF8ANdeLBYRCW6ImB3LkRlc9DXvnhn4Q6NpXi2TWZVWWRSHSEL+7Rz6DPagCn4b8A6jqVhBdanIunmVA3lYLOuexHQGuus/C/h/w3Cl1eASyKwAlmGcMemABXSXepW1tIIpHBmPRB1Ncj4m8aXljrMem2Wmq5Ch5Zps+Xj+6CP4setAF/X9UmZjawNp86Tr5a2zSYdmI6HIxXCeHNF0f4byT3lyftXiW7BJhRspApOQMDgfXvXYeJNYsdG0A63b2oivJl8u3RwOWPQ8fzrxqWW6leSSe4ea8uGLysMKSfy5FAF7WdVuNX1KS5vxukJIXDAlR6DuBWY9yxfyohk9ST8w/EnpTZLSTyyryKEYcrgD9QKREgjTZEVRQeo5yfcnk0AWYIVkYNPJArn/a4/EillVLYbmbCk4BiXcP1qM4Ucuu3OcKNo/WpFdUGRMy7vUbv5UAPRw6h1d278g/yrL8VxNPoN2oQsMZLMo4/I1o/OgGC8o9AuP61jeNZhB4cumKKNwxggKc0AeMBI2v7mEAkPE6cZPUcda4euzSdk1m3OVwWAI3kgfh0rj5htmkX0Yj9aAGH7optOP3RTaACndhTad2FACV7d8JLjfbWyAjmAjP0JFeJV6r8IZ+LZSRxI8eCexANAHsExC2zEYcrzj3r0fw9dreaXaXA/d5UBv8A69edRpHkjKjB6Cup8D3A+y3NoS37t9yg+hoA6y6FrsKwyOX3ZAKcVTcu4k83k54yeKluT8gBGGwDx6VXm2yLks231HU0AQSAOxHCt0HPamrCbuaG3iZmmkYIMemeasEKoydgX8zitvwjps02opqKeX9mTKAMec+ooA7PTrUWdlDbqxYRqFye9cV8TrHZ9i1WGPMkL7JGzj5TXe1keLLFtQ0C7gRgGK7hkZ6c0AebxuCAzNh252lqnMaSt87BCOAO5/Gsizm3QRsyq574rRtbjynwyfITk8ZxQB5j8V0NvcQnauy4iKM69cg8V1PwMTZ4YnbaB5s5C8dcVi/GxFI00QhQuWJ57cV0/wAEyieCxlc7pnYH8aAOv1OUx6fdS7fuRsT2xxXifhVE1aaYmEyKVbLZ6HPHFeweMbpo/DGpFAM+QwyfeuJ8K+HbKDwvA7vJDexkSb0HDZHQ0AdT4FRXuzJc3UltcqvlwsDwp+nQivS11K2itrZ76VC75AfbgZHU+1eNacZvMZbmTzJ2OQQm0MOw+taX2bWpEgN3NHLp8YYqpyHQmgChqIvZNe8QyIbZNDu0zbwRE7zKP4iMYGfan/CrV23GxuGZZRyyHnHtTcsD8xyp45bOa569sn0jV01vTd4cH99EpxuHsPWgD3SPd5bfMFJP40gkCxEONqg53muX8O+KLW9sx5srbwOAw5B9DWf4p8RtbW26Z1EIP3Y26igDqL3XLS2gMrXQSNSclhya8e8feO1k82PSFZSP4m7+prnviNqcy6Zd3928ps441aCJDglz0DD0rgbbVtbtNPa38Qz28d3cIslrFNApYL1wBgdqAE19vEd9aSX+gXErkxlbqFR8/X7y5HI+lcl4e8OanrdxC+tSXVro6OXluJlbHuFB6k12E1vfhxqseo3kqIgCfZ8MisOg29j7Vp+Xealq9hBcXDktgzJ2Bxk8UAdX4f0exit0nsrcw2YGy2XJ4T157mmeLlWw0GUxkKCS7ZPYDOa6SONFjMeR5ajCgccV5v8AGe/NrphhRwCUCYxzlj/gKAPC5nMs0kjHJZiSaZSCloAfAMyqPcfzroNax/bE5yTt24AQZ4Arn4TiRT6EfzrodbeaPVpiVA3KrcqMkEDvQBbdZHijzHKVxn5hgj6Zrvvhr4pFhGum3zEW7NiORyRsb0PtXAk7rWLBx6mQnArovBuk/broKNjKOSEOOKAPbn8wqHjfcG5wh3ZH8qgnWXaciQb+ARjA/Kq9jEtpCiRO+FH3ZGBz9PSpv3ZlQOAGznAzQA2RFTBKupPHK7v17VXnjjLE7JmK8hoyuCPwq4xVPmK8Dp8vB/OoVNtIdyBd56qyNg/TjFAGjodwzbrS4Sb7JP8AK5D525789a73wRp4uvDereHLl3lazkLwE45VhkY9s5/OvKxEon4dgSQQiNtB/AV6B8Mb823irbNhftMRhLEkkkcjOaANn4fRjQ9Vewkjkt4wmCsjd/UnpXpikMoKkEHoRXF+PLOQPayWKDztxY5JxWz4X1Ge9tglxDteNRlx0J9KANysDxv4WsfGHh+40nUjKkUuCHibaykdCDW6Tg85pR9aAPn/AEv4aar4T1SRI2E+nOpAmLZP1PTBrgLXww/i/wCIVw+t3O+xsB/qzzuI+nQV9fS7TGwcArjkGvkL4xeIZdA1+/sNEf7IZ2MhdM5IPUccUAZHji2tNQ1O7sdJKL9kAJO48kdgDVbwn4vuYN1vcgJb24wpGC3v0rhrPVLi1uheQTo0jLtcgnJ9asC8W4aSXzliTOXG7G78aAPeNLWz1uzE0NxDcRONrRvkgexA6Vx3in4YPJcxTaNcJErMPMiYE4GeSpriPB+tXWh6ws0MqmEnLxyMSpHrmvoHQ/EWja5Yt9iuYvMUfNHG+GQ+oz1oA4e20rS4JbrTWDtcJDsRtnQ44wTUnwkW80zV5dInieXTZwRcShT8rn0I7V1er+H3vllms0lFx5e2OVTjJ9Tzya7r4KaMtpoQa7tfLvEJDlwNxbPJJFAHQ+BPBml+Fo5pdNQmS5O5nZieO2M8iutoqvfXS2lu0rjIHbNAFLVbm2srW41GVVVoVIDycD2ryjw5Z+KtZ8VmZnsxpTSGVpSpcN7Cu0+I2pwWuhWwnk8qKZhnIJz7Y/GtTwxbDR/DwmldgmzcExgAdsD1oA4X4ozPeeILWwhUmC0j3YRBw7foOP5153dNGksieeFnVsBcgfhmu41y/isLyaTUAtzd3LGRlQFWjXsK4h9s1xLKIJAJGJIxnj+tAEb8Lk27hwed77c/0p8YL4LwQIenLdabGI0chdzOOzRKfyzTXWDkkEsOSVAG0+hFADFka3uVSPeQwOAVLAfSr8UsgBc/iQgXH51nafukkmJiKuPlVg2V+vStGMTZCCZNw7jCn8QaACWRAu6R5QPZQV/OuB+JdxPJZIqYK56EdR68GvQGYKv7y45/vKB+orzr4oXM2UWOUOhGCQuD+goA8yiLJq8GYAxLjOzk/ka5y7ObqbjHztx+Nb0A3avCVjZwpLM24g1zrnc7H1JNACH7optOP3RTaACndhTad2FABXd/DC4eK44JCrcIT7Z4rhK6rwAzfbLoKwBVVkHvhv8A69AH0grjeCpwfSr/AIZuPs3iNCXytwpQg9MjpWKl1GltHNMSFZASx6VPp00f2qC8gDH5wcnpjpxQB6Ncs73IVeB3qaWLagjx8zDnipkZXUOFGCuc96pxtNqOqrpmmgmfGZJDyIV9frQBVI+1arb6Xak+Y5HmyAZVF9z616vYWUFjbrFboFUDnHc+tVNB0S00W18q2TLtzJK3LOfUmtSgAqC+jkltJY4CokdSoLdOanoJABzQB4ZYI9peXlvLzJBIy4AwMVo2xLNLyi56kDOapNcS3nirWC+cebiNsYDCr8MeCyHbkjJCmgDjPixZ+do1vOyDdA5Tr2IrqfhVB9m8E2a5JDZYEDrzWF8S45P+ESu2VA7jBC56V1vgSAweEdOiJUZiByOcZoAZ47z/AMIvqGDsGzGSM1ei8NmLwtZ3VvIdxtkYoV6njrVfxvGG8O3cbKG3Bc5OO4rrEuSPDNsIocPJEIxE3IOBQB5tqlzbXQFjc/aLOaFgS0Y49j9Kjv11lrNxp97HIZB8jMMxN+PVTVbXpX/te2ubTHnEtHNC/PAq9b6bLDMbyJbmzkccx9Yn/DpQBmWNxLY6eqaxFJHcqNrMvzID65HatJMOqrkMCARkg496bdXSqpW9sn55JQ4LfhWVbx6iulXd0iyIkZLRGZcZ9vpQBoXmmKzGWL93Ied2cCuN8WK62cyMzSM7KEBb+LuaqwX3iDWYGmnvVgCyBAoGQM9OAKayalHKbeU+bNHExUEctnqRnvQBb+32l5BLPc27ztFAPMTbuVynQgeteWeOr691zUr+8njt76zMA+zQq+HgGOG29c8Gup8Y+Kp/DOjWv9jwbJpI/lleLdtJPPX+tcvJ481CNLS41/S7C4R4+fOtUHm84ypXmgC58J9TsNL1G0tJ9QKx3gVVt1zhHPd88ZPtXc+FdPB1nVbxzkrIY0OfvHPauY8B6rpOpX1v9t8MWkG8s9nNBGdmVzjdk5B969H0qxMMKgqFLEu2D0JoAs7QJFVugGTXgXxdvjcX0Y8wt5kjv7YB2j+Rr3fU5Ta6deXDOPkiOPrXzN46nEuteWMjyo1U59Tyf1NAHPUUUUAKOM10GpsZUsrgRh2mhC7ycYI4rnh3+lbmmn7fpElqFjae3Pmxhicle4GPzoA0LAeZYNE0jCRT3YGvRPhlbJ5haYiQ44C4AryvT5ZUuPNEW6M8MM8V1fhfV00zURMoJTI3AE/L+VAHvAijYfKZkA6hVG0fn/SoJIoiAWWQf7XY/jTNN1K31GATQKHVh2PI/OrDMrEFIoRj16/n0oAqKpDNsZpVP8OQpH44p5ZSCJJIzjghp+RT3dQf3hkwB/Bgj86j+RTuaEuT/E4/woAa8kRyhniPP8PB/lU+nTJDPG8Vyd6EFG3kbT7etZtxdy2yEwWRfHO3djj1A6VJpt/DfxO0HmfJ1WRNhU/1oA9+0+/TxN4VF0qP56AhlIwd468ehrl/COrC11toWkZohx8/y7c9ayfhnr39naytnc+aYLz5NxYsqt2+npWn40tBY+ITLA/lqy7ypY7QO5HFAHqRO5Mpg55HPWqTsbOfcUZon+8+ckH0xSaBeR32k200LBl2BSR6gVB4jIjtkm2bmRuO/wCnegCbXdUttJsGuL0uIfukqucZr4s+Krz634uubuAu1lhlgeT5dwHpX1p48tptZ8BXZt45FuRH5saBgpLL2r431i8k1KN47OG7t7uBz5m9iTn0xQByVsizyJG0ahl5DjJzjsa6u00O7vDHKHDWyrkgIcVneGbIyaoIrhnhaR8MCuVPsQa9lhsLay090FygwOdydfpg9KAOBm0OJIoY1thFGQWeQsVJ9gO9c7cwTaTcR3FpJIJgcoUyrj644rstQ1Hywy28g2g4OWyv4dxXMS3TLc7YIpJJ5G4wc/5NAH0P8PLyHW/CFpqMkpEsY2SDcQVcV614Tso7XTBJGzn7QfMbf1Br5fiSOKDSLaxlntJpGHmZZhlu5JHBr6s0OKSHR7OOaTzJBEuX9eKAL1Y8morLqKQrEzRDgvyMH+oq9qiSSafOsJAkKnBNchpVxeGGX7TFK7n93G8YwFJ4zzQBoS28ur6rsmjCQREEfPuDL7isfx54qFpdDSbBFeRFDSMfur6L9e9bF7cv4Z8MTTzMr3zKdoY5y3b8q+fy91cTz3mpXcUkkxLM6uykHPXFAFu9V7i6ee4m3uxJORUATaBmWQn2YnP45qv9sikJS2cXjg4bIOR9eRx71IokIwUWFT1ABIz6UASlgFPlx5bPZs/nSKk5bEsfl8cMSD+tOhgOMRoh9GTK4/xqXyrlPueYqjvgH9DQAiWyov7stGCcnYOD7kd6nES4wXT1ywP8mpimbBLKSR1Mcuw/lUzsoUFlJHowJP4EUAOKsACso2+irk/415J8S7l5NQKt5iBf4mjwTXqTvEUyHI+i5x/I14p8Qr9W1GXfIjqOhVDQBylufLkvbslsLCQp245PFc9Wtcy+XpOPl33D7sjIO0VlUAB+6KbTj90U2gAp3YU2ndhQAVt+EGxqbr13RN39KxK1fCzKutQhjgMGX9KAPo/Syt94fs0ZQFKjdkZzWjEBGqxqDtxgL0ArI8IyB/D9sy/MF4wTWxMiu4OdpP1NAHSa14ki0vQkaH95dsgAUc7fc16J8KdHGneGYrmUl7y9/fSu3U56CvHdGtI5BcCRQ+Seo6V7J8OPENtqOlR2BYR3tquxozxkDoRQB2VFFFABTZUEiFG+6Rg06igDyjxfZxaf4ljWBAC0W4kdOvpUAYRqpwpyM8Va8ePv8WQuvAC7CemSKgWPOTuDt24oA5/x46DQZt0e/cOAD0rpvBcom8LaYyqBmIA57Vz3i+IyaM9uMByfmz6Vs/DdkbwvEigYjJUD0oAm8bMyeG784BYJlfzrW8Ra2un+EtLdTtklRGzn7vGDWJ49mFv4UvjJx8oHzdue1cV488caXqnhywsNGjkM8SqZZJFIxgdBQA6xvbXVdbkt3MiOj7orkDjPuPSuyk8SxQXB0zUreVJwvDoN0cg9Qe1YPg42U62urQbX4EN0gP3T2OK0/iLoVzc6Wl1ozBLmFg20fxCgCtrWpaddW0ljrRe3hkysd0nBQ9gT2rkrEEONDTXbiUxt5kaS42Tr/dz1qs9nqGuwrY3k8IIcOWI25x1FaujeFLG5vbdJo5VmVsrcW75Cke/agDeshAIR9njjiKn7o9fpVPxdbvN4evBHGGuiB5Dg7SrZ6g9uK29VtbWyswLaXz5zLgsCCc+hxWF4imh2WdneskUkr8b3wMkYwPegDw/xz4k0WW0h0a+gmn+znaZonwW9ceoz3rF0jQNL1WTZpl+0tmqbk+1kL5Mh/hGcZ5/A103jbwrpfhBV1OVHucO3lmKTBGRjDA9ue1cCdWe1tpUuLhFhuId0UcWHbJP8TY60AeieBNA1jQda8jVXnhsPvRMwGHc/3cHpXqEbsd5Ziy54x6VxvgO+utY8O6BPcxsyQeZGjyH5mUHAJrtf4dy564ODQBzvji48rQDGetxIqY7kE18065P9p1e7l5w0hxk9s19BfFC5ENvaoSBsR5SD7DivnFzudmPUnNACUUUUAA7/AEqayupbK6juLdtssZyDUI7/AEooA6yO0tdcxcaTcLBqDH95Yscbj6oTwfp1qmZLvTrny7hTE4PKlTv/AErnwSCCCQR3FdFp3iiWOAW2rW0WpWgGAJeJE/3XHP55oA7jwX4plsJlDxTSwN94FiNv4V61pupWmpW4lglMi90JyV+uK+ehp9rqI83QLoyPjLWUpKSL9D0b8KjsNUvdJl3/AL6zmDbQQCG/EUAfSG6M8qzcdAmR/OmsxVifNnyem5QQB7mvJdG+JWowyiK8EN1GeuV2y4rvtG8UaXrREcEzRz90ZdpH50AbLM5wVMkn1KqPwqCSErJ5oCxyE/e5J/XirAjX7odhjnCEDP8AjUb265IMdwpP91gfzzQBh211eaRq01zq1wbi16wlUHyHPfFeyTalF478EpqGkXHmahZDZPCrDJ46MOevWvOHtvlPJSNhjc5H8u9Y2nzax4J8RHxB4fZ7mJsLd2LsAtxH3wB39DQB758K55xoywXKlJOu1hyMfSur11tmnu2VGD1JIx+VcV8O77TvEMi6v4dviLViTcWU4Ky27HqpH1rrtX1CJFntXdVnCB1U87h9KAMnSZpZbS5iRZmPDfvGDK3sO9YHibwxYauklx/ZEUE4+8VIG8+5rmvFHjGXQ9cW3XDK6CXkMoaqvjX4k3uiWunavY2EV/Y3JwxRjhX7hvQ0Ac3rnguJpY3j0mSF1JYvFICc/Tis25S8SwdWtLoELgkjI/8ArV7x4CubXxbok2pSQkJcOAY5ExsI6geo96uXfgyGRz5V1LHGeNoA496APl3SNNnnmmkeyZ48HzARW9Y+G9B+0ae5t70zzDKqZBha+gLXwDpsImWSSWVJFwAeMV85+JzqmmeOLrRI7Upa2sv7mVCVZgeRzQB7r4V8AaTbw2ElxAstxHmU7m+ZSTxxXo6gKoVRgDgAV5NZa9f6Tp0TyzgXbqAsUp3EADoe9dxoWs/areBr2QrNKwCqMAZx0+lAHQ5BJFUJIre2ae5lPkwRje5OAvHU1fwBk/nXhPxl8aNrrTeGPDs4MQO29nU4U/8ATMH+f5UAcl4y+L9jr+tXKWljPdwwSeTAiNhXTu/1P8qwJLS71q6Mg1a4tLJiMWoKlgPQ5OQK09E0pNIttsccAbHLBf69qtyXcUnySzwenKEn8wKAGWunLYRqkUUajoXDkOw9+OasFSq8SYTvlTx+NJF5fAQkex3EH6ZFTKVJGwEY67VUH9aAIsRsDtnWRu6oAGI+tPjjZB+7lldR0WeIHH/AhUrRzuP3cj7R3wh/+uKjMkqy4mx0+8wC/wAqAHkB8KrW6sBwpbaPzxTSkkbcFPcbu9Zmq67puno32q93t/zziYSN+o4rzvxD8SnKPFpJmiUdzjePfpigDsPGeux6TYMhV0uHB2vG/wDTNeI3FwdUvCrXDFpDljuxtXvmm3N5qevXOFuZLlieSy7cfU9KrX9wllC9nazCZ3/10oUAZ/uqfT3oAp6pOs90fKJ8mMbI8+g71UoooAD90U2nH7optABTuwptO7CgAq9oT7NYtD/tgVRqaxJW9tyDgiRf50AfRngRg/h9VVvuuw5rpEwYQTkcfeHSub8CR7dMkXDAhz0rqYyWULv2+oNAEmkCVbl+G937Uh1S40rVjfWRCPEcn5gN3tWF4n8WL4PsHvJ7czhyEQBsbjXlGrfFrU7mR/sVrb26l9wZl3sB6elAH294G8Y2niiwV1/c3QA3xtx+VdVXxt4O1i81/wCxLbX89tdhBMXRdqMmeePWvcPDPxBl0uO4HiaTfYRDK3gIyo9G/wAaAPWaKxtE8U6FrluJ9J1axu4z3imVsfrWsJEKB967CMg54oA4Hxtp4aM3BGXjuW6n+EjpWKmBCGBz7Cuu8WyW8Ph/VLi7lWNC+VO704GK8pi8R25jG5ghC/xd6ALer6xZWM0Md8/7s8AAZLH0p/w9v/Ja+tH/AHaeaXiRuDtNYDzQzQ3Ot3sYkji+W1jIyXftj8a5uZ9X0HUEvNSx5tyhkC909qAPRvitfbtBMIGEZhluorh/A/hZtZ0y6vcjA4Vc5zV19YbWvh3q9zcBWkhcbeelWvhFrD6VpIt7qM+VOfMVqAMbw+bvwzr08SAvZzHbKh6FT0Irq5NS1W3t3S3vBsBLR7xu+XsDWD4iml/t3zm+a1Q7gT2Qnn8qfcalp9lp1xK92ropKhlbIGRwOKALuk3xvZD5sKLKWyzAcA+1b48mGMxsfvd1zn9KoaH5EmjQeWmxpFDnIzye9aFk+9fnGXHFAGJrzXGj2B/sLTJLueTLEk8IfXHU15nrz6h4l0NZrrUWt57WVjuCEssn8K47Divb1GWIVQG6gZrAvNF/4mM89qYkWUDzotmVc+poA+YxrU+o6VPa3vmtdKdhl3DDqDkjB7/Suu0TQIfFHhKE2V/pNvPZkEgQ5ZPXdmtbxB8K7q11Oe/8PXAgkjbekcq7gCerKf8A61U9A8Ka5pFvrWoaqsQadNrPH1cZySccCgDrvANkLDSvsZmju2hbBnQEKc9lHoK6xWKyFQAF7iuc8EW/laJEV3LuJPPeugQ7psuHbA60AeVfF66Ae9HBZIVTntuP/wBavFBXp3xamImueRmWcA/QCvMqACiiigAHf6UUDv8ASigAooooAFYowZCVYHII4IrobXxNJJELfWrdNQgxgM3Eq/R+/wCOa56igDrodLg1BB/wjeoIznk2tydkoPoD0b8DUCzanpl2ouo5Ip0ON3Qj865gZBBBwfUV0Fh4t1O3hS3u3XULNf8AljdDfgezdR+dAHpHh7x9MnlwaiyvF/fBw4/DvXfabrNlqcINvdwkntJw4/DNeGQTeHdV+5cy6PcsfuT5khP/AAIDI/GtFdB1qziM9jF9uthgrPZyCQD8uRQB7bhQx3vx/vnP5GpECxtlmKo3YgZry3Q/Gs+nssGpiRmzj96SSPxrtNM8U6bdttDiOTvv5P50ATTWYtr57nSbiTTrsjIngcqzexHemW+rawmqQyXmq3Ml0jgxyvvdev8AKtW7QXUCzRpC4HQgZB/WmWuTgPtHddnOPbrQB7/q+gWmt2VvdT2Vvd3JiX5ZSQpBGT0rzO98NaxpfiVmg04QadIuFjhUywg/7Sn+dY9v4g1yxtxDYajNEicBOdtX9L8c+ILaVS960pzysmHU+3PIoA9R8Ny6ja+HLjdYwCeJz5aW4wJPfb2+lZ7+JvEyW5b/AIR0+YCMAk4I98dK1bC8Pi7wpJ5FzNp1zKpVpID88TeozXiPju78eeFdZhs7bxW+oQN/y0eEZjHT5sd6APZvD2teI77VfL1LRBZ2RXPmbia8N+J3ivWNK8Y6skEkdtDG2S0MYaQ+mWYHH4V7P8ONH8UWlsbjxbrgvpnw0UUIwirjv60zx34kg0W7itRpUeoXki7/ADJkUIg7AnHNAHzh4Z1m71bU/LZby+uyd2UBY/Q19M6Hs0fwab+7thaTJGWCzcmPjj3rjYfifJax7YdFtElz92MFAf0rA8U+M9S8QWL29+0MFq55t04B9MnvQBymo+ItV1eaeytNYuDaSSlrm5Lsm/J+6gB4FWrWygso0itlAg9GYHJ9881DZ20cA3bHXdwcICMfSrqxQohJztPQyKFC/wBKAG5VN2yIKF6qX3AfgelKZlKKsgRgen7r7v4isDXvEVjpaEGa1lnB+VB3/EcVxF38QtXJb7IILSMdlGSfcCgD1dAr4KhEXuQCR9c5rP1bV9I0xc6hdQK/UANktXjmq+L9RvFVWubrafvM3yq3tgViwG51S4EdhYz3MrfwgEk/SgD1HVfiHawgrYWTSA8B5WG3/GuN1jxjf3YcXE0xi6GGE7V/OqEfhfUBIWu5rSxC/fMtyqlf+A9f0qCW48M6Uc5utZvF/i3eXCD+WWH5UARWdvqmruY9Ns5ivcH+Eepb0qWW10nQ2zql419c97WzlG1fZnx/KsnVfE+p6hF5HnfZ7McC3gGxce+Ov41iUAbWq+Irq9iNvbqllZf88IBjP+8eprFoooAKKKKAA/dFNpx+6KbQAU7sKbTuwoAKfAcXER9GB/WmUqffX6igD6V+HZ26bMrdC+VOc5GK6nClGUjJ7GuX+HfGluQBjIx+VdQQB/CST6UAcX8TPD7eINFgs7dxHdpJvj3H5SfQ+lecXfwm1y1hWQyW9yCBuS1bew/PAr2m+aKNN07OFJK5HVcjFeI6hpeseG9RkuI7m7EQkLgrk5T/ABoA9Z+HWiahpflNqLRxbIvJhRVGQoPc+tZXxqsNZ1M6fZabII7CQEyjcVDSf7WO2Ks+BfGWj6xBDbLqLRaqTny7kbd3sD0Jr0aWNJYmjnA2Yzn1oA+edBsr3TNQs9P0ORvtqEfa5EBKPk8jPbAre8V+LPEWmeJDZnXLiGKGLfHFncrDHcmk0O11fR9W1W81C88u2kkZY4AQVm9yRyMCrdzoNp4lNlBaqmpQxn5yzbJosnkA8bh9aAMb4c69q/iK81G31zVbm5sol85RJISC+eAPr6V6bp+hXV/aLqF8Psxf5I43OMIOrNTdO0O00a7tdKsIfIjlkD7mAZgB1Oe1T/EDxVDKkGleGbaW7jRv382Cd5zyoNAGj4ZK3viy0typGk2is0St/wAtX/vfSqPxlvY76WRk3Rx2pWIyAevXFFr4kh0qzLS2wj1ydfKjhDZ8lPes2ayl8Q3SWyKWgjYPO5Py59PrQBjaLay6ja3VnYl47JwobPr64rurG2gt9H0/bODJbg204H8Lds1DpGgaja3ksmkxxS7lAeB22kgelcbdS6lZeJ9Rhms7hYpzulh2kgD1FAHV6ZcWd34rj02fMsZZoJQTwQwyMU3xHZ+HNP8AGCeHrPTpZbWZVaeNCR5cnRTk9ua5vRL2zg1bZZ25iO8TJKWLNvHrXW6xay3Ouw6zPJsiuVUSDpgj7pH40AWbu/8A7M8VyaSwSGFIkWNT349a14Z2mnwknzRp17EelRapZJqQmeaCN9SeMRxSvwGA7E1n6JcW1tLJidGC5V03Z2t3FAHRxTZwWJQ+h4qRI1bBBznk81GhW5ClMMg5PpTzAg4jzGepx0oAd5KTZVwCD7VwvxE1q2h8vRc7vMI8woPurnvXei2BXDOzDPc1w/xQexsdMhhVI0u55BtKr8xHfJoAfYQQQ2kcduv7qNRgg54+tWFKqr5GT65qHSVUaXDkAHYPapfuW0jEDIBOfbFAHzv8Uji+jG/fud269Oa4aus+I7ltYjQjGELfmTXJ0AFFFFAAO/0ooHf6UUAa/hzQZvEFw9rZXVlFdgZjiup1gEvsrNhc+xIrT1T4d+MdLV2vfDWqrGnJlS3aRMeu5cgj3zXKVu+HfF/iLw1IG0HWr+xwc7YZmCH6r0P4igDEdWRirqVYdQRgikr1NfjVrN+gj8XaL4e8SpjaXv7FRLj2kTaRR/bHwm1tT/aXhzXvDtwR9/S7tbmLP+7LggfQ0AeWUV6p/wAK88Hawf8Ail/iTpYkIyINZgeyYexc5Un6VFd/AvxykPn6ZY2es23UTabexTKfpyCfyoA8wqzp+oXmnTCawupraQchonK/yrR1jwp4h0XcdX0LVLJVOC09q6L+ZGKxKAO0i+IWoyx+Xq9lYamMYDzRbH/Fkxn8at2HiLw3qEm3UNOfR5j0ubN2kU/7ynn8q4CloA9e0qKJfm0XxfpzMf4JmMZI9CGxXS2N74gU7Hi0+5APDxTod30wa+e6crMhyjFT6g4oA+obW81J02yaU2c/wvu5qUy3iMT/AGbdyOBypAwPpXzDHf3kf+ru7hP92Vh/WnrquoqSVv7sH1Ezf40AfUMb6/GFexa7s4mGSokI/P1ql9v8SWd45xLPEf4WQdfXPWvm5tZ1NlKtqN4Qexnb/GpofEWtQDEWq3yj2mb/ABoA+v7H4u69Dp6W91piwzRjb58iMQcfSuV1rxtBqN6ZdT1PErcHchwB7D0rwC0+Ifiu1+5rVy49JcP/ADFXR8T/ABC237T9guQv/PW1Q5/IUAew3HiDSIgGuNSjZD0IGG/Osq68a6YrhVaW6IyB8navNJ/iLPdLi70PR5T6+Uwx+RqtJ8QdVjJ/s6206wTGMQ2yk/m2TQB3978Q7lQDa6cyx9FYruP45rnrjWvEmruVSO7lDc+XGh24+mK5qPx/4mjcsupucjG0xptH0GMVVvPGXiO8BE+sXm08bUk2D8higDqD4a1xw0s9slnH/fup1jz7/MRVSax0S0GdT8RW7sB/qrGNpifbPAH51w8881w++4lklf8AvOxY/rUdAHZP4h8P2Lf8SzRJLx1+7LfzED67F/xrP1Lxlrd9F5IuhaW3QQ2iCJceny8n8TXOUUAKxLMWYkk9STRVixsbvUJ1hsLW4upmOBHDGXY/gK7XRvg/4+1dN9t4Yv4o+73Si3A/7+EUAcFRXqLfCSPTMnxX428LaQV+/Cl19qnX/tnGCc/jUT2fwo0fPnap4k8STr2tLdLOBz/vPl8fhQB5lS13+reO9Gj06ay8KeDNL0jzV2m8ndry5A/2WfhT7gZrgCckknJPegAooooAD90U2nH7optABTuwptO7CgAoX7w+tFHegD6a+HqgaYcHIZVx7cV06nkZHzLwOMZ965rwCmNHjP3lKKSFHXium64Yqw44GecUAZPiW8itLFJ58naw+UDv2rmPFOp3DXlhID5GjwkeeixCQvnsW7Vu+NDGmjtcTyiOGIiR2xnAHrXBeAtbWW5ulZPPsZX+ZZHyzqevyt2+lAE+sfD22ufGFlqlnc29ro8rJK3mZGW67VwO9elX99BGRFPdbQg7dCK0HtrC90yHyLddkIHlwuNqrjpXnnisRWol1HXp/Lto8qkcQzvI7KP60AWbCZnnuXgu0EG4ny5bcOCPYetYWqIlvO7WoeJicn+D9BVKzl1TxZaRz6Js0awicDL5aWUj0YDkV0Y0Wa4RBc5W4XksrZDfWgCl4e8XXemTRRJFBMjHZiQnv15612fh/VNN1OaayEFvpyMx3PBMVc+4BrmJ/DULx/LnzDyOOQfrVkabbhy5s1bMXlgROUO4DqTzzQBN4h0/w9oAeZ7+6u5Xk2tMPmIY9iew96q2fxDh0XQpWg09njtzyjPgvz1JxR4atdUEt2htluYY0y8E5CsR/snuafb+DtG163mmglJkkJ8y3bOU9tvtQB1P9s/2x4dtdc0K4ksLxgHQScH3U+oqyPEOq+JNKntn2WGuQjehUjE49s9jXGXVjc6RZW1rcfvlUkDy/lCnoAAeelVYop72XyriJreWDG1wMMgHTFAFjS79LG7vzqcSQ3jJjaRwD7V2ekSxahpbWs83lDaJLeQ8jnrXA3beVcrDeoJ1dgMyjOR7N2rXhV7aJI7aTzUL4SEn5kI7D1FAHokbKLYQ3jLN8u1woyDisg6KLfUVuLC1i8pgdyMOuaytM1WWG+23IQqwCsDnK/7J9/eu1R0eHfGVI7exoAz7GOSC4ZAQsJ+4qDp6g1rDKlmkkHC8ALzntWdBK6yhGXae1WJXP2V5V5z78igCc3MkVoZDEZPlywU815H4w1KPV9Yi87ekqMI0gK849c169EWJRdg2beWzyPwri/F3h6H7euoqdp4BJ7nPFAE9oPKtolI/hAzmi44sp2JwcECljZljCspwOmT0qHUGK2LsvTbj1FAHzX4+kL+JbhWOfLAX9K52tXxXP9p8RX8mc5lI/KsqgAooooAB3+lFKOM0m4+35UAFFG4+35Ubj7flQAUlLuPt+VG4+35UAJVmxvbvT7hZ7C6ntZ16SQyFGH4g5qvuPt+VG4+35UAd7o3xh+IGkLttfFWoyJ/dumFwP/Igatw/HDU74r/wknhbwjrfZnutMUSN/wACUjH5V5NuPt+VG4+35UAesjx38Nr8k6v8L44HbrJp2qSx4+idKUf8KT1BSSPGukyHsDBMg/rXku4+35Ubj7flQB63/wAIV8LbxN1j8TprVj0jvdHlyPqynFC/CLRrsj+y/if4OlBH/L1cG3P5HNeSbj7fkKNx9vyoA9bX4Ea7cOw03xF4R1ADp9n1VTn9KST9nn4iYLQaXaXC+sN9Cf8A2avJNx9vypyuynKnB9qAPTJvgR8SYjj/AIRiZvdLiE/+z1A3wR+I6nB8K3n4PGf5NXBRalewkGK7nQjptkIq5D4m12HHk6zqUeOmy5cY/WgDrf8AhS3xF5/4pS//APHP/iqVfgp8RW6eFL78WQf+zVzB8Y+Jj18Q6uf+3yT/ABqJvFOvt97W9TP1un/xoA7OP4F/Elzx4WuB/vTwj/2ertv+z38SZuugxxj1kvIR/wCzV5tNrOpzgibUbuQH+/Mx/maqSXEsn+skZ/8AeOaAPWG+APi6AE6heeHtPA6/adTRf5Zo/wCFLxwIG1H4h+Brb1UalvYfgBzXke4+35Ubj7flQB61H8PPAFs2NV+K1gCOos9NmnH4EHBoXS/gxYE/a/EPizViP+fOzjgB/wC/nNeTbj7fkKNx9vyFAHrI8S/CLTlIsfAms6s3Z9R1QxfpFxTT8WtLsQo8O/DfwlZbfuvdwNeSD/gTEV5RuPt+VG4+35CgD03UPjn4+ukaO11eLTYCMCLT7WKEAexC7v1riNZ8S67ref7Z1nUr8E5xc3LyD8iaydx9vyo3H2/KgBMUtG4+35Ubj7flQAUUbj7flRuPt+VABRRuPt+VG4+35UAB+6KbSkk9aSgAp3YU2ndhQAUhpaSgD6Y+GUqv4etmUlWMYIP4V1BDkF9wD+prz34S33meH7RHKsoUpyehFeiuC6DAypGADQByfjOKWTRr4OW5QthemB2ryv4bXL6h4rVpgTGqfvC/KKF6fnXs3iSL7RarZshaO4UpIo4OPTNYdp4YjsLY2mkNBbl1Bdn+aQgdAT6UAa994js9IsJHSRZnkOQo5Cj6Vg2otfE0Eb37SC5iZtm08bT7VRk8J3nmSF7hZH9T0rY0vSCvkSDbFMv3tv8AF9fSgC7a2QwIbOJYLaLAVV4GKTVfMX5B8iKBwDyTV+BmjDQ4Kt1+o9qjuYQWIdQQcYJ5yaAMd5GbLbjjaAADTYhIJECnB559DV6SxYM6KoJPOV6CnR6bIsYZjy3IzxigCASecPKujz2YHBzWTrEt/wD2rHLGpjurfCmWL5fNXtn1Na80Lbyj7GlUZOD1FZ2vxRXulwzyTNE8bFVIOckdBxQB2ejRzarBcQavB/plrhRJgbhkZBptl4TiaSSea5nFw/Iy+ee1ee2viQ2t2kSpqCXk8pTDycS4HtXqkMkr2yKxkJABDHjHtxQBjTaWJLKa3vYkcq3DEYI96oP4eRrFzG0pRyD83Dqw7g1tXGoWi3Edribz3fZu2Fh+PoK2reONrVyhHHyj2oA8/t/tVsHSR/NeYBUuMEHcOm73962tD1WW1mKXqv6MV53H19q6O1sIpGZp0BXHBplxpdrNK+Ew7Y+b2oA11wymSNgykZBxVUQLJlSCAeTz0PrTbUSWzmJWDx46HrVoGTBKhBjnbnrQBFLdzWrqnktOSdoZeMcd64nxhr/2rV7TSxbSwneGZ36Y9q7+KWNCPMIQ5zknA/OuC8R3dpfeLoBbRibyvvsOefagDYEarjZyB1JNVdUPk6ZMx52qc46Yq48pMZ4Getc18QtQFj4SvZdwB8ogfU8f1oA+Z9Ql86/uJT/HIx/WoKM5JJ70UAFFFFAB2P0ptO7H6U2gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAp3YU2ndhQAUUUUAeufB2cSaa8JJ3RTcDPHNe0xhhDvHORXgXwWuQuo3sDNgMquB7g175btuiJ3MBjHPOKAKOoFGljJBJQHHPQ1hM0YvzcREq6DHy5wQa2dWk8qWB5EDKTsJHYHvVM2TCV0UjZjKtQAjXhABAz296cJ4nlIRhyMtnjP1qhIhV5FIwcY565+tev8AhP4U6ZPY215qOpSX8ciB0WD5EIPYnqf0oA81Hmzs/wBl+aTsgGSfYVHLIREillXIywcc/ga9B8ea/pPh9ZvD3hW3t7eQLtvJ4x8yj/nnu6k+vPHTrnHmzX2ZW+U7OMEDr9KACJmki3xSjZn1qaMmVOCz46k8ZqOa4t9iHaoZR3OMfWsyPVPPl2easbpn92GGT9KALd6y+YxXB4CjPGKjaKK400xSJ8ytkc/0qmWHllziNRliXOMD3qyt1b2uiSX8qyXFshU4g5Z+cce3NAHHacG0bxNBqlzb/apJD5f74bBbpnll9TXoOqeMI4GZbSNGLdgece1Zfj/TG1KztFW+hs4GAOyQ4Zh25rkdYmTR9LilvXMVrGRGigfvJvUr7e9AHo/h/wAQm6nbfaxJIwxleGP4GumJBCoQNp5yh6V4BceNdE+xm400X0epR4CJMQEPvuH8qksH8V+OdLuJtNuHtJLchWTzSiTA/wB1jxkelAHviXPkSiITR4fOxGbBbHpUlvPFfQlreaNmXqEYEr9a+RfELa9Yah9k1uW8juoRgLI5yAfQ+lVtD1rUNEvkutOupoZAwLBHID+x9aAPsqJcypk/w9+9WYF27ckhSeuK8s+GfxPtPEWpLY6vILO6Zf3Zb7rnuM9jXW+L/FUOirGtpJHczkZKg5wPfFAEfxG1CJNNNj84uZiCpXgqO5rlPBojk1JgqkxxqdrHqx7msS91m6v7h9UvHEkoPC9segroPAm67M9/IdqE48vb0NAHbx7Ug6Ak5JPtXjHxt1lW0+CxiYfvJCSAeoH/ANevXLqVVtWOTjHU183/ABSuTN4kaHcGEKAcep5NAHH0UUUAFFFFAB2P0ptO7H6U2gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAp3YU2ndhQAUUUUAdZ8L7r7L4vtiSQJFZOK+ktPb7RBnO32Br5b8Gs0fiK0kVd2xskV9IaHqHmYVUCHb09DQBo3luLi1KSHITnrzVWBZriWJIUaWRztjjQZZj6YrRKLvOT8xGD71OniMeH9OW20OyWHU5Qwn1ByHdRn7sfHyjGP84NAGkdD0vw5brd+KQtzqIXfHpkT857GRh0Ht/PpVR/irq1rpt/H5MMYmwlqIUCi0HQhQBzx69D+Vcl9ukd3a5Z7hnbJkY7mY+pJpGt22HZlxknjrz2oAxpvLlu4bli0jE/M4+bn/aNc7b68l/rsuyS6jS1DI1t0U/7WPWty8spFvJcpJ5U2EKpxjHc1ZksosCQZilZSoKgAke5oAiu5TPYSS2yJK+z5YpDtyT2PpWHpw0jUNRM0UO29iI3DfnBA7e1dBZWDwKFOJ5WOXcDG6maN4OtYbiW8gsmtnmzuyxyPwzxQBagjN5+4ZB8w54zkVzXjnStWvHhsdKsGh0+FNjsJQokz6emPSut122ksfDl2uk5F4IsRMGyd3t71wngzWNVXRruPXkuGAYmKSZDuJHUZNAFPxTNd+DvDumWXn/ab5yziSZd/lDPQA8V5tqWoXep3LT39xJPMf4nOcfT0rqPiTrT6pc2UTL8sMedx6kk1xtABXQ+EfFupeGrnNrMz2bn97bMflcf0PvXPUqKzuFRSzHgADJNAHsXiO60fxJ4Re4uLhCwy1tO7fPHJjPlHvz6V45XoPw/sZbNLia8t4JlLKUtp13DeDwxHrTta8Gfb7ye6tClnvbcYcfKM/3R1xQBwulo76jbrFkPvHIr3S0h0+zitLW7jPnzoDLKckAHpXE+HPDdtpf2u7v7hAkCZeVx8oHt3ya7vTvFPg/VoLK3ur5XuIsKnmxmP8Mnj9aAMPWtNksbz7KjAxH5l+nbmvRPB0DxaJBuGCw3NXHeIp5tS1+C2ihEcZwiKB29a9KhVILWJI/lWJRn6AUAYni3UPsVntHbJLegFfMWr3TX2qXNyzFjI5OTXq/xL8Q77S6wwBc+XGAe3evHaACiiigAooooAOx+lNp3Y/Sm0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFO7Cm07sKACiiigDtvBFl5UscuRvcdxXqemXLQyJIckj7wzXnXgq5tpLVEyFkwQea7GJ5YUQnhh904+8KAPSYZFnRZFOSRnntVHWIldfOj+8OCc8GuY0jX1s5ds5/cu2F5ztrtB5c8IGRsdcg8GgDnLJRJdIjAg5446VuCK3hYmfzE2jOV7msy9ge2vY3VtqcZZT0FaLMjx7yQwJ6n0oAEa1uYxMiB4yeWVs5qjqrm0tkfTNPe/uGmVDGGC7VJ5bPtVizjjtIJEgRY7ZeQEXjnrUsYIGUPzMMgHnFAEtztjldI1WMkenP1ppkf7MoYF2j6nH3qztV1SLSxulIluZeI0B+Yn39qz5NTvfKLtNhivAHRfYUAaWoXEFjB5ssipn+D1PtXFalf3WtStFDGUgXhUH8R9TWo9sdQu1ubyRnbHQ1r29vDAV2qoK/xKPve9AHC/wDCHHUoXW9RDjlSeCD9RXGav4A1e03PaRG5iHZfvD8O9e5Fv3aMv3WyMCncbTs5yO54FAHzHLY3cUhjltZ0kH8JjINb3hTTLmK++1TwOkSKQCwxkn6173NDFNFiRBuI9a4rXtOuUJe1JVM/NkcUAUg8ANuYC0c5PzA9/pTdZtLnVri1NpJslhkBk3jB2k9PerWneGr+8YyzMqbBnceB+FbVi9np2rW0Em5w/wB+Rhxkf/XoAwfiRpMlj4Uu7cKxljuUaTb027TgmvG6+jvFXiCxm1C6iZYp4p0EU8bchv8ACsbwv4L0UX0V7BYMVDblMshdV+g/xoA2vhtaSXOhabfX4dZkjCqXXDEDgZrQ8Y6uljayxQvidxtwDyPetTWNRi061eaZwAF4WvE/GXiGQo0m7FxL0B7CgDlPFeoi+vwiHMcQ2/U9zWJQSSSSck8migAooooAKKKKADsfpTad2P0ptABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABTuwptO7CgAooooA1vDd79kv1BGUevVLa9WW2U7jJGOSM9K8WRijqynBByK9K8O3HnWsTK4LEZwe9AG1fMoGWjBTGUYdc+9bXg/wARCOQWd62VY/Kx6iuTvpmYMiZ45H+FZMGpQi4EbSBXz19KAPe5IkukO87lPTtmseSeS2JiXDxL90EYrnfCniVk2Wl4coo+V668JBqCeZCwJA4IoAoR6vIkjSRKFVxhlPIFal2pmsmubG7UQ+UzFwOhA6fnXG+J9PvrWMXVi/l9nQd653RfE81laXtjdyt5VwuwEDJH+FADNGk36hdahqMjOISdpJ+81acGozXDvxtQfyqDRfDz6gjNDcI1vu3eprrtL8Om3VQ4Vg2OetAFXSYJZ49xVihIP4V0XkgxkqPvDHA6Vet7eOJVWMjYDwO5+tTMo+YKMFjzjtQBhDZESC2WPAPc003ClNqZyDjFXNXsVnMRjOGXqxH5VPbWUcQjOA0i/ePbPrQBVS3lkjyF8tvXHIqT+zYiMXWZQSODzWiA3z7OvYn0pXbcwXK56c0ARmCMgpt2oB07VzHizSlFk88C4eMZPFdXkFmXBIAxzVLUl3WssbYBZefYUAeRaTo0mqzorSMZTJ847BfXNereZbaLpyLLwiLj2NYsVzp+hQfMVacqTu9a4Dxf4kaUeZNIwi/gj7mgA8beKDcO0kjHyVOI4/U15lfXct7cNNMcseg9B6UXt3LeTGSVifQdgKgoAKKKKACiiigAooooAOx+lNp3Y/Sm0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFO7Cm07sKACiiigArpfCurx2+Le4B4PyNnH4VzVFAHo9/e27JldynGcqa4LUphNduydAetRm6nMYjMjbPSoaANvRdfmsJVExMkWfXkV3Oj+JJYcy20xeInjnp9a8rqezu57OTfbyFD0I7GgD3hfEr3dsExEwPXPTNcrqdml3OXEawuM8djXJ6Xr0bIYpv3LNgZ/hJ/pXR2Jae4jUyZQ8jnjFAHZeC1jtNwlYK2Ox613cYXajRjg85H9a8TN/NFN+6faN3aup0Lxa9pKY7geZGevtQB6QoXO7jj0GKeFG9iQeR1FZ1jqdpfKrwyqfbPNWppFWJyG4POc0ASfLu5HJ6A0sZ2Bty8HpVdG8xVJHBXp6U8zhULDgKOp60AOUsc7jz6Z5pWHKgD347VUF/B5W8Mo3Dcc9q53XfGFvaRFLQ+bKOPYGgDo9T1K3slL3DhUHTPU15zrni6W5d/L+VOgx3rF1HUptSuVe6l5Ycc/KDWRfzxafH9puRubkKn940AW9d1Vba1je7bdKB8iDvn1rgL+8lvbgyzHk9AOgFGoXk1/ctPO2WPQDoB6Cq9ABRRRQAUUUUAFFFFABRRRQAdj9KbTux+lNoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKd2FNp3YUAFFFFABRRRQAUUUUAFFFFABWroutTaa5XO+Bhgqeo+lZVFAHoMMUcsaXEbeZE3IKnpTjIvmZD7Oa5DQtWfTZ8Nl7dj86enuPeu1iS2vIvtdi++I9VJyQfQ0AWLB7lNxt3YY9PWrv9u6mICDIzhThsii21RLW2SLylEb8MV6n3zUZvmmf7NG6eS7AZI5/GgDf0/xVctD+8UqBwDUWpeKLxh5cIHz9+y1kNj7YkM2DtI2sPu4qqYybuSNWzGG55oAsIuqTO0ayNKicttPWsu9kAUhECnOD71bGqvas627ZjIwVz196psXuCZ7lhHCnzM3SgBIlt7TT57q9YhR9xexNcJqd9Lf3JllPHRV7AVf8Saw2p3ASP5bWLhF9fesagAooooAKKKKACiiigAooooAKKKKADsfpTad2P0ptABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABTuwptO7CgAooooAKKKKACiiigAooooAKKKKACrem6hcadN5ls+M/eU9DVSigDvtP13TtSjWO4xbTDs3Q/Q1sfYIVRJI7iPHUNuH868ppwkcLtDsF9M8UAeoXb6crB7vU4Ff03VCLrR23Y1aHDdRnBrnNB8Ba7rVt9ot7dYoT91p22bvpVXXvB+t6GhkvrJvIHWWM7lH1I6UAdTNcaLaL5kt7G47KhyTXJ6/r76kPIgXyrVTwO7fWsKloASloooAKKKKACiiigAooooAKKKKACiiigA7H6U2ndj9KbQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU7sKbTuMDkUAFFHH94Ucf3hQAUUcf3hRx/eFABRRx/eFHH94UAFFHH94Ucf3hQAUUcf3hRx/eFABRRx/eFHH94UAFei/CjwvFqMkmrXsYlhgcJFEejP6n6V51x/eFemfCjxfpuh2V5Zazc+REziWJhGzc9CPlBoA9oijbyB5hCg/eHTFVrq0ju4nQjzYZVKSKe471gRfEbwkd3m6uee32eb/4imN8RfCYyI9WwCDz9mlz/AOgUAeDeIbIadrd7aKrKsUrKobrjPFZ9dR8RtR0/VvE0t5pU/nQOi5bYy849CAa5fj+8KACijj+8KOP7woAKKOP7wo4/vCgAoo4/vCjj+8KACijj+8KOP7woAKKOP7wo4/vCgAoo4/vCjj+8KADsfpTafxg8imUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT images (coronal view on the left and transverse on the right) showing a markedly dilated and thick walled ileal loop with focal mesenteric edema (arrows). Because the patient developed acute onset of obstruction, the proximal small bowel has not yet dilated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Anthony Samir, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38611=[""].join("\n");
var outline_f37_45_38611=null;
var title_f37_45_38612="Scabies interdigital";
var content_f37_45_38612=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Scabies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38612=[""].join("\n");
var outline_f37_45_38612=null;
var title_f37_45_38613="Femoral hernia anatomy";
var content_f37_45_38613=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Femoral hernia anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 502px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The femoral hernia protrudes below the inguinal ligament and medial to the femoral artery, often in the upper thigh area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Harwood-Nuss A, Wolfson AB, et al. The Clinical Practice of Emergency Medicine, 3rd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38613=[""].join("\n");
var outline_f37_45_38613=null;
var title_f37_45_38614="Vitamin C (ascorbic acid): Drug information";
var content_f37_45_38614=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Vitamin C (ascorbic acid): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?32/27/33205?source=see_link\">",
"    see \"Vitamin C (ascorbic acid): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/18/8485?source=see_link\">",
"    see \"Vitamin C (ascorbic acid): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Acerola [OTC];",
"     </li>",
"     <li>",
"      Asco-Caps-1000 [OTC];",
"     </li>",
"     <li>",
"      Asco-Caps-500 [OTC];",
"     </li>",
"     <li>",
"      Asco-Tabs-1000 [OTC];",
"     </li>",
"     <li>",
"      Ascocid&reg; [OTC];",
"     </li>",
"     <li>",
"      Ascocid&reg;-500 [OTC];",
"     </li>",
"     <li>",
"      C-Gel [OTC];",
"     </li>",
"     <li>",
"      C-Gram [OTC];",
"     </li>",
"     <li>",
"      C-Time [OTC];",
"     </li>",
"     <li>",
"      Cemill 1000 [OTC];",
"     </li>",
"     <li>",
"      Cemill 500 [OTC];",
"     </li>",
"     <li>",
"      Chew-C [OTC];",
"     </li>",
"     <li>",
"      Dull-C&reg; [OTC];",
"     </li>",
"     <li>",
"      Mild-C&reg; [OTC];",
"     </li>",
"     <li>",
"      One Gram C [OTC];",
"     </li>",
"     <li>",
"      Time-C&reg; [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; Vitamin C [OTC];",
"     </li>",
"     <li>",
"      Vita-C&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F136901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Proflavanol C&trade;;",
"     </li>",
"     <li>",
"      Revitalose C-1000&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F136950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vitamin, Water Soluble",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F136905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Recommended daily allowance (RDA):",
"     </b>",
"     Upper limit of intake should not exceed 2000 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Males: 90 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Females: 75 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Pregnant females:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     &le;18 years: 80 mg; upper limit of intake should not exceed 1800 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     19-50 years: 85 mg; upper limit of intake should not exceed 2000 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lactating females:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     &le;18 years: 115 mg; upper limit of intake should not exceed 1800 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     19-50 years: 120 mg; upper limit of intake should not exceed 2000 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adult smoker: Add an additional 35 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Scurvy:",
"     </b>",
"     Oral, I.M., I.V., SubQ: 100-250 mg 1-2 times/day for at least 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Urinary acidification:",
"     </b>",
"     Oral, I.V.: 4-12 g/day in 3-4 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention and treatment of colds:",
"     </b>",
"     Oral: 1-3 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral: 50-200 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F136926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/18/8485?source=see_link\">",
"      see \"Vitamin C (ascorbic acid): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Recommended adequate intake (AI):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0-6 months: 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6 -12 months: 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Recommended daily allowance (RDA):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-3 years: 15 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-8 years: 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     9-13 years: 45 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     14-18 years: Males: 75 mg, females 65 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Scurvy:",
"     </b>",
"     Oral, I.M., I.V., SubQ: Children: 100-300 mg/day in divided doses for at least 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Urinary acidification:",
"     </b>",
"     Oral, I.V.: Children: 500 mg every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral: Children: 35-100 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F136906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F136883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral: 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, timed release, oral: 500 mg, 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild-C&reg;: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, softgel, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     C-Gel: 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, sustained release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     C-Time: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, timed release, oral: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Asco-Caps-500: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Asco-Caps-1000: 1000 mg [sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Time-C&reg;: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Crystals for solution, oral:  (170 g, 1000 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild-C&reg;:  (170 g, 1000 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vita-C&reg;:  (113 g, 454 g) [dye free, gluten free, sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 500 mg/mL (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 500 mg/mL (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral: 500 mg/5 mL (118 mL, 473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lozenge, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicks&reg; Vitamin C: 25 mg (20s) [contains sodium 5 mg/lozenge; orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ascocid&reg;:  (227 g, 454 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dull-C&reg;:  (113 g, 454 g) [dye free, gluten free, sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 100 mg, 250 mg, 500 mg, 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Asco-Tabs-1000: 1000 mg [sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ascocid&reg;-500: 500 mg [sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     C-Gram: 1000 mg [dye free, gluten free, sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     One Gram C: 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral: 250 mg, 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Acerola: 500 mg [cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild-C&reg;: 250 mg [orange-tangerine flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral [buffered]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chew-C: 500 mg [orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, timed release, oral: 500 mg, 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cemill 500: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cemill 1000: 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild-C&reg;: 1000 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F136867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F136886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid rapid I.V. injection.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F136955\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in dextran 6% in D",
"     <sub>",
"      5",
"     </sub>",
"     W, dextran 6% in NS, D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in fat emulsion 10%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Warfarin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Etomidate, propofol, thiopental.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Metoclopramide.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Cefazolin, doxapram.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F136885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention and treatment of scurvy; acidify the urine",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F136946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In large doses, to decrease the severity of &ldquo;colds&rdquo;; dietary supplementation; a 20-year study was recently completed involving 730 individuals which indicates a possible decreased risk of death by stroke when ascorbic acid at doses &ge;45 mg/day was administered",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F3149850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Rubex [Ireland] may be confused with Brivex brand name for brivudine [Switzerland]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Rubex: Brand name for ascorbic acid [Ireland], but also the brand name for doxorubicin [Brazil]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F136948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%: Renal: Hyperoxaluria (incidence dose related)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Dizziness, faintness, fatigue, flank pain, headache",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F136871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Patients with diabetes mellitus should not take excessive doses for extended periods of time.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal calculi: Patients prone to recurrent renal calculi (eg, dialysis patients) should not take excessive doses for extended periods of time.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Aluminum: Some parenteral products contain aluminum; use caution in patients with impaired renal function and neonates.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F136876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aluminum Hydroxide: Ascorbic Acid may increase the absorption of Aluminum Hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Gastrointestinal Acidifying Agents may decrease the serum concentration of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bortezomib: Ascorbic Acid may diminish the therapeutic effect of Bortezomib.  Management: Patients should avoid taking vitamin C supplements and vitamin C-containing multivitamins during their bortezomib therapy.  It is probably unnecessary to advise patients to avoid foods/beverages that contain vitamin C (e.g., citrus fruits, etc.).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Copper: May decrease the serum concentration of Ascorbic Acid. Management: To minimize the risk for ascorbic acid degradation, add multivitamin product to TPN solution immediately prior to infusion or administer multivitamin and copper in separate containers.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Ascorbic Acid may decrease the serum concentration of CycloSPORINE (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferoxamine: Ascorbic Acid may enhance the adverse/toxic effect of Deferoxamine. Left ventricular dysfunction is of particular concern.  Management: Avoid ascorbic acid doses greater than 200 mg/day.  Lower doses may be given to patients without cardiac failure, after one month of regular treatment with deferoxamine alone, ideally soon after setting up the infusion pump.  Monitor cardiac function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Estrogen Derivatives: Ascorbic Acid may increase the serum concentration of Estrogen Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F136879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A/C (dose exceeding RDA recommendation) (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6789328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F136910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/compatible",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F4844417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F6133143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Vitamin C Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $4.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Liquid C 500 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/15 mL (237 mL): $13.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Ascor L 500 Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/mL (50 mL): $11.95",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Ascor L NC Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/mL (50 mL): $16.95",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Ascorbic Acid Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/mL (50 mL): $12.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Cenolate Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/mL (1 mL): $1.67",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Sodium Ascorbate Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg/mL (30 mL): $10.35",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Syrup",
"     </b>",
"     (Protexin Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/15 mL (118.3 mL): $8.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, controlled release",
"     </b>",
"     (Cemill Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $6.48",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, controlled release",
"     </b>",
"     (Cemill SR Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 mg (100): $8.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Ascorbic Acid Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $2.89",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $4.18",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 mg (100): $8.33",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F136881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor pH of urine when using as an acidifying agent",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F136891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Appeton Activ-C (MY);",
"     </li>",
"     <li>",
"      Ascofer (LU);",
"     </li>",
"     <li>",
"      Asconvita (PH);",
"     </li>",
"     <li>",
"      Ascorbin (PH);",
"     </li>",
"     <li>",
"      Ascormin (TW);",
"     </li>",
"     <li>",
"      Ascorvit (DE);",
"     </li>",
"     <li>",
"      Askorbin (ID);",
"     </li>",
"     <li>",
"      Askorbinsyre &ldquo;Dak&rdquo; (DK);",
"     </li>",
"     <li>",
"      Biferce (ID, SG);",
"     </li>",
"     <li>",
"      Biovital Vitamin C (HU);",
"     </li>",
"     <li>",
"      C Vitamin Pharmavit (HU);",
"     </li>",
"     <li>",
"      C-Dose (BE);",
"     </li>",
"     <li>",
"      C-Vimin (FI, NO, SE);",
"     </li>",
"     <li>",
"      C-Will (BE, LU, TH);",
"     </li>",
"     <li>",
"      Ce-Vi-Sol (CR, DO, GT, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Cebion (AE, AT, BH, CN, CY, EG, ES, GR, IL, IQ, IR, IT, JO, KW, LB, LY, OM, PE, PL, PT, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Cecai (TW);",
"     </li>",
"     <li>",
"      Cecap (HK);",
"     </li>",
"     <li>",
"      CeCe (KP);",
"     </li>",
"     <li>",
"      Cecon (BB, BM, BS, BZ, GY, JM, PH, PR, SR, TT);",
"     </li>",
"     <li>",
"      Cecon Drops (AU);",
"     </li>",
"     <li>",
"      Ceelin (SG);",
"     </li>",
"     <li>",
"      Celin (IN);",
"     </li>",
"     <li>",
"      Celon (BE);",
"     </li>",
"     <li>",
"      Cenol (LU);",
"     </li>",
"     <li>",
"      Cetamine (BE, LU);",
"     </li>",
"     <li>",
"      Cetebe (BG, HU);",
"     </li>",
"     <li>",
"      Cetrinets (MY);",
"     </li>",
"     <li>",
"      Cevalin (MX);",
"     </li>",
"     <li>",
"      Cevi Drops (LU);",
"     </li>",
"     <li>",
"      Cevidrops (BE);",
"     </li>",
"     <li>",
"      Cewin (BR);",
"     </li>",
"     <li>",
"      Citravite (IN, NZ);",
"     </li>",
"     <li>",
"      Dayvital (NL);",
"     </li>",
"     <li>",
"      Femiprim (MX);",
"     </li>",
"     <li>",
"      Fit-C (ID);",
"     </li>",
"     <li>",
"      Flavettes (SG);",
"     </li>",
"     <li>",
"      Hicee (JP);",
"     </li>",
"     <li>",
"      Leder C (TW);",
"     </li>",
"     <li>",
"      Limcee (IN);",
"     </li>",
"     <li>",
"      Nutricee (PH);",
"     </li>",
"     <li>",
"      Ophtavit C (BE, LU);",
"     </li>",
"     <li>",
"      Plivit C (HR);",
"     </li>",
"     <li>",
"      Pro-C (AU);",
"     </li>",
"     <li>",
"      Redoxon (AE, AR, AT, AU, BE, BH, BR, CH, CO, CY, CZ, EC, EG, ES, FI, GB, GR, HK, IE, IL, IQ, IR, IT, JO, KW, LB, LU, LY, OM, PE, PT, PY, QA, SA, SY, TR, UY, VE, YE);",
"     </li>",
"     <li>",
"      Redoxon C (BB, BF, BJ, BM, BS, BZ, CI, ET, GH, GM, GN, GY, JM, KE, LR, MA, ML, MR, MU, MW, NE, NG, PR, SC, SD, SL, SN, SR, TN, TT, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Redoxon Forte (IN);",
"     </li>",
"     <li>",
"      Scorbex (ZA);",
"     </li>",
"     <li>",
"      Sweetcee (TH);",
"     </li>",
"     <li>",
"      Tanvimil-C (AR);",
"     </li>",
"     <li>",
"      Teddy-C (TH);",
"     </li>",
"     <li>",
"      Tropicee (PH);",
"     </li>",
"     <li>",
"      Upha C (MY);",
"     </li>",
"     <li>",
"      Upsa-C (AE, BE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Vamcee (PH);",
"     </li>",
"     <li>",
"      Vicef (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Vit'C (BE);",
"     </li>",
"     <li>",
"      Vita-Cedol Orange (BB, BM, BS, BZ, GY, JM, PR, SR, TT);",
"     </li>",
"     <li>",
"      Vitac (CN);",
"     </li>",
"     <li>",
"      Vitamin C (HR, HU);",
"     </li>",
"     <li>",
"      Vitamine C Lambo (BE);",
"     </li>",
"     <li>",
"      Vitamine C OJG (BE);",
"     </li>",
"     <li>",
"      Vitamine C Repha (BE);",
"     </li>",
"     <li>",
"      Vitamine C Roter (LU);",
"     </li>",
"     <li>",
"      Vitamine-C-Qualiphar (LU);",
"     </li>",
"     <li>",
"      Vitascorbol (FR);",
"     </li>",
"     <li>",
"      Vitonic (LU);",
"     </li>",
"     <li>",
"      Vorange (HK, MY, SG);",
"     </li>",
"     <li>",
"      Xon-ce (ID);",
"     </li>",
"     <li>",
"      &Aacute;cido asc&oacute;rbico (MX)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F136870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not fully understood; necessary for collagen formation and tissue repair; involved in some oxidation-reduction reactions as well as other metabolic pathways, such as synthesis of carnitine, steroids, and catecholamines and conversion of folic acid to folinic acid",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F136888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Readily absorbed; an active process thought to be dose dependent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Large",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via oxidation and sulfation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (with high blood levels)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American College of Obstetricians and Gynecologists, &ldquo;ACOG Practice Bulletin No. 95: Anemia in Pregnancy,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2008, 112(1):201-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/18591330/pubmed\" id=\"18591330\" target=\"_blank\">",
"        18591330",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Anbe SC, Alpert JS, et al, &ldquo;ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 110(5):588-636. Available at  file://www.circulationaha.org/cgi/content/full/110/5/588",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/15289388/pubmed\" id=\"15289388\" target=\"_blank\">",
"        15289388",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baker WF Jr, &ldquo;Iron Deficiency in Pregnancy, Obstetrics, and Gynecology,&rdquo;",
"      <i>",
"       Hematol Oncol Clin North Am",
"      </i>",
"      , 2000, 14(5):1061-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/11005034/pubmed\" id=\"11005034\" target=\"_blank\">",
"        11005034",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ballin A, Brown EJ, Koren G, et al, &ldquo;Vitamin C-Induced Erythrocyte Damage in Premature Infants,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1988, 113(1 Pt 1):114-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/3385519/pubmed\" id=\"3385519\" target=\"_blank\">",
"        3385519",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Giunta JL, &ldquo;Dental Erosion Resulting From Chewable Vitamin C Tablets,&rdquo;",
"      <i>",
"       J Am Dent Assoc",
"      </i>",
"      , 1983, 107(2):253-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/6578267/pubmed\" id=\"6578267\" target=\"_blank\">",
"        6578267",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of  Medicine),",
"      <i>",
"       Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc",
"      </i>",
"      , Washington, DC: National Academy Press, 2001, 162-84.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Korallus U, Harzdorf C, and Lewalter J, &ldquo;Experimental Basis for Ascorbic Acid Therapy of Poisoning by Hexavalent Chromium Compounds,&rdquo;",
"      <i>",
"       Int Arch Occup Environ Health",
"      </i>",
"      , 1984, 53(3):247-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/6706420/pubmed\" id=\"6706420\" target=\"_blank\">",
"        6706420",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lawton JM, Conway LT, Crosson JT, et al, &ldquo;Acute Oxalate Nephropathy After Massive Ascorbic Acid Administration,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1985, 145(5):950-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/3994472/pubmed\" id=\"3994472\" target=\"_blank\">",
"        3994472",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McAllister CJ, Scowden EB, Dewberry FL, et al, &ldquo;Renal Failure Secondary to Massive Infusion of Vitamin C,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1984, 252(13):1684.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Myrianthopoulos M, &ldquo;Dietary Treatment of Hyperlipidemia in the Elderly,&rdquo;",
"      <i>",
"       Clin Geriatr Med",
"      </i>",
"      , 1987, 3(2):343-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/3581018/pubmed\" id=\"3581018\" target=\"_blank\">",
"        3581018",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Nutrition During Lactation.&rdquo; Subcommittee on Nutrition During Lactation, Committee on Nutritional Status During Pregnancy and Lactation, Food and Nutrition Board Institute of Medicine, National Academy of Sciences Washington, DC: National Academy Press, 1991. Available at",
"      <a href=\"file://www.nap.edu\" target=\"_blank\">",
"       file://www.nap.edu",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perrone G, Hideshima T, Ikeda H, et al, &ldquo;Ascorbic Acid Inhibits Activity of Bortezomib",
"      <i>",
"       in vivo",
"      </i>",
"      ,&rdquo;",
"      <i>",
"       Leukemia",
"      </i>",
"      , 2009, 23(9):1679-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/19369963/pubmed\" id=\"19369963\" target=\"_blank\">",
"        19369963",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pru C, Eaton J, and Kjellstrand C, &ldquo;Vitamin C Intoxication and Hyperoxalemia in Chronic Hemodialysis Patients,&rdquo;",
"      <i>",
"       Nephron",
"      </i>",
"      , 1985, 39(2):112-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/3974772/pubmed\" id=\"3974772\" target=\"_blank\">",
"        3974772",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Recommendations to Prevent and Control Iron Deficiency in the United States. Centers for Disease Control and Prevention,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 1998, 47(RR-3):1-29.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/9563847/pubmed\" id=\"9563847\" target=\"_blank\">",
"        9563847",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Routine Iron Supplementation During Pregnancy. Review Article. US Preventive Services Task Force,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1993, 270(23):2848-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/8133626/pubmed\" id=\"8133626\" target=\"_blank\">",
"        8133626",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tunget CL, Clark RF, Manoguerra AS, et al, &ldquo;Iron Overdose and Detection of Gastrointestinal Bleeding With the Hemoccult&reg; and Gastroccult&reg; Assays,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1995, 26(1):54-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/45/38614/abstract-text/7793721/pubmed\" id=\"7793721\" target=\"_blank\">",
"        7793721",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9776 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38614=[""].join("\n");
var outline_f37_45_38614=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136900\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136901\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136950\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136905\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136926\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136906\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136883\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136867\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136886\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136955\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136885\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136946\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3149850\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136948\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136871\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298776\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136876\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136879\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6789328\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136910\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4844417\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6133143\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136881\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136891\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136870\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136888\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9776\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9776|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?32/27/33205?source=related_link\">",
"      Vitamin C (ascorbic acid): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/18/8485?source=related_link\">",
"      Vitamin C (ascorbic acid): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_45_38615="Human Th subsets";
var content_f37_45_38615=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F58150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F58150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Human T helper (Th) cell subsets",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 445px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38615=[""].join("\n");
var outline_f37_45_38615=null;
var title_f37_45_38616="Dent's disease (X-linked recessive nephrolithiasis)";
var content_f37_45_38616=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dent's disease (X-linked recessive nephrolithiasis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/45/38616/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38616/contributors\">",
"     Steven J Scheinman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/45/38616/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38616/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/45/38616/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38616/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/45/38616/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dent's disease is an X-linked recessive disorder of the proximal tubules that is characterized by hypercalciuria, nephrocalcinosis, kidney stones, renal failure, and rickets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In most cases, it is due to mutations that inactivate a voltage-gated chloride transporter named CLC-5. In others, it is associated with mutations in the OCRL1 gene, which is also mutated in the oculocerebrorenal syndrome of Lowe. Further genetic heterogeneity is assumed to exist since there are patients with the distinctive phenotype of Dent's disease without mutation in either of these genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Molecular genetics'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The following topic review will present the genetics, clinical manifestations, and treatment of Dent's disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NOMENCLATURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although different features of Dent's disease predominated among early reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/4-7\">",
"     4-7",
"    </a>",
"    ], an accurate description of the phenotype was offered in the report entitled, \"Dent's disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure, and a marked male predominance\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    \"Dent's disease\" is accepted as the encompassing name of this disease, based upon this limited renal phenotype that includes a partial Fanconi syndrome. The disease is distinguished clinically from the Lowe syndrome by the absence of cataracts, mental developmental delay, and renal tubular acidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MOLECULAR GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 60 percent of cases, Dent's disease is due to mutations that inactivate a voltage-gated chloride transporter, CLC-5, which is expressed in the kidney and is encoded by a gene at Xp11.22 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/9\">",
"     9",
"    </a>",
"    ]. In another 15 percent of cases, it is associated with mutations in the OCRL1 gene, which is also mutated in the oculocerebrorenal syndrome of Lowe. Further genetic heterogeneity is assumed to exist since there are patients with the distinctive phenotype of Dent's disease who do not have mutation in either of these genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10890273\">",
"    <span class=\"h2\">",
"     CLCN5 gene (Dent's disease 1)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The defective gene identified in the majority of patients with Dent's disease, CLCN5, which encodes the CLC-5 protein, is a member of the CLC family of chloride transporters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Although some members of the CLC family act as chloride channels, the members of the branch of this family that includes CLC-5 function as chloride-proton antiporters. CLC-5 is found primarily, but not exclusively, in the kidneys. It is expressed in subapical endosomes in the proximal tubule, medullary thick ascending limb, and type A intercalated cells of the collecting duct [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large number of different mutations in this channel have been identified in families affected by Dent's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1,14-25\">",
"     1,14-25",
"    </a>",
"    ], and these mutations inactivate the function of the protein in various ways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/9,16,17,20,26\">",
"     9,16,17,20,26",
"    </a>",
"    ]. There is no correlation between the nature of the mutation and the presence of particular clinical features or the overall severity of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CLC-5 transporter is a homodimer, and many missense mutations result in amino acid changes at or near the interface of the two subunits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/27\">",
"     27",
"    </a>",
"    ]. Missense mutations fall into three categories or classes: one group of mutations leads to retention and subsequent degradation of the protein in the endoplasmic reticulum; the second group of mutations impairs transport function; and the third group of mutations impairs trafficking of the proteins and their distribution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10890288\">",
"    <span class=\"h2\">",
"     OCRL1 gene (Dent's disease 2)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most patients with Dent's disease have a mutation in the CLCN5 gene, mutations in the OCRL1 gene have also been described in approximately 15 percent of affected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/3,29\">",
"     3,29",
"    </a>",
"    ]. This gene is also located on the X chromosome and encodes a phosphatidylinositol 4,5-bisphosphate 5-phosphatase. Patients with Dent's disease who have mutations in the OCRL1 gene have been designated as having Dent's disease 2 (Dent-2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     OCRL1 gene and the Lowe oculocerebrorenal syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Lowe oculocerebrorenal syndrome is phenotypically similar to Dent's disease. However, all patients with this syndrome appear to have mutations in OCRL1, while those with Dent's disease have defects in either CLCN5 or OCRL1.",
"   </p>",
"   <p>",
"    <br/>",
"    OCRL1 mutations that have been found in patients with the Lowe syndrome are different from those reported in patients with Dent-2 disease. Although missense mutations in the phosphatase domain of the OCRL1 sequence are common in both disorders, the nonsense and frameshift mutations in patients with the Lowe syndrome occur only in exons 8 to 23, while all such mutations in Dent-2 patients occur in the first seven exons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/23,31\">",
"     23,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This implies that the phenotypic differences between patients with Lowe syndrome and those with Dent-2 might result from tissue-specific expression of alternative OCRL1 transcripts. On the other hand, variability of symptom severity or organ involvement could reflect variations in the expression of modifying phosphatase genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CLC-5 is present in the membrane of subapical endosomes in the proximal tubule. Along with a proton-ATPase that is also present in the membrane, CLC-5 in part facilitates maximal acidification of these endosomes by allowing for chloride entry and proton exit from the endosome, thereby dissipating the positive charge generated by the proton pump (",
"    <a class=\"graphic graphic_figure graphicRef62203 \" href=\"mobipreview.htm?40/24/41344\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H193923264\">",
"    <span class=\"h2\">",
"     Mechanisms of proteinuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inactivation of CLC-5 and the consequent failure to maximally acidify subapical endosomes explains the low-molecular-weight proteinuria in patients with Dent's disease. Low-molecular-weight proteins are filtered freely at the glomerulus, adsorbed to receptors (including megalin) on the apical surface of the proximal tubular cells, and then endocytosed. Impaired endosomal acidification results in a failure to process adsorbed proteins (",
"    <a class=\"graphic graphic_figure graphicRef69370 \" href=\"mobipreview.htm?8/40/8838\">",
"     figure 2",
"    </a>",
"    ). This may also lead to decreased recycling of the endosomal membrane back to the apical surface. Studies in knockout mice have confirmed the importance of CLC-5 in receptor-mediated endocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/34-36\">",
"     34-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CLC-5 protein also interacts directly with components of the actin pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/37\">",
"     37",
"    </a>",
"    ] and with kinesin family member 3B (KIF3B), a protein involved in the translocation of intracellular organelles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/38\">",
"     38",
"    </a>",
"    ]. Thus, CLC-5 can substantially affect membrane trafficking in the proximal tubule. This is consistent with the observations that urinary megalin is reduced in patients with Dent's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/39\">",
"     39",
"    </a>",
"    ] and in CLCN5-knockout mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/34\">",
"     34",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    The discovery that mutations in OCRL1 can cause the Dent's disease phenotype points to overlap in the physiological functions of the OCRL phosphatase and the CLC-5 protein. The OCRL phosphatase affects endosomal trafficking both through altered cellular levels of PIP2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/40\">",
"     40",
"    </a>",
"    ] and through a direct interaction with clathrin, a protein involved in endosomal assembly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H193923279\">",
"    <span class=\"h2\">",
"     Mechanisms of hypercalciuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypercalciuria in patients with Dent's disease appears to be due to hyperabsorption of calcium from the gastrointestinal tract instead of a calcium leak in the kidney. This is supported by the observation that mice develop hypercalciuria that can be eliminated with a low-calcium diet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. In addition, affected patients and mice with partial inhibition of CLC-5 both have an exaggerated calciuretic response to oral calcium loading. In addition, the hypercalciuria often corrects with dietary calcium restriction (which, however, is not recommended as therapy; see below). This pattern is consistent with a role for calcitriol (1,25-dihydroxyvitamin D) excess in the hypercalciuria. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    On the other hand, a small degree of hypercalciuria persists when dietary calcium is severely restricted in CLCN5-knockout mice that have biochemical evidence of increased bone turnover [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/44\">",
"     44",
"    </a>",
"    ]. In this respect, these growing mice resemble children with Dent's disease who have a component of fasting hypercalciuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/43\">",
"     43",
"    </a>",
"    ]. However, in children and adults with Dent's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/43\">",
"     43",
"    </a>",
"    ], as in the knockout mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/44\">",
"     44",
"    </a>",
"    ], the largest component of hypercalciuria is diet-dependent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H193923372\">",
"    <span class=\"h2\">",
"     Mechanisms of hyperphosphaturia and increased calcitriol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies of knockout mice demonstrate that recycling of phosphate transporters in the proximal tubule, although slowed, is intact. Thus, the hyperphosphaturia and increased 1 alpha-hydroxylation of 25-hydroxyvitamin D in knockout mice and patients with Dent's disease cannot be explained by impaired trafficking of phosphate transporters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Instead, hyperphosphaturia and increased 1 alpha-hydroxylation may be due to increased activation of parathyroid hormone (PTH) receptors on the apical membrane of the late proximal tubule by PTH. PTH is a low-molecular-weight protein that is filtered at the glomerulus, and thus diminished low-molecular-weight protein reabsorption due to non-functional CLC-5 may lead to high levels of the hormone in the late proximal tubule, promoting receptor activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/2\">",
"     2",
"    </a>",
"    ]. Urinary PTH excretion is high in both knockout mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/34\">",
"     34",
"    </a>",
"    ] and humans with Dent's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/45\">",
"     45",
"    </a>",
"    ]. Phosphaturia and increased activation of vitamin D may combine to promote the disorder in calcium and phosphate metabolism seen in Dent's disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected patients usually present in childhood with polyuria, microscopic hematuria, asymptomatic proteinuria, or kidney stones. The prevalences of these clinical features among affected males with documented mutations are summarized in the following table (",
"    <a class=\"graphic graphic_table graphicRef74862 \" href=\"mobipreview.htm?36/20/37195\">",
"     table 1",
"    </a>",
"    ). Symptomatic disease is almost exclusively confined to males, with inheritance being X-linked recessive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Proximal tubular reabsorptive failure and proteinuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant low-molecular-weight proteinuria is present in affected males and, to a lesser degree, in many carrier females. Protein excretion of 1 to 2",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    is present from early childhood, approximately one-half of which consists of albumin. The nephrotic syndrome does not occur.",
"   </p>",
"   <p>",
"    Other signs of proximal tubular dysfunction, such as glucosuria, aminoaciduria, and phosphaturia, are also common in affected males. However, these findings vary among patients and can occur intermittently in a given patient. As an example, hypophosphatemia occurs in about one-third of patients and is usually mild. However, renal tubular acidosis is not typically seen in Dent's disease, although it does occur in Lowe syndrome. (See",
"    <a class=\"local\" href=\"#H131450907\">",
"     'Lowe syndrome'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Hypercalciuria, nephrocalcinosis, and kidney stones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most affected males are hypercalciuric until renal function starts to decline. The degree of hypercalciuria can be impressive in young children, who may excrete 8 to 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    body weight (normal &lt;4.0",
"    <span class=\"nowrap\">",
"     mg/kg).",
"    </span>",
"    However, in teenagers and adults, the hypercalciuria is usually moderate, comparable to that in patients with idiopathic hypercalciuria.",
"   </p>",
"   <p>",
"    Nephrocalcinosis occurs in 75 percent of patients and is often evident in childhood. Kidney stones occur in one-half of patients. These stones consist of calcium oxalate, calcium phosphate, or both. The main risk factor for stones is the hypercalciuria since urinary excretion of oxalate and citrate is normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/53/33626?source=see_link\">",
"     \"Risk factors for calcium stones in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17081?source=see_link\">",
"     \"Nephrocalcinosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum calcitriol tends to be normal or slightly elevated, serum calcium tends to be normal, and serum parathyroid hormone (PTH) tends to be normal or low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1,46\">",
"     1,46",
"    </a>",
"    ]. In one study, elevated levels of calcitriol fell to normal when patients were given oral phosphate replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/47\">",
"     47",
"    </a>",
"    ]. However, it is unclear whether hypophosphatemia is the cause of high serum calcitriol concentrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Renal insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately two-thirds of affected males develop some degree of chronic kidney disease, with decreased creatinine clearance evident in some patients by late childhood. A similar fraction of patients with CLCN5 mutations progress to end-stage renal disease (ESRD), usually between the ages of 30 and 40 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/8,48\">",
"     8,48",
"    </a>",
"    ]. Although most such patients have nephrocalcinosis, the development of renal failure does not consistently correlate with the presence or severity of nephrocalcinosis.",
"   </p>",
"   <p>",
"    The cause of renal failure is not known. It may be related to the development of glomerular sclerosis (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Pathology'",
"    </a>",
"    below); the presence of bioactive low-molecular-weight hormones, growth factors, and cytokines in the tubule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/45\">",
"     45",
"    </a>",
"    ]; or to abnormal renal handling of proteins that may inhibit calcification, such as osteopontin. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41066?source=see_link\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Rickets or osteomalacia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 25 percent of affected males with Dent's disease have rickets or osteomalacia, which can present in infancy with severe deforming bone disease. However, most patients paradoxically have no signs of bone disease, have normal bone mineral density, and achieve a normal height [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/43\">",
"     43",
"    </a>",
"    ]. Most reports of rickets have been from Europe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/6-8\">",
"     6-8",
"    </a>",
"    ], although it has occurred in North America [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/14,46\">",
"     14,46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/54/27494?source=see_link\">",
"     \"Epidemiology and etiology of osteomalacia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of rickets does not correlate with particular mutations, as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rickets can occur in a single affected male within a family in which other affected males who share the same mutation are free of bone disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The most common CLCN5 mutation involves a substitution of leucine for serine at codon 244 (S244L), which has been reported in seven unrelated families. In two European families with this mutation, all nine affected males had rickets [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]; however, in a large pedigree which observed patients from the southern United States who had the same mutation, none of the affected males had any evidence for rickets [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unknown if the occurrence of rickets represents the effects of modifying genes, the severity of hypophosphatemia, diet, or other factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Dent's disease often have nocturia and polyuria from early childhood, with relative resistance to antidiuretic hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/8,43,47\">",
"     8,43,47",
"    </a>",
"    ]. In adults, impaired concentrating ability correlates with the degree of renal insufficiency or nephrocalcinosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/8,43\">",
"     8,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Urinary acidification is usually normal, and impaired acidification does not appear to be an intrinsic feature of the disease. Impaired acidification can occur in the setting of nephrocalcinosis or renal insufficiency, which are themselves sufficient explanations for the defect.",
"   </p>",
"   <p>",
"    In one case report, a boy presented with prominent hypokalemia and metabolic alkalosis, features suggestive of Bartter syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/49\">",
"     49",
"    </a>",
"    ]. The patient, however, also had hypophosphatemia, proteinuria, and nephrocalcinosis, as well as a verified defect in CLCN5.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H131450907\">",
"    <span class=\"h2\">",
"     Lowe syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Lowe oculocerebrorenal syndrome is phenotypically similar to Dent's disease; low-molecular-weight proteinuria and hypercalciuria are present in both disorders. However, patients with Lowe oculocerebrorenal syndrome also have renal tubular acidosis, congenital cataracts, and mental retardation, findings which are absent in Dent's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/3,29,30,50\">",
"     3,29,30,50",
"    </a>",
"    ]. In addition, patients with the Lowe oculocerebrorenal syndrome commonly have growth failure, which corrects with alkali therapy, and progressive renal impairment that is typically more aggressive and occurs at an earlier age than the renal impairment in Dent's disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal biopsy findings are nonspecific. Glomerular sclerosis is seen without any basement membrane abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/51\">",
"     51",
"    </a>",
"    ]. Tubular atrophy, varying degrees of interstitial inflammation, and interstitial fibrosis are also observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H74083558\">",
"    <span class=\"h1\">",
"     EVALUATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected males commonly present with symptoms of kidney stones or polyuria, or when a urinalysis (which is performed in an infant or older child) reveals proteinuria often accompanied by microscopic hematuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1,48,53\">",
"     1,48,53",
"    </a>",
"    ]. Children with Dent's disease are diagnosed at a young age in Japan because urinalyses are performed as part of a public health screening program meant to detect heavy metal toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of Dent's disease is made clinically, based upon the presence of the following characteristics in a male [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/54\">",
"     54",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low-molecular-weight proteinuria &minus; A test for urinary beta-2-microglobulin, a low-molecular-weight protein, is readily available and is therefore a practical screening test for Dent's disease, although assay of urinary retinol-binding protein is more sensitive and specific [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypercalciuria &minus; More than 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      of body weight in a 24-hour urine collection.",
"     </li>",
"     <li>",
"      At least one of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Nephrocalcinosis",
"     </li>",
"     <li>",
"      Nephrolithiasis",
"     </li>",
"     <li>",
"      Hematuria",
"     </li>",
"     <li>",
"      Hypophosphatemia",
"     </li>",
"     <li>",
"      Chronic kidney disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25214618\">",
"    <span class=\"h2\">",
"     Role of genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A family history indicating an X-linked inheritance of one or more of these clinical characteristics supports the diagnosis, and identification of a mutation in either CLCN5 or OCRL1 confirms the diagnosis. Genetic testing for CLCN5 and OCRL1 is available through various commercial laboratories.",
"   </p>",
"   <p>",
"    However, as noted above, not all affected patients have a mutation in one of these two genes. In addition, some patients with confirmed mutations in CLCN5 or OCRL1 will not fulfill all three clinical criteria. Thus, while the identification of a mutation in one of these two genes confirms the diagnosis in someone with suggestive clinical manifestations, a negative genetic test does",
"    <strong>",
"     not",
"    </strong>",
"    rule out the diagnosis of Dent's disease. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Molecular genetics'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Family members of affected individuals may be at risk of having affected progeny, particularly females who are potentially heterozygous for the patient's mutation. Thus, asymptomatic family members should be offered genetic counseling when they reach adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H193923453\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of Dent's disease includes other entities that can cause generalized proximal tubule dysfunction (Fanconi syndrome), such as cystinosis, galactosemia, multiple myeloma,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/25/38297?source=see_link\">",
"     ifosfamide",
"    </a>",
"    , and Chinese herbs. The absence of renal tubular acidosis will favor Dent's disease over other diagnoses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/22/17768?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology and clinical manifestations of renal tubular acidosis in infants and children\", section on 'Fanconi syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/18/12584?source=see_link\">",
"     \"Cystinosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30886?source=see_link\">",
"     \"Clinical features and diagnosis of galactosemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27400?source=see_link&amp;anchor=H12#H12\">",
"     \"Types of renal disease in multiple myeloma\", section on 'Renal tubular dysfunction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/29/14806?source=see_link&amp;anchor=H3#H3\">",
"     \"Ifosfamide nephrotoxicity\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/49/6933?source=see_link&amp;anchor=H4#H4\">",
"     \"Nephropathy induced by aristolochic acid (AA) containing herbs\", section on 'Presentation and prognosis'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although it is unknown to what extent hypercalciuria is responsible for the renal failure in Dent's disease, it is the major factor responsible for nephrolithiasis. Thus, an attempt to reduce calcium excretion is reasonable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10890640\">",
"    <span class=\"h2\">",
"     Reduction in calcium excretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reduction in calcium excretion should be approached by restricting dietary sodium intake (since sodium excretion promotes calcium excretion) and administering a thiazide diuretic, which stimulates the reabsorption of calcium. Anecdotal reports and the results of one trial indicate that thiazides correct the hypercalciuria in patients with Dent's disease when used in doses similar to those effective for idiopathic hypercalciuria (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/14/26854?source=see_link\">",
"     chlorthalidone",
"    </a>",
"    at 25",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1,55\">",
"     1,55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/2/38953?source=see_link\">",
"     \"Prevention of recurrent calcium stones in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Restriction of dietary calcium intake is",
"    <strong>",
"     not",
"    </strong>",
"    recommended because it may exacerbate the risk of bone disease. In addition, lower calcium intakes are associated with an increased annual incidence of kidney stones in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10890647\">",
"    <span class=\"h2\">",
"     Other therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In experimental models of Dent's disease, a diet high in citrate has been effective in retarding the progression of the renal disease, perhaps via a beneficial effect of enhancing calcium solubility in the urine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/2/38953?source=see_link\">",
"     \"Prevention of recurrent calcium stones in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Improvement in bone disease has been reported with oral phosphate therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/47\">",
"     47",
"    </a>",
"    ] and supplementation with vitamin D [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38616/abstract/8\">",
"     8",
"    </a>",
"    ]. When using vitamin D, it is important to titrate the dose carefully, following both serum levels of alkaline phosphatase and urinary calcium excretion, to avoid exacerbating the hypercalciuria via increased intestinal calcium absorption.",
"   </p>",
"   <p>",
"    Patients with end-stage renal failure do well on dialysis and are often excellent candidates for transplantation (the disease does not recur after transplantation). Patients without preexisting rickets are not predisposed to renal osteodystrophy if they are compliant with conventional therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13443417\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dent's disease is an X-linked recessive disorder of the proximal tubules that is characterized by hypercalciuria, nephrocalcinosis, kidney stones, renal failure, and rickets. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      \"Dent's disease\" is accepted as the encompassing name of this disease, based upon this",
"      <strong>",
"       limited",
"      </strong>",
"      renal phenotype that includes a partial Fanconi syndrome. The disease is distinguished clinically from the Lowe syndrome by the absence of cataracts, mental developmental delay, and renal tubular acidosis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Nomenclature'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In 60 percent of cases, Dent's disease is due to mutations that inactivate a voltage-gated chloride transporter, CLC-5, which is expressed in the kidney and is encoded by a gene at Xp11.22. In another 15 percent of cases, it is associated with mutations in the OCRL1 gene, which is also mutated in the oculocerebrorenal syndrome of Lowe. Further genetic heterogeneity is assumed to exist since there are patients with the distinctive phenotype of Dent's disease who do not have mutation in either of these genes. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Molecular genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CLC-5 is present in the membrane of subapical endosomes in the proximal tubule. Along with a proton-ATPase that is also present in the membrane, CLC-5 in part facilitates acidification of these endosomes by allowing for chloride entry and proton exit from the endosome, thereby dissipating the positive charge generated by the proton pump (",
"      <a class=\"graphic graphic_figure graphicRef62203 \" href=\"mobipreview.htm?40/24/41344\">",
"       figure 1",
"      </a>",
"      ). The inactivation of CLC-5 and the consequent endosomal dysfunction explains the low-molecular-weight proteinuria in patients with Dent's disease (",
"      <a class=\"graphic graphic_figure graphicRef69370 \" href=\"mobipreview.htm?8/40/8838\">",
"       figure 2",
"      </a>",
"      ). The discovery that mutations in OCRL1 can cause the Dent's disease phenotype points to overlap in the physiological functions of the OCRL phosphatase and the CLC-5 protein. The OCRL phosphatase also affects endosomal trafficking. Hypercalciuria reflects, at least in part, excessive intestinal absorption and dysregulation of vitamin D metabolism. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations, which are usually present in childhood, include polyuria, microscopic hematuria, asymptomatic proteinuria, and kidney stones (associated with hypercalciuria and nephrocalcinosis). The prevalences of these clinical features among affected males with documented mutations are summarized in the following table (",
"      <a class=\"graphic graphic_table graphicRef74862 \" href=\"mobipreview.htm?36/20/37195\">",
"       table 1",
"      </a>",
"      ). In addition, such patients may have glucosuria, aminoaciduria, hyperphosphaturia, chronic kidney disease, and rickets or osteomalacia. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal manifestations of the Lowe oculocerebrorenal syndrome include those of Dent's disease; low-molecular-weight proteinuria, hypercalciuria, and progression to renal failure occur in both disorders. However, patients with Lowe oculocerebrorenal syndrome also have renal tubular acidosis, congenital cataracts, and mental retardation, findings which are absent in Dent's disease. (See",
"      <a class=\"local\" href=\"#H131450907\">",
"       'Lowe syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In affected males, Dent's disease commonly presents with symptoms of kidney stones or polyuria, or when a urinalysis (which is performed in an infant or older child) reveals proteinuria often accompanied by microscopic hematuria. (See",
"      <a class=\"local\" href=\"#H74083558\">",
"       'Evaluation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of Dent's disease is made",
"      <strong>",
"       clinically",
"      </strong>",
"      , based upon the presence of the following characteristics in a male (see",
"      <a class=\"local\" href=\"#H74083558\">",
"       'Evaluation and diagnosis'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Low-molecular-weight proteinuria &minus; A test for urinary beta-2-microglobulin, a low-molecular-weight protein, is readily available and is therefore a practical screening test for Dent's disease, although assay of urinary retinol-binding protein is more sensitive and specific.",
"     </li>",
"     <li>",
"      Hypercalciuria &minus; More than 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      of body weight.",
"     </li>",
"     <li>",
"      At least one of the following &minus; nephrocalcinosis, nephrolithiasis, hematuria, hypophosphatemia, chronic kidney disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identification of a mutation in either CLCN5 or OCRL1 confirms the diagnosis. Genetic testing for CLCN5 and OCRL1 is available through various commercial laboratories. However, not all affected patients have a mutation in one of these two genes. In addition, some patients with confirmed mutations in CLCN5 or OCRL1 will not fulfill all three clinical criteria. Thus, while the identification of a mutation in one of these two genes confirms the diagnosis in someone with suggestive clinical manifestations, a negative genetic test does",
"      <strong>",
"       not",
"      </strong>",
"      rule out the diagnosis of Dent's disease. (See",
"      <a class=\"local\" href=\"#H25214618\">",
"       'Role of genetic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of Dent's disease includes other entities that can cause generalized proximal tubule dysfunction (Fanconi syndrome), such as cystinosis, galactosemia, multiple myeloma,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/25/38297?source=see_link\">",
"       ifosfamide",
"      </a>",
"      , and Chinese herbs. The absence of renal tubular acidosis will favor Dent's disease over other diagnoses. (See",
"      <a class=\"local\" href=\"#H193923453\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although it is unknown to what extent hypercalciuria is responsible for the renal failure in Dent's disease, it is the major factor responsible for nephrolithiasis. Thus, an attempt to reduce calcium excretion is reasonable. The principal approach to reducing calcium excretion should be to restrict dietary sodium intake (since sodium excretion promotes calcium excretion). Administration of a thiazide diuretic, which stimulates the reabsorption of calcium, augments the benefit of sodium restriction. Restriction of dietary calcium intake is not recommended because it may exacerbate the risk of bone disease. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy with citrate, phosphate, and vitamin D may be helpful for other manifestations; the latter is important in managing those patients with bone disease but needs to be monitored carefully. Patients with end-stage renal disease (ESRD) do well on dialysis and are often excellent candidates for transplantation (the disease does not recur after transplantation). (See",
"      <a class=\"local\" href=\"#H10890647\">",
"       'Other therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/1\">",
"      Scheinman SJ. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 1998; 53:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/2\">",
"      Devonald MA, Karet FE. Renal epithelial traffic jams and one-way streets. J Am Soc Nephrol 2004; 15:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/3\">",
"      Hoopes RR Jr, Shrimpton AE, Knohl SJ, et al. Dent Disease with mutations in OCRL1. Am J Hum Genet 2005; 76:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/4\">",
"      Frymoyer PA, Scheinman SJ, Dunham PB, et al. X-linked recessive nephrolithiasis with renal failure. N Engl J Med 1991; 325:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/5\">",
"      Igarashi T, Hayakawa H, Shiraga H, et al. Hypercalciuria and nephrocalcinosis in patients with idiopathic low-molecular-weight proteinuria in Japan: is the disease identical to Dent's disease in United Kingdom? Nephron 1995; 69:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/6\">",
"      Bolino A, Devoto M, Enia G, et al. Genetic mapping in the Xp11.2 region of a new form of X-linked hypophosphatemic rickets. Eur J Hum Genet 1993; 1:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/7\">",
"      Oudet C, Martin-Coignard D, Pannetier S, et al. A second family with XLRH displays the mutation S244L in the CLCN5 gene. Hum Genet 1997; 99:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/8\">",
"      Wrong OM, Norden AG, Feest TG. Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 1994; 87:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/9\">",
"      Lloyd SE, Pearce SH, Fisher SE, et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996; 379:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/10\">",
"      Scheinman SJ, Pook MA, Wooding C, et al. Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies. J Clin Invest 1993; 91:2351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/11\">",
"      Pook MA, Wrong O, Wooding C, et al. Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum Mol Genet 1993; 2:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/12\">",
"      Fisher SE, van Bakel I, Lloyd SE, et al. Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 1995; 29:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/13\">",
"      Devuyst O, Christie PT, Courtoy PJ, et al. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum Mol Genet 1999; 8:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/14\">",
"      Hoopes RR Jr, Hueber PA, Reid RJ Jr, et al. CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis. Kidney Int 1998; 54:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/15\">",
"      Kelleher CL, Buckalew VM, Frederickson ED, et al. CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets. Kidney Int 1998; 53:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/16\">",
"      Lloyd SE, Pearce SH, G&uuml;nther W, et al. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). J Clin Invest 1997; 99:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/17\">",
"      Lloyd SE, Gunther W, Pearce SH, et al. Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet 1997; 6:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/18\">",
"      Igarashi T, Inatomi J, Ohara T, et al. Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease. Kidney Int 2000; 58:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/19\">",
"      Cox JP, Yamamoto K, Christie PT, et al. Renal chloride channel, CLCN5, mutations in Dent's disease. J Bone Miner Res 1999; 14:1536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/20\">",
"      Yamamoto K, Cox JP, Friedrich T, et al. Characterization of renal chloride channel (CLCN5) mutations in Dent's disease. J Am Soc Nephrol 2000; 11:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/21\">",
"      Matsuyama T, Awazu M, Oikawa T, et al. Molecular and clinical studies of Dent's disease in Japan: biochemical examination and renal ultrasonography do not predict carrier state. Clin Nephrol 2004; 61:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/22\">",
"      Tosetto E, Ghiggeri GM, Emma F, et al. Phenotypic and genetic heterogeneity in Dent's disease--the results of an Italian collaborative study. Nephrol Dial Transplant 2006; 21:2452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/23\">",
"      Hichri H, Rendu J, Monnier N, et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 2011; 32:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/24\">",
"      Tosetto E, Ceol M, Mezzabotta F, et al. Novel mutations of the CLCN5 gene including a complex allele and A 5' UTR mutation in Dent disease 1. Clin Genet 2009; 76:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/25\">",
"      Dinour D, Davidovitz M, Levin-Iaina N, et al. Truncating mutations in the chloride/proton ClC-5 antiporter gene in Seven Jewish Israeli families with Dent's 1 disease. Nephron Clin Pract 2009; 112:c262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/26\">",
"      Grand T, Mordasini D, L'Hoste S, et al. Novel CLCN5 mutations in patients with Dent's disease result in altered ion currents or impaired exchanger processing. Kidney Int 2009; 76:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/27\">",
"      Wu F, Roche P, Christie PT, et al. Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney Int 2003; 63:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/28\">",
"      Smith AJ, Reed AA, Loh NY, et al. Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure. Am J Physiol Renal Physiol 2009; 296:F390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/29\">",
"      Utsch B, B&ouml;kenkamp A, Benz MR, et al. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis 2006; 48:942.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/30\">",
"      B&ouml;kenkamp A, B&ouml;ckenhauer D, Cheong HI, et al. Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 2009; 155:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/31\">",
"      Shrimpton AE, Hoopes RR Jr, Knohl SJ, et al. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiol 2009; 112:p27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/32\">",
"      G&uuml;nther W, L&uuml;chow A, Cluzeaud F, et al. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci U S A 1998; 95:8075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/33\">",
"      Picollo A, Pusch M. Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 2005; 436:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/34\">",
"      Piwon N, G&uuml;nther W, Schwake M, et al. ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 2000; 408:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/35\">",
"      Wang SS, Devuyst O, Courtoy PJ, et al. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 2000; 9:2937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/36\">",
"      Devuyst O, Guggino WB. Chloride channels in the kidney: lessons learned from knockout animals. Am J Physiol Renal Physiol 2002; 283:F1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/37\">",
"      Hryciw DH, Wang Y, Devuyst O, et al. Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines. J Biol Chem 2003; 278:40169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/38\">",
"      Reed AA, Loh NY, Terryn S, et al. CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease. Am J Physiol Renal Physiol 2010; 298:F365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/39\">",
"      Norden AG, Lapsley M, Igarashi T, et al. Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. J Am Soc Nephrol 2002; 13:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/40\">",
"      Dressman MA, Olivos-Glander IM, Nussbaum RL, Suchy SF. Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells. J Histochem Cytochem 2000; 48:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/41\">",
"      Apodaca G. Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton. Traffic 2001; 2:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/42\">",
"      Luyckx VA, Leclercq B, Dowland LK, Yu AS. Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression. Proc Natl Acad Sci U S A 1999; 96:12174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/43\">",
"      Reinhart SC, Norden AG, Lapsley M, et al. Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 1995; 5:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/44\">",
"      Silva IV, Cebotaru V, Wang H, et al. The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res 2003; 18:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/45\">",
"      Norden AG, Lapsley M, Thakker RV, et al. The tubular proteinuria of Dent's disease (CLCN5 mutation) comprises proteins in the mass range from insulin to intact immunoglobulin G and provides a new approach to estimation of in vivo glomerular sieving coefficients (abstract). J Am Soc Nephrol 2000; 11:93A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/46\">",
"      Langlois V, Bernard C, Scheinman SJ, et al. Clinical features of X-linked nephrolithiasis in childhood. Pediatr Nephrol 1998; 12:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/47\">",
"      Bosio M, Bianchi ML, Lloyd SE, Thakker RV. A familial syndrome due to Arg648Stop mutation in the X-linked renal chloride channel gene. Pediatr Nephrol 1999; 13:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/48\">",
"      Scheinman SJ. Nephrolithiasis. Semin Nephrol 1999; 19:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/49\">",
"      Besbas N, Ozaltin F, Jeck N, et al. CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent's disease. Nephrol Dial Transplant 2005; 20:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/50\">",
"      Bockenhauer D, Bokenkamp A, van't Hoff W, et al. Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol 2008; 3:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/51\">",
"      Copelovitch L, Nash MA, Kaplan BS. Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2007; 2:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/52\">",
"      Yanagida H, Ikeoka M, Kuwajima H, et al. A boy with Japanese Dent's disease exhibiting abnormal calcium metabolism and osseous disorder of the spine: defective megalin expression at the brushborder of renal proximal tubules. Clin Nephrol 2004; 62:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/53\">",
"      Claverie-Mart&iacute;n F, Ramos-Trujillo E, Garc&iacute;a-Nieto V. Dent's disease: clinical features and molecular basis. Pediatr Nephrol 2011; 26:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/54\">",
"      Devuyst O, Thakker RV. Dent's disease. Orphanet J Rare Dis 2010; 5:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/55\">",
"      Raja KA, Schurman S, D'mello RG, et al. Responsiveness of hypercalciuria to thiazide in Dent's disease. J Am Soc Nephrol 2002; 13:2938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/56\">",
"      Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38616/abstract/57\">",
"      Cebotaru V, Kaul S, Devuyst O, et al. High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. Kidney Int 2005; 68:642.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7363 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-160F99BB66-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38616=[""].join("\n");
var outline_f37_45_38616=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13443417\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NOMENCLATURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MOLECULAR GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10890273\">",
"      CLCN5 gene (Dent's disease 1)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10890288\">",
"      OCRL1 gene (Dent's disease 2)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      OCRL1 gene and the Lowe oculocerebrorenal syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H193923264\">",
"      Mechanisms of proteinuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H193923279\">",
"      Mechanisms of hypercalciuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H193923372\">",
"      Mechanisms of hyperphosphaturia and increased calcitriol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Proximal tubular reabsorptive failure and proteinuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hypercalciuria, nephrocalcinosis, and kidney stones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Rickets or osteomalacia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H131450907\">",
"      Lowe syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74083558\">",
"      EVALUATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25214618\">",
"      Role of genetic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H193923453\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10890640\">",
"      Reduction in calcium excretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10890647\">",
"      Other therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13443417\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7363\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7363|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/24/41344\" title=\"figure 1\">",
"      Proximal tubule endosomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/40/8838\" title=\"figure 2\">",
"      Protein in proximal tubule cell",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7363|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/20/37195\" title=\"table 1\">",
"      Clinical features Dents disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30886?source=related_link\">",
"      Clinical features and diagnosis of galactosemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/18/12584?source=related_link\">",
"      Cystinosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/54/27494?source=related_link\">",
"      Epidemiology and etiology of osteomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41066?source=related_link\">",
"      Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/22/17768?source=related_link\">",
"      Etiology and clinical manifestations of renal tubular acidosis in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/29/14806?source=related_link\">",
"      Ifosfamide nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17081?source=related_link\">",
"      Nephrocalcinosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/49/6933?source=related_link\">",
"      Nephropathy induced by aristolochic acid (AA) containing herbs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/2/38953?source=related_link\">",
"      Prevention of recurrent calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/53/33626?source=related_link\">",
"      Risk factors for calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27400?source=related_link\">",
"      Types of renal disease in multiple myeloma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_45_38617="Common variable immunodeficiency in children";
var content_f37_45_38617=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Common variable immunodeficiency in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/45/38617/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38617/contributors\">",
"     Mary Beth Hogan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38617/contributors\">",
"     Nevin W Wilson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/45/38617/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38617/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/45/38617/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/45/38617/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/45/38617/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H10572287\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common Variable Immunodeficiency (CVID) is a heterogeneous disorder involving immune dysfunction of B and T lymphocytes and dendritic cells. The characteristic immunologic defect is the inability of B cells to differentiate into plasma cells capable of secreting all immunoglobulin types. While CVID is often regarded as a disease of adults, it does affect children, and diagnosis in young children can be challenging.",
"   </p>",
"   <p>",
"    Clinical features of CVID and issues in the diagnosis and management of this disorder that are specific to pediatric patients (less than 18 years of age) will be reviewed here. Additional reviews of CVID, which emphasize adult manifestations and management, are found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/29/9688?source=see_link\">",
"     \"Pathogenesis of common variable immunodeficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30457?source=see_link\">",
"     \"Treatment and prognosis of common variable immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572295\">",
"    <span class=\"h1\">",
"     DEFINITION AND CLASSIFICATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572304\">",
"    <span class=\"h2\">",
"     Definition",
"    </span>",
"    &nbsp;&mdash;&nbsp;CVID is defined by the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age specific reduction in serum concentrations of IgG, in combination with low levels of IgA",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      IgM",
"     </li>",
"     <li>",
"      Presence of B cells",
"     </li>",
"     <li>",
"      Poor or absent response to immunizations",
"     </li>",
"     <li>",
"      An absence of any other defined immunodeficiency state",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572319\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CVID in children is not uncommon. In one large series of primary immunodeficiency in children diagnosed over a 10 year period, CVID made up 12 of 189 total cases (9 percent) and 20 percent of the 87 cases of antibody deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/2\">",
"     2",
"    </a>",
"    ]. Most patients with CVID present after puberty and the disorder is usually diagnosed in the second or third decade of life. However, about 25 percent of all CVID patients present in childhood or adolescence, and there is an earlier peak of diagnosis at approximately eight years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. A diagnosis of CVID before age six is particularly problematic because of immunologic immaturity and the persistence of transient hypogammaglobulinemia of infancy in some children.",
"   </p>",
"   <p>",
"    Additional information about the epidemiology of CVID is found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link&amp;anchor=H1191865#H1191865\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572368\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many children with CVID are small and appear chronically ill. They often have chronic cough. They may show signs of chronic upper or lower respiratory infections including otitis, purulent nasal discharge, or visible post-nasal drainage. Tonsils and lymphoid tissue are usually present and sometimes enlarged. Pulmonary findings of rales, wheezing and digital clubbing may be present. Hepatosplenomegaly suggests gastrointestinal or autoimmune problems. Signs of arthritis, vasculitis, or vitiligo may be present. Skin infections or eczema may be noted.",
"   </p>",
"   <p>",
"    The types of disorders that develop in patients with CVID are similar in adults and children, although there are some differences in the prevalence of certain manifestations of the disease. Two pediatric series demonstrate the various presenting disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series of 12 children with CVID, the most common presenting infections were sinusitis (75 percent), otitis media (67 percent), and pneumonia (58 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/5\">",
"       5",
"      </a>",
"      ]. Bronchiectasis was seen in three children. One patient presented with chronic diarrhea due to Giardia infection. Autoimmune disorders including immune thrombocytopenia (ITP) and neutropenia were noted. Asthma was seen in 10 patients but was not typically a presenting disorder. Two patients presented with failure to thrive. Other disorders included growth hormone deficiency, hypothyroidism, end-stage renal disease, and sarcoma.",
"     </li>",
"     <li>",
"      A second series of 32 children noted similar presenting disorders: Chronic respiratory tract infections (88 percent), sinusitis (78 percent), otitis media (78 percent), and intestinal tract infections (34 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/3\">",
"       3",
"      </a>",
"      ]. Meningitis, sepsis, and pyelonephritis were also observed. A significant number of children (31 percent) experienced an autoimmune disease. Bronchiectasis was noted in 34 percent and lymphoid malignancy in 13 percent. Vaccine related poliomyelitis occurred in two patients. Several children had growth and developmental delay.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2154824\">",
"    <span class=\"h2\">",
"     Recurrent infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric patients with CVID often experience recurrent pyogenic infections of the upper and lower respiratory tracts and chronic gastrointestinal infections, with the same spectrum of organisms seen in adult patients. (See",
"    <a class=\"local\" href=\"#H10572409\">",
"     'Gastrointestinal problems'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link&amp;anchor=H9597804#H9597804\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\", section on 'Gastrointestinal disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic enteroviral infections causing neurodegenerative diseases or encephalitis, which are rarely reported in the adults with CVID, have not been noted in children to date [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/6\">",
"     6",
"    </a>",
"    ] other than in one series of 32 children in which two case of poliovirus-related vaccine paresis were reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572385\">",
"    <span class=\"h2\">",
"     Pulmonary manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to 73 percent of CVID patients (all ages) develop chronic structural pulmonary complications, including bronchiectasis and bronchial wall thickening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/7\">",
"     7",
"    </a>",
"    ]. In a study of 54 children with either CVID or similar disorders, structural lung disease was found in more than 85 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/8\">",
"     8",
"    </a>",
"    ]. Most children had mild bronchiectasis scores, although five percent were scored moderate-to-severe. Twenty-five percent of CVID children had multiple lung nodules, which tended to resolve after treatment with systemic glucocorticoids. The etiology of these nodules is not fully understood, and they may result from either direct damage induced by infectious organisms, or from an altered compensatory immune response leading to granulomatous changes.",
"   </p>",
"   <p>",
"    High resolution computerized tomography (HRCT) has been found to be the most sensitive method for identification of these structural abnormalities. It is an important diagnostic tool for pulmonary complications because it can detect abnormalities that are missed by chest radiographs or pulmonary function testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link&amp;anchor=H1193479#H1193479\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\", section on 'Pulmonary disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Obstructive flow-volume curves have been found in 50 to 94 percent of patients (all ages) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/7\">",
"     7",
"    </a>",
"    ]. Children with CVID frequently have pulmonary airway obstructive disease indistinguishable from asthma. In the series of 12 children described previously, 83 percent had asthma, although none had life-threatening symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/5\">",
"     5",
"    </a>",
"    ]. The prevalence of obstructive lung disease in children with CVID appears to be higher than what is reported in adults. This may be in part due to recurrent viral illnesses associated with childhood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572393\">",
"    <span class=\"h2\">",
"     Allergic diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the two pediatric series mentioned above, 38 percent of patients in one of the cohorts had some evidence of an allergic disease, including food allergy, eczema, urticaria, rhinitis, and asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/3\">",
"     3",
"    </a>",
"    ] and 83 percent had asthma in the other [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/5\">",
"     5",
"    </a>",
"    ]. It is sometimes argued that IgE sensitization, which is a type of specific antibody response, is uncommon in patients with CVID. Indeed, some patients with allergic symptoms have undetectable serum IgE. However, given the frequency of these diseases in the two available pediatric series, we believe that allergic symptoms in children should be thoroughly evaluated with skin testing or assays for allergen-specific IgE. In addition, we have observed that aggressive asthma or allergy specific treatment appear to improve outcomes and quality of life by reducing the frequency of complications, such as recurrent otitis media and sinopulmonary infections, although definitive studies have not been performed. It is our impression that our pediatric CVID patients follow the same general course as immune competent children with atopy and experience fewer complications, such as recurrent otitis media and sinusitis, if allergy is addressed and managed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572401\">",
"    <span class=\"h2\">",
"     Failure to thrive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to thrive (FTT) is an important manifestation of immunodeficiency in children and is usually attributed to repetitive illnesses. However, primary growth hormone deficiency and hypothyroidism have also been reported in immunodeficient children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38233?source=see_link\">",
"     \"Poor weight gain in children older than two years of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/12/14538?source=see_link&amp;anchor=H11#H11\">",
"     \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572409\">",
"    <span class=\"h2\">",
"     Gastrointestinal problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diarrhea, malabsorption, and weight loss are common problems in both children and adults with CVID [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/12\">",
"     12",
"    </a>",
"    ]. Gastrointestinal infections include Helicobacter pylori and Giardia lamblia. Other intestinal pathogens such as Salmonella, Shigella, and Campylobacter are also reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/13\">",
"     13",
"    </a>",
"    ]. Crohn's disease and ulcerative colitis are reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/12\">",
"     12",
"    </a>",
"    ], although similar findings can be a manifestation of granulomatous disease associated with immune dysregulation, similar to the pattern which has been noted in the lungs. Nodular intestinal hyperplasia occurs relatively frequently in adolescents with CVID (",
"    <a class=\"graphic graphic_picture graphicRef80570 \" href=\"mobipreview.htm?33/4/33870\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/14\">",
"     14",
"    </a>",
"    ]. Manifestations are similar in adults and children. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link&amp;anchor=H9597804#H9597804\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\", section on 'Gastrointestinal disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572417\">",
"    <span class=\"h2\">",
"     Autoimmune disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmunity is seen in 20 to 25 percent of patients with CVID when all ages are considered together. Autoimmune cytopenias are a more common presenting disorder in children than adults and may be the initial manifestation of the disease. Autoimmune neutropenia, immune thrombocytopenia (ITP), hemolytic anemia, or combinations of these disorders are possible. Insulin-dependent diabetes, psoriasis, systemic lupus erythematosus, rheumatoid arthritis, and juvenile idiopathic arthritis are also associated with CVID, although these are less common. Children with these diseases may be cared for in hematology, rheumatology, or endocrine clinics for a period of time before the underlying diagnosis is appreciated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link&amp;anchor=H1193493#H1193493\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\", section on 'Autoimmune disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2154908\">",
"    <span class=\"h3\">",
"     Evans syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evans syndrome is characterized by autoimmune hemolytic anemia and immune thrombocytopenia (ITP) and has been associated with immune deficiency and lymphoproliferation. Fas expression on peripheral blood T and B cells and Fas-mediated elimination of activated T cells were found to be elevated in seven children with Evans syndrome, compared with control children with acute immune thrombocytopenia (ITP) or other nonimmune disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/15\">",
"     15",
"    </a>",
"    ]. Among the seven with Evans syndrome, five eventually developed CVID. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/59/18362?source=see_link&amp;anchor=H27#H27\">",
"     \"Autoimmune hemolytic anemia in children\", section on 'Autoimmune disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572425\">",
"    <span class=\"h2\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults with CVID, the lifetime risk of malignancy has been estimated to be between 1.4 and 7 percent, and the most frequently diagnosed disorder is a B cell lymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link&amp;anchor=H1193528#H1193528\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\", section on 'Malignancies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data specific to children are limited, although early development of cancer (especially prior to diagnosis) is uncommon in children with CVID. In the series of 32 children already mentioned, four developed a malignancy during the follow-up period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/3\">",
"     3",
"    </a>",
"    ]. Two had Hodgkin&rsquo;s disease, one had non Hodgkin&rsquo;s lymphoma, and one patient had Burkett&rsquo;s lymphoma. In our series, one patient had undifferentiated sarcoma prior to the identification of CVID, suggesting that malignancy may also occur as a primary event prior to identification of immunodeficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2154993\">",
"    <span class=\"h2\">",
"     Neurodegenerative diseases or encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults with CVID, enteroviral and JC virus infection can cause neurodegeneration leading to death despite immunoglobulin replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/6,19\">",
"     6,19",
"    </a>",
"    ]. However, this complication of enteroviral infection has not yet been described in pediatric CVID. In contrast, neurodegenerative diseases have been described in other pediatric immunodeficiencies (specifically X-linked agammaglobulinemia and &micro;-chain deficiency) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Thus, this complication of enteroviral infection in a child with severe hypogammaglobulinemia should prompt a search for primary disorders of B cell development (unclassified patients with &lt;1 percent B cells). Neurologic complications of CVID in adults are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link&amp;anchor=H1193549#H1193549\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\", section on 'Neurologic degeneration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572433\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of CVID is not always possible to make with certainty in young children. However, it is important to follow the patient regularly and make the diagnosis as expediently as possible, because prolonged delays between the onset of symptoms and the beginning of immunoglobulin replacement therapy are common and are associated with more extensive lung damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/7,22\">",
"     7,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of CVID is based upon the findings of hypogammaglobulinemia, defective antibody formation, and exclusion of other causes of antibody deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1529357\">",
"    <span class=\"h2\">",
"     Indications for referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient&rsquo;s history and physical examination raise concern about a possible diagnosis of CVID, immunoglobulin levels should be evaluated initially. Referral to a clinical immunologist is indicated, whenever possible, to assess vaccine responsiveness and exclude other causes of hypogammaglobulinemia. Following diagnosis, immunology specialists can also determine the most appropriate therapies (such as prophylactic antibiotics and immune globulin) and help monitor the patient for associated disorders. Most pediatric immunologists are versed in the care of children with CVID. In the United States, the Clinical Immunology Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/23\">",
"     23",
"    </a>",
"    ], the American Academy of Allergy Asthma and Immunology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/24\">",
"     24",
"    </a>",
"    ], and the American College of Allergy Asthma and Immunology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/25\">",
"     25",
"    </a>",
"    ] maintain databases of physicians who have appropriate expertise in the care of patients with immunodeficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155544\">",
"    <span class=\"h2\">",
"     Immunoglobulin levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of CVID requires decreased IgG levels, in association with low levels of IgA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    IgM. When assessing pediatric patients for hypogammaglobulinemia, it is important to use age-related normal values. A normal IgG level for children 6 to 16 years is about 1000",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    with a 1 standard deviation range of 250, whereas children with CVID will typically have IgG levels below 500",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    IgM and IgA levels are also reduced but are less valuable in establishing a diagnosis. We also obtain an IgE level, which is useful in excluding other disorders and may indicate that the child has atopic disease. IgG subclass determinations are indicated if antibody titers are decreased but immunoglobulin levels are near normal. (See",
"    <a class=\"local\" href=\"#H650981\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Hypogammaglobulinemia secondary to other disorders should be excluded. Total protein and albumin levels will exclude diseases that cause loss of immunoglobulins, such as protein-losing enteropathies or renal disease. A history of treatment with immunosuppressive medications and anti-seizure drugs should be sought to exclude drug-induced hypogammaglobulinemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/0/29706?source=see_link\">",
"     \"Secondary immune deficiency induced by drugs and biologics\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7561?source=see_link\">",
"     \"Secondary immune deficiency due to miscellaneous causes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155585\">",
"    <span class=\"h2\">",
"     Antibody function studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The demonstration of adequate antibody responses essentially excludes the diagnosis of CVID in young children. After obtaining a thorough vaccination history, we assess titers to diphtheria, tetanus, Haemophilus influenza, and serotypes in the protein conjugated pneumococcal vaccine (",
"    <a class=\"graphic graphic_table graphicRef77758 \" href=\"mobipreview.htm?33/12/33997\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Evaluation of polysaccharide responses can be obtained after two years of age if the patient has received the unconjugated polysaccharide pneumococcal or N. meningitis vaccines.",
"   </p>",
"   <p>",
"    The challenge in assessing specific antibody formation lies in correctly interpreting the significance of an impaired response, which may be truly pathologic or simply indicative of an immature immune system particularly in the infant or child less than six years of age. Assessing the immune response to vaccination is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24328?source=see_link\">",
"     \"Assessing the immunologic response to vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2335351\">",
"    <span class=\"h2\">",
"     Other testing at the time of diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following additional tests may be appropriate:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A complete CBC and differential",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A low platelet count with microplatelets suggests a diagnosis of Wiskott-Aldrich syndrome (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=see_link\">",
"       \"Wiskott-Aldrich syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If lymphopenia is present (absolute lymphocyte count &lt;1500 in a child over age five), we obtain flow cytometric studies, including CD3, CD4, CD8, CD19, and",
"      <span class=\"nowrap\">",
"       CD16/56,",
"      </span>",
"      to help identify combined immunodeficiencies. If B or T cells are decreased in number, we obtain tests of B and T cell function, as described below (See",
"      <a class=\"local\" href=\"#H2350217\">",
"       'B cell studies'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H2350224\">",
"       'T cell studies'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A blood chemistry panel to search for other hematologic or metabolic illnesses that may increase the risk of infection (eg, diabetes or renal disorders). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7561?source=see_link&amp;anchor=H2#H2\">",
"       \"Secondary immune deficiency due to miscellaneous causes\", section on 'Disorders of biochemical homeostasis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      B cell enumeration is indicated if the patient has a profound deficiency of immunoglobulins to exclude congenital agammaglobulinemias. (See",
"      <a class=\"local\" href=\"#H2392650\">",
"       'Agammaglobulinemia'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Infection evaluation includes appropriate cultures, evidence of inflammatory markers such as ESR or CRP, and appropriate imaging, such as sinus films, chest radiograph, or CT or MRI studies.",
"     </li>",
"     <li>",
"      In patients with signs or symptoms of autoimmunity, an ANA and other appropriate autoantibodies should be assessed. Patients with CVID may produce organ specific autoantibodies (eg, including Coombs tests, thyroid peroxidase and thyroglobulin antibodies) despite overall antibody deficiency.",
"     </li>",
"     <li>",
"      Evaluation of family members should be considered if there is a relative affected by frequent infections. CVID, as well as selective IgA deficiency, are found with increased frequency among family members of patients with CVID. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/29/9688?source=see_link&amp;anchor=H10#H10\">",
"       \"Pathogenesis of common variable immunodeficiency\", section on 'Genetics'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2350217\">",
"    <span class=\"h3\">",
"     B cell studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The absence of B cells excludes the diagnosis of CVID. Advanced study of B cell characteristics by flow cytometric studies is not required for the diagnosis of CVID, although it can be helpful in excluding other disorders and may provide some prognostic information (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/6/23656?source=see_link\">",
"     \"Flow cytometry for the diagnosis of primary immunodeficiencies\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Quantifying B cells is helpful in distinguishing CVID from X-linked agammaglobulinemia, since patients with the latter disorder typically have absent or nearly absent B cells. (See",
"      <a class=\"local\" href=\"#H2392650\">",
"       'Agammaglobulinemia'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Tests of B cell function (ie, pokeweed mitogen stimulation) are appropriate if B cell numbers are low.",
"     </li>",
"     <li>",
"      Advanced B cell phenotyping, when available, may provide prognostic information. Many reference laboratories can do these studies. It is not uncommon to detect a deficiency of CD27",
"      <sup>",
"       +",
"      </sup>",
"      IgM",
"      <sup>",
"       -",
"      </sup>",
"      IgD negative",
"      <sup>",
"      </sup>",
"      switched memory B cells. In a study of 45 pediatric patients, those with lower switched memory B cells had lower T-cell counts and CD19",
"      <sup>",
"       +",
"      </sup>",
"      B cell levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/4\">",
"       4",
"      </a>",
"      ]. Those children with fewer than five switched memory B",
"      <span class=\"nowrap\">",
"       cells/microliter",
"      </span>",
"      had a higher incidence of meningitis, sepsis, bronchiectasis, granulomatous lung disease, autoimmune cytopenias, and hematologic malignancy. A second series confirmed this, but found that serious complications were not restricted to this subgroup and also occurred in patients with higher numbers of switched memory B cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. Thus, identification of patients with very low switched memory B cells can help the clinician identify patients at risk for serious complications, although other parameters are likely needed to find other subgroups that are also at risk. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/6/23656?source=see_link\">",
"       \"Flow cytometry for the diagnosis of primary immunodeficiencies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2350224\">",
"    <span class=\"h3\">",
"     T cell studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of circulating T cells is not required for the diagnosis but can be useful in identifying patients at risk for more severe complications. Subsets of",
"    <sup>",
"    </sup>",
"    CVID patients with low T cell numbers tend to experience more severe infectious complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/1,15,16\">",
"     1,15,16",
"    </a>",
"    ]. Evaluation of T cell numbers with CD3, CD4, and CD8 should be performed, as mentioned above. If T cell numbers are low, evaluation of cellular immunity in the form of mitogen and antigen studies ie: phytohemagglutinin (PHA), concanavalin A (Con A), pokeweed (PWM) mitogens and tetanus and candida antigens may be useful in determining which CVID patients need prophylaxis for specific pathogens such as Pneumocystis jirovecii. These studies are also readily obtainable through advanced immunology commercial laboratories.",
"   </p>",
"   <p>",
"    T cells often decrease with time so that periodic assessment of T cell numbers is worthwhile, especially if the patient starts to have infections despite immunoglobulin therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1132162\">",
"    <span class=\"h3\">",
"     Genetic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defects in the genes TACI, BAFFR, and ICOS have been identified in some patients with CVID. The clinical significance of these genetic variants has not been established. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/29/9688?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathogenesis of common variable immunodeficiency\", section on 'Genetics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2350472\">",
"    <span class=\"h3\">",
"     Endocrine studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with CVID who have failure to thrive should be evaluated for thyroid function and growth hormone deficiency. Thyroid autoimmunity is not uncommon. Growth hormone replacement therapy should be offered if deficiency is identified. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/82?source=see_link\">",
"     \"Diagnosis of growth hormone deficiency in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/0/14345?source=see_link\">",
"     \"Treatment of growth hormone deficiency in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4034194\">",
"    <span class=\"h2\">",
"     Diagnostic uncertainties",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is difficult to diagnose CVID in children younger than six years of age because CVID may not be distinguishable from transient hypogammaglobulinemia of infancy (THI) in this age group. Both disorders involve hypogammaglobulinemia, but patients with THI ultimately produce adequate specific antibodies (in response to vaccines and infections) while those with CVID cannot. However, normal children below the age of two years, and sometimes older children, have impaired responses to polysaccharide antigens, and so this distinction can be challenging to make. However, if a young child demonstrates adequate responses to protein antigens, then the diagnosis of THI is more likely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1396504\">",
"    <span class=\"h3\">",
"     Periodic reassessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who are suspected of having CVID must be periodically reevaluated, to assure that their immune status has not improved with age. We suggest repeating immunoglobulin levels and specific antibody titers one to two years after initial evaluation. If the patients have been started on immune globulin replacement therapy, the treatments must be withheld for four months. After this period of time has elapsed, the patient&rsquo;s IgG should be compared with the last trough level before the final immune globulin treatment, in order to appreciate the patient&rsquo;s current level of antibody deficiency. Also at this time, specific antibody titers to various vaccines can be drawn, immunization with killed vaccines given (eg, pneumococcal vaccine, Hemophilus influenzae vaccine, and tetanus vaccine) and the specific antibody titers repeated in one month. We have seen children with resolution of both hypogammaglobulinemia and impaired specific antibody production as late as ten years of age.",
"   </p>",
"   <p>",
"    The natural history of hypogammaglobulinemia in childhood was investigated in a study of 37 patients with unclassified symptomatic hypogammaglobulinemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/28\">",
"     28",
"    </a>",
"    ]. The mean age of clinical presentation was 21.4 months, and patients were followed for an average of 34 months. Approximately one-half (48.6 percent) of these children spontaneously corrected their immunoglobulin abnormalities. Among the remaining children, just two were eventually diagnosed with CVID.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H650981\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypogammaglobulinemia is the primary laboratory feature of common variable immunodeficiency. The differential diagnosis of hypogammaglobulinemia in children is reviewed in this section. Because there are several other causes of hypogammaglobulinemia in childhood, the diagnosis of CVID in a child may not be certain until a series of evaluations over a period of years has been completed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392324\">",
"    <span class=\"h2\">",
"     Primary hypogammaglobulinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;If no secondary cause of hypogammaglobulinemia is apparent, then other primary immunodeficiencies causing hypogammaglobulinemia should be considered. Genetic mutation analyses are available for some of these disorders, although this type of testing is generally best done in consultation with an immunodeficiency specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392650\">",
"    <span class=\"h3\">",
"     Agammaglobulinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic X-linked agammaglobulinemia with low or absent B cells is caused by defects in the gene for Bruton&rsquo;s tyrosine kinase that result in profound hypogammaglobulinemia. Autosomal recessive forms of this disorder also exist and are due to mutations in genes contributing to the maturation and function of B cells.",
"   </p>",
"   <p>",
"    Congenital agammaglobulinemia is distinguished clinically from CVID by onset in infancy, hypoplastic lymphoid tissue, and severe reduction in all serum immunoglobulin isotypes. In addition, B cells are nearly absent or absent from the peripheral blood. B cells can be quantitated by flow cytometric evaluation of CD19 expression on lymphocytes. In agammaglobulinemia, B cells in the peripheral blood are usually &lt;2 percent and may be absent. In contrast, B cells in patients with CVID are usually normal or only mildly reduced. However, rare patients with CVID can have &le;1 percent B cells. In this situation, the patient should be tested for a defect in the Bruton&rsquo;s tyrosine kinase (BTK) gene or Btk expression should be assessed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/52/21321?source=see_link\">",
"     \"Agammaglobulinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392331\">",
"    <span class=\"h3\">",
"     Transient hypogammaglobulinemia of infancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young children with transient hypogammaglobulinemia of infancy (THI) have low levels of IgG, IgA, and usually IgM levels, which typically normalize by 24 months. They also ultimately demonstrate adequate vaccine responses (ie, usually by age five) and have intact cellular immune function. In contrast, children with CVID have persistently impaired responses to protein and polysaccharide vaccines, and about 40 percent may eventually have impaired cellular function (although this may not be apparent at the time of diagnosis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392599\">",
"    <span class=\"h2\">",
"     Selective antibody deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective antibody deficiency with normal immunoglobulin levels (SADNI) is a disorder characterized by recurrent sinopulmonary infections and normal immunoglobulin levels, but an inability to produce specific antibodies to polysaccharide antigens",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    (rarely) protein antigens or premature loss of specific antibodies. This condition is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17209?source=see_link\">",
"     \"Selective antibody deficiency with normal immunoglobulins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    SADNI is distinguished from CVID by the presence of normal levels of IgG, IgA, and IgM. However, the diagnosis of SADNI cannot be made in young children because it is based upon response to polysaccharide antigens, which can be abnormal in children until approximately the age of five years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392606\">",
"    <span class=\"h2\">",
"     IgG subclass deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgG subclass deficiency is defined as a deficit in one or more subclasses of IgG with normal or near normal total IgG levels. Although the clinical presentation of patients with IgG1 or IgG2 subclass deficiency who also have impaired antibody production can be similar to those with CVID, the conditions are distinguished by the normal (or near normal) level of total IgG, IgA, and IgM. IgG subclass deficiency is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/60/13258?source=see_link\">",
"     \"IgG subclass deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392345\">",
"    <span class=\"h2\">",
"     Hyper-IgM syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyper-IgM syndromes (HIGM) can arise from rare genetic defects in the nucleic acid modifying enzymes called activation induced cytidine deaminase (AICDA or AID) or uracil nucleoside glycosylase (UNG). Class-switching cannot occur without functional AICDA or UNG, therefore B cells can only produce appreciable quantities of IgM. Patients with AICDA and UNG deficiencies generally present with the recurrent and severe sinopulmonary infections with encapsulated bacteria that are characteristic of antibody deficiencies. Gastrointestinal infections (including Giardiasis), bacterial meningitis, viral encephalitis, and severe hepatitis B infections have also been observed, and patients are susceptible to autoimmune disorders.",
"   </p>",
"   <p>",
"    Among those with AICDA and UNG deficiencies, IgG levels are generally &lt;200",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    while IgA is &lt;20",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and IgM ranges from 100 to 3700",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    IgG specific antibody responses are nonexistent. Numbers of T and B cells in the circulation are normal, and T cell function is intact. Tests for both AICDA and UNG deficiency are commercially available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/32/21001?source=see_link\">",
"     \"Hyperimmunoglobulin M syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392352\">",
"    <span class=\"h2\">",
"     X-linked lymphoproliferative disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;X-linked lymphoproliferative disease (XLP) is a rare disorder of immune dysregulation resulting in lymphoproliferation, liver failure, hypogammaglobulinemia,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymphoma. The clinical and immunologic abnormalities are triggered after Epstein-Barr virus infection. Testing for XLP is appropriate in boys with a history of preceding viral hepatitis or other features suggestive of this disorder, as well as a family history of early death in males in the family. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/38/33384?source=see_link&amp;anchor=H14#H14\">",
"     \"X-linked lymphoproliferative disease\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392359\">",
"    <span class=\"h2\">",
"     Combined immunodeficiency disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combined immunodeficiency disorders are characterized by markedly decreased T cells with varying levels of circulating B cells. Various genetic abnormalities have been identified; among the more common are adenosine deaminase deficiency and common gamma chain deficiency. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/58/40873?source=see_link\">",
"     \"Combined immunodeficiencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572441\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of children with CVID involves immune globulin therapy, various measures to avoid infections, prompt and complete evaluation of infections that do occur, use of prophylactic antibiotics in refractory infections, monitoring of the patient&rsquo;s pulmonary function as well as physical and emotional development, and vigilance for the various associated disorders (ie, autoimmunity and malignancy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155614\">",
"    <span class=\"h2\">",
"     Immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immune globulin replacement therapy, in subcutaneous (SCIG) or intravenous (IVIG) form, has significantly decreased the frequency of life-threatening infections in pediatric patients with CVID. If appropriate IgG replacement therapy is started early, the cycle of recurrent infections leading to progressive lung damage can be mitigated. However, it is not apparent that",
"    <strong>",
"     non",
"    </strong>",
"    -infectious complications of CVID, such as autoimmune cytopenias, are prevented or treated by immune globulin therapy. Dosing and administration of immunoglobulin in CVID are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30457?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment and prognosis of common variable immunodeficiency\", section on 'Immunoglobulin replacement therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If possible, immune globulin should not be given until there has been a thorough evaluation of the patient's immune system including specific antibody responses. Immune globulin is expensive, will negate an antibody investigation for several months, and has potential adverse effects, as reviewed separately (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/36/41544?source=see_link&amp;anchor=H22#H22\">",
"       \"Transient hypogammaglobulinemia of infancy\", section on 'Immunoglobulin replacement'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If immune globulin therapy was already initiated prior to diagnosis to treat an autoimmune disorder or an infection causing critical illness, then plans should be made to discontinue the infusions for at least four months, in order to reassess the patient&rsquo;s current immune status. (See",
"      <a class=\"local\" href=\"#H1396504\">",
"       'Periodic reassessment'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      We often do this in the summer when there are fewer circulating respiratory tract infections. While an immune evaluation is being performed, the child with recurrent or chronic bacterial infections (eg, otitis media, sinusitis, bronchitis, pneumonia) can be treated with a six week course of antibiotic therapy (eg,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"       cefdinir",
"      </a>",
"      ), followed by prophylactic antibiotics (eg,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/15/35056?source=see_link\">",
"       azithromycin",
"      </a>",
"      5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      orally two or three times a week, maximum dose 250",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155607\">",
"    <span class=\"h2\">",
"     Evaluation of illnesses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children generally have a higher rate of viral infection than adults, due to increased exposure and other factors, which complicates the management of febrile episodes in children with CVID. Children with CVID and fever should be evaluated promptly. Attempts to identify responsible organisms should be undertaken, such as rapid viral identification kits for influenza or RSV. IgG based diagnostic tests will not be useful in those children receiving immune globulin due to presence of donor antibodies. Basing the choice of antibiotics on culture data and test results and using narrow-spectrum drugs whenever possible should help avoid bacterial resistance. Antiviral agents may be needed to treat persistent or severe viral infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155635\">",
"    <span class=\"h2\">",
"     Monitoring pulmonary status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring the child for progressive but subclinical pulmonary damage is important since patients can develop chronic pulmonary disease. Such monitoring usually takes the form of serial pulmonary function tests.",
"   </p>",
"   <p>",
"    High resolution CT (HRCT) examinations of the chest may be of value in detecting early and progressive pulmonary structural damage, although the risks of cumulative radiation exposure should be taken into account as well. We typically do not perform \"scheduled\" HRCT. Instead, we reserve repeat exams for situations in which the result is likely to influence a significant management decision, such as the administration of antibiotics or immune suppressants or an increase in the dose of immune globulin.",
"   </p>",
"   <p>",
"    Below are some clinical situations in which repetition of a HRCT examination would be useful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An older child who is being followed with repeat pulmonary function testing demonstrates reduced lung function and no bronchodilator response to account for these changes, or develops a new decrease in diffusing capacity for carbon monoxide (DLCO)",
"     </li>",
"     <li>",
"      Pulmonary infections continue to occur despite ongoing adherence to immune globulin therapy at standard starting doses (400 to 500",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per month)",
"     </li>",
"     <li>",
"      Evaluation of certain abnormalities, such as nodules, under the direction of a consulting specialist (pulmonologist or infectious disease specialist)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4034135\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Live viral vaccines are contraindicated in patients with CVID. Although patients with this disorder have impaired responses to vaccines, some clinicians, including the authors, still immunize these patients with killed viral and bacterial vaccines in the hope that they will generate T cell-mediated immune responses that may afford some additional protection beyond that obtained with immune globulin replacement therapy. In addition, many children will retain the ability to mount responses to some polysaccharide antigens, even while they are non-responsive to others. Immunization against transmissible infectious agents is encouraged for close family members. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Passive protection against certain infections with hyperimmune globulin preparations, such as those for tetanus and varicella, is usually not necessary in patients already receiving standard immune globulin replacement therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2350864\">",
"    <span class=\"h2\">",
"     Autoimmune cytopenias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of autoimmune cytopenias in patients with primary immune deficiencies is difficult because the treatments result in further immune suppression in an already-compromised patient. Immunosuppressant medication should be used only when the benefits are clear and in those patients whose autoimmune disorders are clearly causing symptomatic disease. The lowest dose and the shortest course sufficient to treat the condition are recommended. Careful monitoring during treatment is required. The treatment of these conditions in patients",
"    <strong>",
"     without",
"    </strong>",
"    CVID, including glucocorticoid dosing, is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/53/37721?source=see_link\">",
"     \"Treatment and prognosis of immune (idiopathic) thrombocytopenic purpura in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/59/18362?source=see_link&amp;anchor=H32#H32\">",
"     \"Autoimmune hemolytic anemia in children\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systemic glucocorticoids have long been the primary treatment for cytopenias, although prolonged use can be associated with significant complications in immunocompromised patients. Specific agents and dosing are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/53/37721?source=see_link\">",
"       \"Treatment and prognosis of immune (idiopathic) thrombocytopenic purpura in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/59/18362?source=see_link&amp;anchor=H32#H32\">",
"       \"Autoimmune hemolytic anemia in children\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The utility of immune globulin in the treatment of autoimmune cytopenias is controversial and data are scant. It is possible that immune globulin may provide some protection against these disorders or recurrences of them based on the observation that most cases have reported in patients not yet on immune globulin replacement, although prospective studies have not been done. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30457?source=see_link&amp;anchor=H26#H26\">",
"       \"Treatment and prognosis of common variable immunodeficiency\", section on 'Autoimmune disorders'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      If immune thrombocytopenia (ITP) occurs in a patient already on immune globulin, high doses IVIG (eg, 1 to 2",
"      <span class=\"nowrap\">",
"       grams/kilogram)",
"      </span>",
"      can be administered [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/29\">",
"       29",
"      </a>",
"      ] with or without glucocorticoids.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/47/34551?source=see_link\">",
"       Rituximab",
"      </a>",
"      (anti-CD20) may be useful as an adjunctive steroid-sparing agent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. In a study of eight children with immunodeficiencies (including CVID) and autoimmune cytopenias, 90 percent responded to rituximab, albeit with high relapse rates and requirement for repeat courses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155628\">",
"    <span class=\"h2\">",
"     Psychosocial and educational issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with primary immune deficiencies including CVID have a number of significant psychosocial concerns when compared with children with other chronic diseases such as chronic renal disease or severe asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/45/38617/abstract/33\">",
"     33",
"    </a>",
"    ]. These concerns included depression, anxiety, somatization, social withdrawal, and decreased social skills. The increasing severity of the immune deficiency was associated with a number of school adjustment issues, including concomitant psychiatric diagnoses and requiring special education services. Clinicians taking care of children with CVID should be aware of these problems and make early use of available social and psychological services in the long-term management of these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4034085\">",
"    <span class=\"h2\">",
"     General supportive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CVID should take measures to avoid infection. Common sense approaches, such as hand washing, are the most practical. Patients should also avoid ingestion of untreated drinking water if possible. Specific measures that the authors have found helpful in children with CVID are described here. General care of immune deficient patients is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link&amp;anchor=H8#H8\">",
"     \"Medical management of immune deficiency\", section on 'Avoidance of infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We have not limited pets in the family, largely because many children have pets prior to their diagnosis, and we have not seen infectious complications from pet ownership in our population so far. It does seem reasonable to leave clean up of pet waste to the immunologically intact members of the household.",
"     </li>",
"     <li>",
"      In our experience, children with CVID successfully attend school. Close communication is required with the school nurse and administration to make allowances for absences due to clinician follow-up care or hospitalizations. Depending upon the child&rsquo;s history, it may be better for the child to remain home when gastroenteritis, influenza, or other infectious diseases are affecting a large number of the children at the school, and the school nurse is the person best able to identify such situations.",
"     </li>",
"     <li>",
"      Some proactive education about immunodeficiency can be tremendously helpful in ensuring that school staff fully engage with the child and participate in their daily care. Many people (including nurses and other staff) equate immunodeficiency with HIV infection, and it is useful to explain that CVID is not a transmittable disease. Age-appropriate education of other children can also prevent alienation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bullying.",
"      <span class=\"nowrap\">",
"       Parents/",
"      </span>",
"      caregivers often take the lead in these matters, although the clinician should initiate the discussion and help the caregivers chose the information to be shared.",
"     </li>",
"     <li>",
"      Our population of pediatric CVID patients has participated in a wide range of extracurricular activities. There may be a few situations in which a specific activity is not appropriate for a given patient (eg, a child with bronchiectasis should probably not spend significant time gardening with peat due to risk of Aspergillus exposure). However, in most cases, we encourage the children to pursue whatever they wish in terms of physical activities, pending consultation with general pediatricians, because of the psychosocial benefits and long-term good health habits, sports, and hobbies provide.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H301175\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The life span of children with CVID has been significantly lengthened since immune globulin replacement therapy became standard of care, and prognosis is good. Unfortunately, information about patients diagnosed in childhood is limited.",
"   </p>",
"   <p>",
"    Death during childhood from complications of CVID is extremely rare once immune globulin therapy is instituted. Quality of life improves as complications are appropriately managed. There is no evidence that patients diagnosed in childhood fare better or worse than those diagnosed later in life, provided diagnosis occurs before pulmonary structural issues develop. Those children diagnosed after irreversible pulmonary disease has developed may have a shorter life span, based upon findings in adults with CVID. However, specific data about children are lacking. Likewise, long-term outcome studies of patients with very low numbers of switched memory B cells or low T cell numbers have not yet been performed.",
"   </p>",
"   <p>",
"    The prognosis of CVID in all age groups considered together is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30457?source=see_link&amp;anchor=H31#H31\">",
"     \"Treatment and prognosis of common variable immunodeficiency\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10572449\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common Variable Immunodeficiency (CVID) is a heterogeneous disorder characterized by the inability of B cells to differentiate into plasma cells capable of secreting all immunoglobulin types. While CVID is often regarded as a disease of adults, it does affect children, and diagnosis in young children is difficult, particularly in children ages two to six years of age.",
"     </li>",
"     <li>",
"      Approximately 25 percent of all CVID patients present in childhood, with a peak in diagnosis around eight years of age. (See",
"      <a class=\"local\" href=\"#H10572319\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In all age groups, sinopulmonary infections and complications of infections are the most common presentation. However, children have more problems with ear infections, and certain disorders, such as autoimmune cytopenias and allergic disease, are more prominent in pediatric series. In addition, children may present with failure to thrive. (See",
"      <a class=\"local\" href=\"#H10572368\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of CVID is based upon the findings of hypogammaglobulinemia, defective antibody formation (ie, vaccine response), and exclusion of other causes of antibody deficiency. Diagnosis in young children is difficult, because there are several causes of hypogammaglobulinemia that must be excluded and because response to polysaccharide antigens is normally weak in young children. Definitive diagnosis may not be possible until the child has undergone serial evaluations over a period of years. (See",
"      <a class=\"local\" href=\"#H10572433\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H650981\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of CVID is similar in adults and children. Important aspects include immune globulin replacement, avoidance of infection, monitoring of pulmonary status, and vigilance for known associated disorders, such as cytopenias. Issues that are of special importance in children include monitoring of physical and emotional development, early intervention for psychosocial and educational problems, and attention to cumulative radiation exposure resulting from radiologic studies. (See",
"      <a class=\"local\" href=\"#H10572441\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/1\">",
"      Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/2\">",
"      Mart&iacute;n-Nalda A, Soler-Palac&iacute;n P, Espa&ntilde;ol Bor&eacute;n T, et al. [Spectrum of primary immunodeficiencies in a tertiary hospital over a period of 10 years]. An Pediatr (Barc) 2011; 74:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/3\">",
"      Urschel S, Kayikci L, Wintergerst U, et al. Common variable immunodeficiency disorders in children: delayed diagnosis despite typical clinical presentation. J Pediatr 2009; 154:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/4\">",
"      Yong PL, Orange JS, Sullivan KE. Pediatric common variable immunodeficiency: immunologic and phenotypic associations with switched memory B cells. Pediatr Allergy Immunol 2010; 21:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/5\">",
"      Ogershok PR, Hogan MB, Welch JE, et al. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol 2006; 97:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/6\">",
"      Rudge P, Webster AD, Revesz T, et al. Encephalomyelitis in primary hypogammaglobulinaemia. Brain 1996; 119 ( Pt 1):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/7\">",
"      Touw CM, van de Ven AA, de Jong PA, et al. Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol 2010; 21:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/8\">",
"      van de Ven AA, van Montfrans JM, Terheggen-Lagro SW, et al. A CT scan score for the assessment of lung disease in children with common variable immunodeficiency disorders. Chest 2010; 138:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/9\">",
"      Wilson NW, Daaboul J, Bastian JF. Association of autoimmunity with IgG2 and IgG4 subclass deficiency in a growth hormone-deficient child. J Clin Immunol 1990; 10:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/10\">",
"      Bl&uuml;mel P, Eibl M. [Growth hormone therapy in STH deficiency with immunologic deficiency and chromosome fragility]. Monatsschr Kinderheilkd 1992; 140:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/11\">",
"      van Bilsen K, Driessen GJ, de Paus RA, et al. Low level IGF-1 and common variable immune deficiency: an unusual combination. Neth J Med 2008; 66:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/12\">",
"      Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/13\">",
"      Sneller MC, Strober W, Eisenstein E, et al. NIH conference. New insights into common variable immunodeficiency. Ann Intern Med 1993; 118:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/14\">",
"      Khodadad A, Aghamohammadi A, Parvaneh N, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007; 52:2977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/15\">",
"      Sava��an S, Warrier I, Buck S, et al. Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans' syndrome. Clin Immunol 2007; 125:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/16\">",
"      Filipovich AH, Heinitz KJ, Robison LL, Frizzera G. The Immunodeficiency Cancer Registry. A research resource. Am J Pediatr Hematol Oncol 1987; 9:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/17\">",
"      Kersey JH, Shapiro RS, Filipovich AH. Relationship of immunodeficiency to lymphoid malignancy. Pediatr Infect Dis J 1988; 7:S10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/18\">",
"      Cunningham-Rundles C, Cooper DL, Duffy TP, Strauchen J. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol 2002; 69:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/19\">",
"      Narula S, LaRosa DF, Kamoun M, et al. Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 2007; 98:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/20\">",
"      Vetrie D, Vorechovsk&yacute; I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/21\">",
"      Lopez Granados E, Porpiglia AS, Hogan MB, et al. Clinical and molecular analysis of patients with defects in micro heavy chain gene. J Clin Invest 2002; 110:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/22\">",
"      Sala Cunill A, Soler-Palac&iacute;n P, Mart&iacute;n De Vicente C, et al. [Common variable immunodeficiency. Prognostic factors for lung damage]. Med Clin (Barc) 2010; 134:64.",
"     </a>",
"    </li>",
"    <li>",
"     file://cis.execinc.com/edibo/PublicDirectory (Accessed on August 24, 2012).",
"    </li>",
"    <li>",
"     file://aaaai.execinc.com/find-an-allergist/ (Accessed on August 24, 2012).",
"    </li>",
"    <li>",
"     file://www.acaai.org/allergist/Pages/locate_an_allergist.aspx (Accessed on August 24, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/26\">",
"      van de Ven AA, van Montfrans JM. Clinical complications in pediatric CVID are not restricted to patients with severely reduced class-switched memory B cells. Pediatr Allergy Immunol 2011; 22:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/27\">",
"      van de Ven AA, van de Corput L, van Tilburg CM, et al. Lymphocyte characteristics in children with common variable immunodeficiency. Clin Immunol 2010; 135:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/28\">",
"      Kutukculer N, Gulez N. The outcome of patients with unclassified hypogammaglobulinemia in early childhood. Pediatr Allergy Immunol 2009; 20:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/29\">",
"      Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005; 25:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/30\">",
"      Mah&eacute;vas M, Le Page L, Salle V, et al. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol 2006; 81:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/31\">",
"      El-Shanawany TM, Williams PE, Jolles S. Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab. J Clin Pathol 2007; 60:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/32\">",
"      Kim JJ, Thrasher AJ, Jones AM, et al. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency. Br J Haematol 2007; 138:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/45/38617/abstract/33\">",
"      Piazza-Waggoner C, Adams CD, Cottrell L, et al. Child and caregiver psychosocial functioning in pediatric immunodeficiency disorders. Ann Allergy Asthma Immunol 2006; 96:298.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16132 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-199.231.185.123-7C4F869326-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38617=[""].join("\n");
var outline_f37_45_38617=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10572449\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10572287\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10572295\">",
"      DEFINITION AND CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10572304\">",
"      Definition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10572319\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10572368\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2154824\">",
"      Recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10572385\">",
"      Pulmonary manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10572393\">",
"      Allergic diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10572401\">",
"      Failure to thrive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10572409\">",
"      Gastrointestinal problems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10572417\">",
"      Autoimmune disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2154908\">",
"      - Evans syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10572425\">",
"      Malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2154993\">",
"      Neurodegenerative diseases or encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10572433\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1529357\">",
"      Indications for referral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2155544\">",
"      Immunoglobulin levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2155585\">",
"      Antibody function studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2335351\">",
"      Other testing at the time of diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2350217\">",
"      - B cell studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2350224\">",
"      - T cell studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1132162\">",
"      - Genetic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2350472\">",
"      - Endocrine studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4034194\">",
"      Diagnostic uncertainties",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1396504\">",
"      - Periodic reassessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H650981\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2392324\">",
"      Primary hypogammaglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2392650\">",
"      - Agammaglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2392331\">",
"      - Transient hypogammaglobulinemia of infancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2392599\">",
"      Selective antibody deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2392606\">",
"      IgG subclass deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2392345\">",
"      Hyper-IgM syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2392352\">",
"      X-linked lymphoproliferative disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2392359\">",
"      Combined immunodeficiency disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10572441\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2155614\">",
"      Immune globulin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2155607\">",
"      Evaluation of illnesses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2155635\">",
"      Monitoring pulmonary status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4034135\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2350864\">",
"      Autoimmune cytopenias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2155628\">",
"      Psychosocial and educational issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4034085\">",
"      General supportive care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H301175\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10572449\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/16132\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16132|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/4/33870\" title=\"picture 1\">",
"      Lymphoid hyperplasia TI Endosc",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16132|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/12/33997\" title=\"table 1\">",
"      Pneu vaccine antibody testing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/52/21321?source=related_link\">",
"      Agammaglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24328?source=related_link\">",
"      Assessing the immunologic response to vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/59/18362?source=related_link\">",
"      Autoimmune hemolytic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=related_link\">",
"      Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/58/40873?source=related_link\">",
"      Combined immunodeficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/82?source=related_link\">",
"      Diagnosis of growth hormone deficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/6/23656?source=related_link\">",
"      Flow cytometry for the diagnosis of primary immunodeficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/32/21001?source=related_link\">",
"      Hyperimmunoglobulin M syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/60/13258?source=related_link\">",
"      IgG subclass deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/29/9688?source=related_link\">",
"      Pathogenesis of common variable immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38233?source=related_link\">",
"      Poor weight gain in children older than two years of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7561?source=related_link\">",
"      Secondary immune deficiency due to miscellaneous causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/0/29706?source=related_link\">",
"      Secondary immune deficiency induced by drugs and biologics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17209?source=related_link\">",
"      Selective antibody deficiency with normal immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/36/41544?source=related_link\">",
"      Transient hypogammaglobulinemia of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30457?source=related_link\">",
"      Treatment and prognosis of common variable immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/53/37721?source=related_link\">",
"      Treatment and prognosis of immune (idiopathic) thrombocytopenic purpura in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/0/14345?source=related_link\">",
"      Treatment of growth hormone deficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=related_link\">",
"      Wiskott-Aldrich syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/38/33384?source=related_link\">",
"      X-linked lymphoproliferative disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_45_38618="Fixed drug eruption arm";
var content_f37_45_38618=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F52192%7EDERM%2F86671%7EDERM%2F67733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F52192%7EDERM%2F86671%7EDERM%2F67733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fixed drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fixed drug eruption. An oval lesion occurred at the identical site where it had occurred previously. In both episodes, the rash emerged after this patient ingested a sulfonamide antibiotic. Note the eroded blister in the center of the lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fixed drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    On dark skin, fixed drug eruption presents as a dark brown/slate-gray patch.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fixed drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple violaceous round&nbsp;plaques are present on the skin. A central bulla is present in one lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from:",
"     <a href=\"file://www.visualdx.com\" target=\"_blank\">",
"      www.visualdx.com",
"     </a>",
"     . Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38618=[""].join("\n");
var outline_f37_45_38618=null;
var title_f37_45_38619="Smallpox vaccine complications";
var content_f37_45_38619=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Complications of smallpox vaccination after 14.2 million doses in the 1968 United States National Surveillance Study",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary (N = 5.6 million)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Secondary (N = 8.6 million)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contacts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total complications",
"       </td>",
"       <td>",
"        418 (6 deaths)",
"       </td>",
"       <td>",
"        40 (2 deaths)",
"       </td>",
"       <td>",
"        114 (1 death)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postvaccine encephalitis",
"       </td>",
"       <td>",
"        16 (4 deaths)",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Progressive vaccinia (vaccinia necrosum)",
"       </td>",
"       <td>",
"        5 (2 deaths)",
"       </td>",
"       <td>",
"        6 (2 deaths)",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eczema vaccinatum",
"       </td>",
"       <td>",
"        58",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        60 (1 death)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Generalized vaccinia",
"       </td>",
"       <td>",
"        131",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Accidental inoculation",
"       </td>",
"       <td>",
"        142",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        44",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other",
"       </td>",
"       <td>",
"        66",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Lane JM, Ruben FL, Neff JM, Millar JD. N Engl J Med 1969; 281:1201.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38619=[""].join("\n");
var outline_f37_45_38619=null;
var title_f37_45_38620="Longitudinal relaxation in MRI";
var content_f37_45_38620=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Longitudinal relaxation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 321px; height: 199px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Evolution of magnetization after a 180&deg; radiofrequency excitation. Magnetization is flipped 180&deg; at time zero (t=0). Magnetization relaxes toward equilibrium as energy is lost. Magnetization recovery is 63 percent complete at time t=T1 and 100 percent complete at time t&gt;&gt;T1.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38620=[""].join("\n");
var outline_f37_45_38620=null;
var title_f37_45_38621="AV nodal conduction in EAVNC";
var content_f37_45_38621=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Patterns of AV nodal conduction in EAVNC",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The atrial to His (A-H) interval, which represents atrioventricular (AV) nodal conduction time, is plotted against the pacing cycle length or A1-A2 interval. The normal response is a progressive lengthening of the AH interval with a shorter pacing cycle length (ie, faster heart rate), a phenomenon known as decremental conduction. In patients with enhanced AV nodal conduction (EAVNC), four patterns of response are seen. Type I represents reduced AH interval prolongation in response to atrial pacing; type II shows an initial increase in the AH interval followed by a plateau and then a further increase in the AH interval with faster pacing rates; type III reveals no change in AH interval in response to increasing atrial pacing rates; type IV represents no change in AH interval until the pacing cycle lengths are very short, thereby resulting in marked AH prolongation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38621=[""].join("\n");
var outline_f37_45_38621=null;
var title_f37_45_38622="High fiber diet 1 PI";
var content_f37_45_38622=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F57015%7EPI%2F67749%7EPI%2F76458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F57015%7EPI%2F67749%7EPI%2F76458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    High-fiber diet guidelines for children, part 1",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Why we need fiber",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fiber helps children and adults have regular bowel movements and helps prevent constipation and other health problems. Dietary fiber helps keep the bowel and digestive tract healthy and enhances feelings of fullness after eating.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       How much fiber is needed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       The recommended intake for dietary fiber is 14 grams/1000 kcals in the diet.* For children, this translates to an intake of about 20 grams/day in early childhood, rising to 29 grams/day for adolescent girls and young women, and 38 grams/day for adolescent boys and young men. To find out the number of grams of fiber in a certain food, read the label, or see the foods listed in this table. High-fiber foods contain 3 or more grams of fiber per serving.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       How to help your child eat more fiber",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       A high-fiber diet should be a balanced diet with foods fromall the food groups. The most common sources of fiber are whole grain breads and cereals, legumes and nuts, fruits, and vegetables. Include these in your child's balanced diet:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Offer your child a variety of high-fiber foods during the day rather than giving only one or two high fiber foods.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Mix a high-fiber cereal with a cereal your child likes.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Offer fresh fruits with the skin on. Prunes and pears act as natural laxatives.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Offer raw vegetables, such as carrots, jicama, or cherry tomatoes for snacks and with meals. Offer a salad with dark green lettuce each day.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Use whole-wheat bread or white bread with added fiber, brown rice, whole-wheat crackers, bran muffins, barley, bran cereals, or oatmeal. Use less refined white flour bread, cereal, and other starches.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Offer 4 to 6 ounces of prune, apple, orange, or pear juice each day. Remember that fresh fruit has more fiber than juice.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Offer snacks that have fiber, like granola bars, fruit bars, fig cookies, or popcorn (after age 3 years).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Help your child develop a taste for bran. Try to include 2 to 4 tablespoons of some form of bran each day.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Add nuts or seeds to breads and salads, or use them as a snack. This is not recommended for children younger than three years.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Preventing constipation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       If your child is constipated, follow the dietary guidelines above. Also, encourage your child to drink at least 4 to 8 cups (32 to 64 ounces) of fluid per day, preferably water, low-fat milk, and low-sugar decaffeinated beverages.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These guidelines are continued.",
"    <div class=\"footnotes\">",
"     * Dietary Guidelines for Americans 2005. US Department of Health and Human Services. Available at: www.health.gov/dietaryguidelines/pubs.htm.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    High-fiber diet guidelines (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       High-fiber diet guidelines from Texas Children's Hospital",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       Read labels on foods, and look for 3 or more grams of fiber per serving. Eat 3 or more servings each day of breads and cereals made from whole grains and bran. Eat 5 or more servings each day of fruits and vegetables, including beans. It is important to increase water in the diet when you increase fiber.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       Meat, poultry, fish, milk, milk products, and fats such as oil, margarine, and salad dressings do not normally have fiber, but it is important to include these in your child's diet to provide a complete balance of foods.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       High-fiber dry cereals",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       One serving equals 1/2 cup.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Cereal",
"      </td>",
"      <td class=\"subtitle2\">",
"       Fiber, grams",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fiber One",
"      </td>",
"      <td>",
"       13",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       100 percent Bran",
"      </td>",
"      <td>",
"       12",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       All Bran",
"      </td>",
"      <td>",
"       12",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bran Buds",
"      </td>",
"      <td>",
"       12",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Kellogg's Complete Bran Flakes",
"      </td>",
"      <td>",
"       5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Grape Nuts",
"      </td>",
"      <td>",
"       5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Raisin Bran",
"      </td>",
"      <td>",
"       3 to 5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cracklin' Oat Bran",
"      </td>",
"      <td>",
"       4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       100 percent Whole Grain Wheat Chex",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fruit and Fibre",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Great Grains",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Frosted Mini Wheats",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Kellogg's Low-Fat Granola",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cheerios",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Wheaties",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       High-fiber vegetables (cooked unless indicated)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       One serving of vegetables is 1/2 to 1 cup.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Vegetable",
"      </td>",
"      <td class=\"subtitle2\">",
"       Fiber, grams",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pinto, kidney, black, lima beans (1/2 cup)",
"      </td>",
"      <td>",
"       4 to 7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sweet potato (1 medium)",
"      </td>",
"      <td>",
"       4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lentils (1/2 cup)",
"      </td>",
"      <td>",
"       4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Jicama (1/2 raw)",
"      </td>",
"      <td>",
"       3 to 4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Baked potato with skin (medium)",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Corn (1/2 cup)",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Peas (1/2 cup)",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Broccoli (1/2 cup)",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cabbage (1/2 cup)",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Spinach (1/2 cup)",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cauliflower (3/4 cup)",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carrots (1 medium raw or 1/2 cup cooked)",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       High-fiber fruits",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       One serving of fruit is usually one piece.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Fruit",
"      </td>",
"      <td class=\"subtitle2\" colspan=\"3\">",
"       Fiber, grams",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pear",
"      </td>",
"      <td colspan=\"3\">",
"       4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Strawberries (one cup)",
"      </td>",
"      <td colspan=\"3\">",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Apple (with skin)",
"      </td>",
"      <td colspan=\"3\">",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dried fruits like raisins (3 tablespoons)",
"      </td>",
"      <td colspan=\"3\">",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Papaya",
"      </td>",
"      <td colspan=\"3\">",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Peach (fresh)",
"      </td>",
"      <td colspan=\"3\">",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Plums (2)",
"      </td>",
"      <td colspan=\"3\">",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mango",
"      </td>",
"      <td colspan=\"3\">",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nectarine",
"      </td>",
"      <td colspan=\"3\">",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Avocado (1/2 medium)",
"      </td>",
"      <td colspan=\"3\">",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tomato (1 medium)",
"      </td>",
"      <td colspan=\"3\">",
"       2",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These guidelines are continued.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sample menu for a high-fiber diet for children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Sample menu (for a 7- to 10-year old)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Breakfast",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 cup instant oatmeal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 slice whole-grain toast",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 teaspoon margarine or butter",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 medium banana",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 ounces skim milk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Lunch",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Turkey sandwich on whole-grain bread",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 teaspoon mustard",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 ounce whole-grain chips",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 medium apple",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 baby carrots",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Bottled water",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Snack 1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       4 fig bar cookies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 ounces skim milk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Dinner",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       3 ounces pork tenderloin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1/2 cup mashed sweet potatoes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1/2 cup green beans",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 small whole-grain roll",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       2 teaspoons margarine or butter",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 ounces skim milk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Snack 2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1/2 cup vanilla bean ice cream",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38622=[""].join("\n");
var outline_f37_45_38622=null;
var title_f37_45_38623="Pneumococcal adherence EM";
var content_f37_45_38623=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumococcal adherence",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 308px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scanning electron micrograph of a pneumococcus attaching to a human lung cell. Pneumococci rarely make pili or fimbriae in order to adhere to cells. Rather, they decorate their cell wall with proteins that bind to human cell carbohydrates or the receptor for platelet activating factor, creating direct contact between the bacteria and the host cell over a large area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Elaine Tuomanen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_45_38623=[""].join("\n");
var outline_f37_45_38623=null;
